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Abstract
Amines, in particular a-chiral amines, are highly valuable products and key 
intermediates of great importance in chemical synthesis. Therefore, developing 
new methods for the synthesis of optically pure amines is an important task in 
organic chemistry. Chapter 1 presents a general introduction to recent 
development in the asymmetric reduction of imino bonds, focusing on the metal- 
catalysed asymmetric hydrogenation of imines. This introduction will be 
followed by the presentation of several methodologies for the synthesis of 
amines, with an emphasis on chiral ammes.
Chapter 2 describes the synthesis of ct-chiral amines by direct reductive 
amination of ketones using H2 as the hydrogen source. The catalyst is formed by 
the combination of a chiral h'(III)-diamine complex and a chiral phosphate 
counteranion. We believe that the catalysis is brought about by the cooperative 
action of the metal and the counteranion, the former activating H2 whilst the 
latter ion-pairing with the protonated substrate.
Chapter 3 describes the synthesis and characterization of several 
cyclometallated Ir(III)-imine complexes, and their application to imine 
hydrogenation. These cyclometallated iridium complexes are highly active for 
imine hydrogenation. Kinetic studies suggest that the hydrogen coordination to 
the metal centre is the rate-determining step.
Chapter 4 is a natural extension of Chapter 3. Chiral cyclometallated iridium 
complexes containing a chiral oxazoline ligand were applied to the asymmetric 
hydrogenation of imines using an A-benzylimine as a model substrate. The 
catalysts provide enantioselectivity up to 78% ee.
Chapter 5 presents the synthesis of p-chiral amines by a metal- and organo- 
catalysed hydroaminomethylation pathway. Styrene is selectively 
hydroformylated to tire corresponding a-branched aldehyde with a Rli(f) 
complex, and subsequent reductive amination occurs with Hantzsch ester as the 
hydrogen source and a chiral phosphoric acid as the organocatalyst. Moderate 
yields and good enantioselectivities have been obtained.
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Chapter 1: Introduction
Chapter 1 
Introduction
1.1 Chiral amines
Amines, in particular a-chiral amines, are highly valuable products or key 
intermediates of great importance in organic chemistry. They are present in a 
vast number of bioactive compounds, with activities of relevance to 
agrochemical and pharmaceutical industries, and are used as versatile chiral 
ligands,1'2 auxiliaries3 or catalysts4 in asymmetric catalysis.
Figure 1.1 outlines examples of chiral amines of commercial or academic 
interest. Chiral amine 1 is a building block for the herbicide metolachlor.5 
Tamsulosin, the active ingredient in the blockbuster drug Flomax, can improve 
symptoms in patients with chronic prostatitis.6 Additionally, chiral cyclic 
amines, such as the tetrahydro-p-carboline moiety, frequently appear in natural 
products and biologically important molecules, like tubulosine displaying high 
antitumor activity.7
Chiral amines are widely present in asymmetric catalysis, displaying a 
variety of roles, hi the field of asymmetric organocatalysis, amino catalysts 
have proven to be tremendously useful.8'9 For instance, the natural amino acid 
L-proline has been shown to be an excellent catalyst for asymmetric 
intramolecular and intermolecular aldol reaction, and proceeds via an enamine 
intermediate.10 hi the role of ligand, a variety of monosulfonylated 
diphenylethylenediamiiies (DPEN) have been widely reported in transition 
metal complexes for asymmetric catalysis.11 Wliitesell developed the use of C2- 
symmetrical chiral amines as chiral auxiliaries in 1977,12 and they have been
1
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extensively used since then.13-14 For instance, diamine 2 performs asymmetric 
lactonisation reactions with high enantioselectivity.15
HN
(S)-Metolachlor 
MeO OMe
cvf
H 0H
L-Proline
Figure 1.1: Examples of chiral amines used in agrochemical and pharmaceutical industries and
in asymmetric catalysis.
1.2 Methods for chiral amine synthesis
Due to the importance of chiral amines as intennediates in pharmaceutical 
and agrochemical industries, several strategies have been developed for the 
synthesis of enantiomerically pure amines.16 Here, an outline of some of the 
most successful methods, from a practical point of view, is presented.
Amine enantiomers can be separated from a racemic mixture by formation 
and crystallisation of diastereomeric salts with chiral carboxylic acids, such as
2
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((i?)-mandelic acid 3 and (7?,i?)-tartaric acid 4. Although the chiral carboxylic 
acid tends to be relatively inexpensive and may be recycled, a maximum of 
50% can only be obtained for the desired enantiomer (Scheme 1.1).16
OH
Scheme 1.1: Crystallization of diastereomeric salts with chiral carboxylic acids.
Transamination is a biotechnological process developed at Celgene in the
1980s for the synthesis of chiral amines.16 An amino group is transferred to a
prochiral ketone in the presence of enantioselective transaminases and the 
cofactor pyridoxal phosphate 5 (Scheme 1.2). Although both R~ and ^-selective 
transaminases have been developed, these enzymes are only effective in 
aqueous solution or in a mixture of organic-aqueous solution; so for those 
amine products only slightly soluble in water, very low concentrations of 
products are accomplished.
3
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Scheme 1.2: Example of transamination dependent on cofactor 5.
Both the enantioselective hydrolysis of amides and kinetic racemate 
resolution by acylation of amines have been reported in the literature as 
potential industrial biotechnological process for the synthesis of chiral amines, 
although the acylation has proven to be more successful (Scheme 1.3). Fu and 
co-workers developed a ferrocene derivative complex as the acylation catalyst 
for a series of aryl primary amines.17 However, the combination of biocatalysts 
with acylation agents is still dominant on this kinetic resolution. Once again, 
the main drawback of these processes is the maximum yield being only 50% 
for the desired enantiomer.
Scheme 1.3: General scheme for enantioselective hydrolysis and synthesis of amides.
4
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Asymmetric catalysis has also played an important role in the synthesis of 
chiral amines, although it is still in its infancy from an industrial point of view. 
Different approaches to chiral amines have been reported involving a chiral 
catalyst, e.g. Mannich reaction, hydrosilylation of imines, etc. However, the 
asymmetric catalytic hydrogenation of ON double bonds has not been 
extensively developed in industry,16 as there are only a few good catalysts 
reported {vide infra) (Scheme 1.4). This is partly due to difficulties in the 
synthesis and isolation of the imine, and cleavage of the frequently encountered 
A-aryl group to give primary amines.
R
N .r3A, [M], [H] Reduction
hn'R3
Rf^R2
NH2___ ^ y
Cleavage R-i R2
Scheme 1,4: General method for the imine reduction leading to primary amine.
hi comparison with that of ketone and olefin, the asymmetric 
hydrogenation of imines has been less explored. The main problems are:
- The net hydrogenation of C=N and OO (~ -60 kJ/mol) is slightly less 
exothermic than C=C bond (~ -130 kJ/mol).18
- In case of substrate coordination to the metal centre, C=N and C=0 
bonds tend to exhibit the rj1-binding mode through the lone pair on the N or O 
atom, whereas olefins tend to prefer Ti2~binding. rj1-Binding results in a less 
effective orbital overlap with the metal centre.
- hi the case of imine hydrogenation, the amine product may coordinate to 
the metal complex, leading to a poisoning of the catalyst.
5
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- The easy interconversion between E- and Z-isomers in solution for 
acyclic imines poses a problem for the achievement of high 
enantioselectivity.19
Nevertheless, the asymmetric hydrogenation of imines represents an eco- 
friendly, economical and effective method for the production of optically 
active amines. Therefore, the main work of this thesis has been focused on the 
review and development of highly selective metal catalysts for the synthesis of 
chiral amines by reduction of ON double bonds.
1.3 Metal-catalysed asymmetric hydrogenation of imines
Although catalytically highly enantioselective hydrogenation of imines is 
still considered a challenging endeavour, the recent literature presents a wide 
variety of transition metal complexes for asymmetric imine 
hydrogenation,16,18’20'23 where iridium complexes have shown to be the best 
choice in terms of enantioselectivity.22 However, there are still two main issues 
that need to be addressed: the improvement of the substrate scope and the use 
of cheap, non-toxic metals for the metal catalysts.
1.3.1 Chiral rhodium catalysts
The first example of enantioselective imine hydrogenation was reported by 
Scorrano in 1975.24 A Rh-DIOP complex [DIOP: 2,2-Dimethyl-4,5- 
(diphenylphosphino)dimethyl)dioxolane)] was able to reduce alkenes, ketones 
and imines under comparable conditions. However, for imines only one 
substrate was shown and the enantioselectivity was very low (22% ee) 
(Scheme 1.5).
6
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22% ee
\ / 
Ph2P PPh2
DIOP
Scheme 1.5: First enantioselective inline hydrogenation.
This low selectivity was not smpassed until the early 1990s, when Bakos 
reported a water-soluble rhodium catalyst.25 The reaction takes place in a H20- 
AcOEt two-phase solvent system, with 1 mol% catalyst loading, 70 bar H2 at 
20 °C and an excellent 96% ee was reported, although only a single example 
was presented (Scheme 1.6).
Scheme 1.6: Water-soluble catalyst for inline hydrogenation.
Osborn showed an enhancement of the enantioselectivity in the presence 
of reverse micelles formed by AOT (AOT: sodium bis(2-ethylhexyl) 
sulfosuccinate) for asymmetric hydrogenation of inline 6 with the [Rh((15',»S)-
7
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BDPP)(NBD)]C104 catalyst (NBD: norbornadiene) (Figure 1.2).26 It is well- 
known that the use of an organized medium can have pronounced effects on 
certain transition-metal catalysed reactions,27 and the increase in 
enantioselectivity had been previously shown in other catalytic 
hydrogenations,28 The reduction takes place in benzene, under 70 bar H2 at 25 
°C, affording an excellent enantioselectivity (89% ee).
9 (S,S)-BDPP
Figure 1.2: Ligands applied for the Rh-catalysed hydrogenation of 6.
Bonier and co-workers reported the study of a range of diphosphine and 
diphosphinite ligands for Rh-catalysed hydrogenation of 6.29 An initial 
screening with achiral diphosphine ligands showed that seven-membered Rli(I) 
chelate was the most effective, diarylphosphines were superior to di alkyl 
phosphines, and the addition of TsOH had a positive effect on the rate of the 
reaction. Upon moving to asymmetric hydrogenation, they continued their 
studies based on these initial results. Neutml precatalysts had better activity 
than the analogue cationic complexes. For the range of diphosphine ligands 
tested, very low enantioselectivity were reported (up to 27% ee). Surprisingly, 
rhodium complexes of chiral diphosphinites showed an excellent reactivity and 
good enantioselectivity, with cationic species being more effective. The best 
result was obtained with [Rh(9)COD]BF4 (COD: 1,5-cyclooctadiene) (Figure
1.2).
8
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Our group reported tire asymmetric hydrogenation of 3,4- 
dihydroisoquinolines and 3,4-diliydro-6,7-dimethoxyisoquinolines with a 
cationic Rh-TsDPEN catalyst. Excellent yields and enantioselectivities were 
shown under 20 bar H2 and 20 °C in CH2C12“H20 (Scheme 1.7).30 The key to 
the success of 10 lies in its bulky counter-ion, SbFe’. Smaller and coordinating 
anions exert a dramatically inhibiting effect on the catalysis. Thus, chloride 
complexes lead to a much lower activity; This is probably due to unfavoured 
anion dissociation from the Rh(III) catalyst, which retards H2 coordination. To 
our knowledge, this is the most effective rhodium catalyst for asymmetric 
hydrogenation of cyclic imines to date.
'2
10
Scheme 1.7: Rh-TsDPEN for asymmetric reduction of cyclic imines.
1.3.2 Chiral iridium catalysts
The first example of enantioselective iridium-catalysed imine 
hydrogenation was reported by Spindler and co-workers in 1990.31 They tested 
a series of diphosphine ligands with [Ir(COD)Cl]2, forming the catalyst in situ. 
The best results were obtained when (S^-BDPP was used as the ligand, where 
84% ee was obtained for the reduction of imine 11, at 1 mol% catalyst loading, 
20 bar H2 and 0 °C (Scheme 1.8). There is a strong halogen effect, as addition
9
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of 2 eq of iodide lead to an increase of both activity and enantioselectivity. The 
same would be observed for some other catalysts in the following years.32'33 A 
bulky TV-aryl group was required in order to obtain good enantioselectivity, 
probably due to restricted movement of the imino group.
11 84% ee
Scheme 1.8: First example of Ir-catalysed asymmetric imine hydrogenation.
Simultaneously and independently, Osborn and co-workers reported the 
discovery of a series of iridium(III)-diphosphine-monohydrido complexes 12 
(Figure 1.3) and application to imine hydrogenation, DIOP and BDPP being 
superior over other diphosphine ligands.34 Although lower catalyst loadings 
were used compared to Spindler’s work (0.2-0.05 mol%), the 
enantioselectivities were also lower, in the range of 22-63% ee for 
hydrogenation of 11.
12
Figure 1.3: Iridium-diphosphine catalyst developed by Osbom.
Due to these initial studies with DIOP for Ir-catalysed imine 
hydrogenation, other groups investigated derivatives of DIOP for the same
10
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reduction. Zhang and co-workers extended this ligand family to ligand 13 that 
possesses an acyclic backbone.33 This ligand was applied for Ir-catalysed 
hydrogenation of cyclic imine 14 (Scheme 1.9). With 1 mol% catalyst and 10 
mol% I2 as an additive, 85% ee was obtained at 0 °C in CH2CI2 under ~60 bar 
H2. Under the same conditions, only 29% ee was obtained with the simple 
DIOP.
H
85% ee
14
PPh2
PPh2
13
Scheme 1.9; Modified DIOP for asymmetric imine hydrogenation.
A modified DIOP ligand was also applied by Kanai for the synthesis of a 
key intermediate 16 for the antibacterial agent levofloxacin.35 He reported the 
asymmetric hydrogenation of 15 by 1 mol% an Ir-MOD-DIOP catalyst at -10 
°C under 40 bar H2 in benzene/MeOH in the presence of 2 mol% Bil3 (Scheme 
1.10).36
F
F
15 16
90% ee
MOD-DIOP
Scheme 1.10: Synthesis of key intermediate for levofloxacin.
11
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A wide range of chiral 1,4-diphosphine ligands have been applied for 
rhodium and iridium-catalysed imine hydrogenation (vide supra), although the 
selectivity is significantly variable. To date, the most effective 1,4 diphosphine 
is most certainly DDPPM.37 A range of vV-aryl acyclic imines were 
hydrogenated with excellent enantioselectivities with 1 mol% of catalyst, at 
ambient pressure and room temperature (Scheme 1.11). Interestingly, the 
increase of hydrogen pressure had a negative effect on both the activity and 
selectivity, probably due to the formation of inactive iridium(III) hydride 
clusters. This type of complex is ineffective for A-benzyl acyclic imines and 
cyclic imines.
1 mol% [lr(DDPPM)]+,
CHjrM u
DDPPM
Scheme 1.11: Ir-DDPPM catalyst for asymmetric acyclic imine hydrogenation.
BINAP and its derivatives also showed good performance for Ir-catalysed 
hydrogenation of imines. Tani found the iridium(I)-TolBINAP catalytic system 
to be effective for the hydrogenation of acyclic imine 6 and cyclic imine 17 
(Scheme 1.12).38 Good enantioselectivities were reported (68 and 90% ee, 
respectively) at 1 mol% catalyst, 60 bar H2 and 20 °C in MeOH. Interestingly, 
addition of 5 mol% of a protic amine, such as benzylamine, increased both the 
catalytic activity and the enantioselectivity.39 As a result, the catalytic system
12
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without the protic amine was much less effective, with enantioselectivity no 
higher than 23%.
(S)-TolBINAP: Ar: p-CHaC^ 
(S)-BINAP: Ar: C6H5
Scheme 1.12: Asymmetric hydrogenation of 17 with Ir-TolBlNAP catalyst.
Morimoto also applied an iridium(I)-BINAP system (Scheme 1.12) for the 
asymmetric hydrogenation of dihydroisoquinoline 18, a key step towards the 
synthesis of alkaloid (S)-calycotomine (Figure 1.4).40 The reaction was carried 
out in a MeOH/toluene mixed solvent, at 0.5 mol% catalyst loading in the 
presence of 1 mol% phthalimide under 100 bar H2 and 20 °C; good yield and 
enantioselectivity were reported.
Meorn^
OH
(S)-calycotomine
Figure 1.4: Imine 18 as key intermediate for alkaloid (S^-calycotomine.
13
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Later in the last decade, Pfaltz and co-workers reported the 
enantioselective inline hydrogenation with cationic iridimii-phosphino 
oxazoline complexes at 4 mol% catalyst, 100 bar H2 and 23 °C.41 Good 
activities and enantioselectivities were obtained for derivatives of //-benzyl and 
//-aryl phenyl methyl imines. As observed with other catalysts where 
enantioselectivity was controlled by steric effects in the imine, ortho- 
substituted //-benzyl imines lead to lower enantioselectivities (from 76 to 35% 
£?<?). Dialkyl and cyclic imines show a significant decrease in reactivity and 
enantioselectivity or are just unreactive (Scheme 1.13).
R HN
19
Scheme 1.13: Asymmetric hydrogenation of imines with cationic Ir-phosphine oxazoline
catalyst.
Phosphine oxazolines (PHOX) possess a modular structure that allows 
extensive variation of the structure in the backbone, oxazoline and phosphorus 
substituents. For this reason, several groups have studied different ligands from 
this PHOX family and applied them for Ir-catalysed imine hydrogenation in 
order to enhance the application range of this transformation. For example, 
Cozzi prepared some PHOX ligands with heterocyclic frameworks
14
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(HetPHOX), which provides higher stability to the ligands. A series of cationic 
Ir-HetPHOX complexes were formed and applied to hydrogenation of an 
unfimctionalised olefin and imine 20.42 For the latter, complete reaction and 
86% ee were obtained after 4 hours when ligand 21 was used (Scheme 1.14), 
with 1 mol% catalyst under 50 bar H2 and room temperature.
Scheme 1.14; P,N-ligaiid for asymmetric imine hydrogenation.
Zhou reported the synthesis of PHOX ligands bearing a spirobiindane 
backbone (SIPHOX), which is extremely rigid and bulky; then the cationic 
iridium complex was formed and applied in asymmetric hydrogenation of TV­
ary 1 acyclic imines.43 There was a clear match/mismatch effect between the 
chirality in the spirobiindane backbone and the oxazoline ring, the best 
combination being (S,R) configuration (Scheme 1.15). Excellent yields and 
enantioselectivities were reported at ambient hydrogen pressure and 10 °C in 
methyhe/V-butyl ether (MTBE) (Scheme 1.15).
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r\JL
Ar: 3,5-(Me)2C6H3
(S,R)-22
Scheme 1.15: Example of SIPHOX ligand for Ir-catalysed asymmetric imine hydrogenation.
More recently, Ding and co-workers extended this family of spiro PHOX 
ligands by developing the corresponding spiro[4,4]-l,6~nonadiene system 
(SpinPHOX) 23 (Scheme 1.16), and applied them for asymmetric imine 
hydrogenation.44 Forming a cationic Ir-complex, this type of catalysts 
surpassed Zhou’s Ir-SIPHOX in terms of activity and especially scope. A wide 
range of substrates were hydrogenated with excellent yields and 
enantioselectivities, including in particular the more challenging TV-alkyl 
imines. The reduction undergoes at ambient hydrogen pressure, 10 °C with 1 
mol% catalyst and complete conversion is achieved after only 8-12 hours 
(Scheme 1.16).
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1 mol% [lr-23]*, CH2CI2,
98% ee
23
Scheme 1.16: Example of //-alkyl imine hydrogenation with Ir-SpinPHOX.
Ill addition to the PHOX type ligands, several groups developed other P,N 
ligands for iridium-catalysed hydrogenation of imines. Pfaltz and co-workers 
synthesised a series of phosphinite-oxazoline ligands derived from serine45 and 
threonine46 and applied them to iridium-catalysed uiifunctionalised olefin 
hydrogenation. For those ligands derived from threonine, the hydrogenation of 
iV-aryl imine 20 was briefly investigated.46 The Ir-24 catalyst shows good 
activity, and the reaction goes to completion after 4 hours with 1 mol% catalyst 
under 50 bar H2 at room temperature; but good enantioselectivity is only 
reported with ligand 24 (80% ee) (Figure 1.5).
Ar: o-MeC6H4
24
Figure 1.5: Phosphinite-oxazoline ligand derived from threonine.
Ill the last decade, Pfaltz and co-workers synthesised a wide range of novel 
P,N ligands, applying them to hydrogenation of olefins.47 Very recently, they 
reinvestigated the asymmetric imine hydrogenation by applying the cationic Ir-
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P,N ligand complexes developed in their laboratory in the previous years. 
Three different chiral oxazoline-based P,N ligands, including some PHOX 
ligands, were identified as highly efficient for the enantioselective 
hydrogenation of iV-aryl imines from arylalkylketones (Figure 1.6).48 Only 0.5 
mol% catalyst is required to achieve completion after 6-8 hours, at a pressure 
of 5 bar H2 at -20 °C. Enantioselectivities in the range of 74-96% ee were 
reported.
Figure 1.6: Three most efficient Pfaltz P,N-ligands for asymmetric imine hydrogenation.
Blanc reported the application of aminophosphine-oxazoline ligands for Ir- 
catalysed enantioselective imine hydrogenation.49 These ligands are prepared 
from two optically active aminoacids; one provides the chiral oxazoline unit 
while the other one the chiral aminophosphine moiety. The cationic iridium 
complexes were then prepared and applied for imine hydrogenation of N- 
phenyl and 77-benzyl phenylmethyl imines. At the same time, Andersson 
reported a different class of chiral aminophosphine-oxazoline ligands for the Ir- 
catalysed asymmetric hydrogenation of iV-arylimines.50 At 0.5 mol% catalyst 
loading, 20 bar H2 and room temperature, good yields and excellent 
enantioselectivities were reported (83-90%). Low pressure (5 bar H2) and 
lower catalyst loading (0.05 mol%) can be applied without effect on the
18
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enantioselectivity, albeit with low activity. They then extended this work to the 
reduction of bulkier imines, such as imine 25, derived from 1 -indanone, where 
only moderate ee’s were obtained (Scheme 1.17).51
Scheme 1.17: Asymmetric hydrogenation of bulky imine 25.
Diphosphine ligands with a ferrocene backbone have been highly efficient 
for asymmetric imine hydrogenation. Blaser applied the ligand XYLfPHOS 
(Figure 1.7) for the synthesis of herbicide (5)-metolachlor by reductive 
amination or industrially by imine hydrogenation (vide infra).52 The fact that 
the two phosphine groups in this class of ferrocenyl diphosphine ligands can be 
introduced sequentially provides a great advantage in terms of tunability of the 
ligand, in this regard, Blaser and co-workers studied the relationship between 
structure and selectivity for the Ir-catalysed enantioselective hydrogenation of 
A-aryl imines.53 Although high enantioselectivities were obtained for various 
imines, every substrate required an optimal combination of R and R groups, 
and therefore, the catalyst lacks generality, requiring optimisation for each 
substrate. Furthermore, Reetz reported moderate enantioselectivity (79% ee)
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for the Ir-catalysed hydrogenation of 14 with a ferrocene-backbone 
diphosphine ligand 27, containing only planar chirality (Figure 1.7).54
XYLIPHOS
Figure 1.7: Ferrocene-based diphosphine ligands applied for Ir-catalysed imine hydrogenation.
Zhang reported the first highly enantioselective imine hydrogenation using 
an Ii-f-BINAPHANE complex. At 60 bar H2 and room temperature, a series of 
imines derived from aromatic ketones were hydrogenated with excellent 
enantioselectivities (Scheme 1.18).32 However, the catalyst is not effective for 
the hydrogenation of imines from aliphatic ketones, with low conversions and 
enantioselectivities reported. Best results were obtained when weaker 
coordinating solvents were used, such as CH2CI2. The enantioselectivity 
improves when sterically hindered anilines were used, as best ee’s were 
obtained with 2,6-dimethylaniline. The effect of addition of I2 is not clear.55 
When imines from less bulky anilines were used, the addition of I2 had a 
positive effect on the enantioselectivity. However, when the imine came from 
the bulky 2,6-dimethylaniline, both the activity and enantioselectivity dropped 
considerably in the presence of I2 (from 64% and 98% to 8% and 69%, 
respectively). They then applied this catalyst for the reductive amination of 
ketones (vide infra).
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1 mol% Ir-f-BINAPHANE, 
10 mol% l2l CH2CI2,
60 bar H2, rt, 12-44 h
44-96% ee
f-BINAPHANE
Scheme 1.18: Asymmetric imine hydrogenation with Ir-f-BINAPHANE catalyst.
As Ir-f-BINAPHANE proved to be an excellent catalyst for imine 
hydrogenation, Zhang et al then applied the complex to the first example of 
enantioselective hydrogenation of unprotected N-H imines, leading to chiral 
primary amines without the need of protection/deprotection (Scheme 1.19).56 
The hydrogenation takes place under high pressure of 100 bar H2, at room 
temperature in a solvent combination of CH2CI2 and MeOH. Interestingly, the 
substitution of chloride by non-coordinating counterions in the imine had a 
negative effect on the enantioselectivity. Excellent enantioselectivities were 
reported for aryl-methyl imines, while hydrogenation of alkyl-methyl imines 
led to poor ee’s.
NH2CI 5 m0|% Ir-f-BINAPHANE, NH3CI
R
80-95% ee
Scheme 1.19: Enantioselective hydrogenation of unprotected N-H imines.
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Some P-cliiral diphosphine ligands have also shown to be effective for 
hydrogenation of imines with iridium catalyst. Imamoto reported the synthesis 
of (iS^-t-Bu-BisP* ligand 28 (Figure l.B) and its application for Ir-catalysed 
hydrogenation of acyclic 7Vr-aryl imines.57 The reaction proceeds under mild 
conditions at ambient hydrogen pressure and temperature and only 0.5 mol% 
catalyst loading, affording excellent enantioselectivities (up to 99% ee), which 
smpassed other diphosphine ligands in iridium complexes, such as BINAP or 
P,N-ligands such as Ph-PHOX and zPr-PHOX. Better selectivity is obtained 
when electron-deficient imines are used as substrates. Unfortunately, this 
catalyst shows no effectiveness for the hydrogenation of TV-aryl dialkyl imines.
28
Figure 1.8: P-chiral diphosphine ligand applied to Ir-catalysed hydrogenation of imines.
More recently, Zhang and co-workers reported highly efficient asymmetric 
hydrogenation of acyclic A-arylimines catalysed by the Ir-DuanPHOS complex
(Figure 1.9).58 Excellent enantioselectivities were reported for a series of
substrates under 50 bar H2 and room temperature at 0.5 mol% catalyst loading. 
Interestingly, much milder conditions can be used without detriment of the 
selectivity. Thus, the imine can be completely hydrogenated at 5 bar H2 with 
only 0.01 mol% catalyst after 18 hours. This is one of the best turnover number 
(TON) (10,000) for iridium-catalysed imine hydrogenation.
22
Chapter 1: Introduction
fBu tBu
Figure 1.9: Ligand DuanPHOS.
The phosphine-olefin ligand 29 (Figure 1.10) has been applied for the 
iridium-catalysed hydrogenation of imine 20, providing good enantioselectivity 
(86% ee).59 It was the first example of a chiral olefin used as directing ligand 
for enantioselective hydrogenation.
Figure 1.10: Phosphine olefin ligand.
Leaving the world of phosphine-containing ligands for Ir-catalysed imine 
hydrogenation, other ligands have also shown high selectivity. Feringa studied 
the application of chiral secondary phosphine oxides (SPOs) as monodentate 
ligands.60 These phosphine oxides exist in tautomeric equilibrium between the 
pentavalent (phosphine oxide) and the trivalent (phosphinite) forms and it is 
the latter that coordinates to the transition metal centre (Figure 1.11). The 
iridium catalyst reduces JV-benzyl imines with good to high enantioselectivity 
but only racemic mixture is obtained in the reduction of 20. The reaction takes
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place at high catalyst loading of 5 mol% under 25 bar H2 and room 
temperature. This is the first example of the application of SPOs as ligands in 
asymmetric catalysis.
OH
Figure 1.11: Tautomeric equilibrium of SPOs.
Subsequently, Faller reported an iridium catalyst containing a chiral 
monodentate phosphoramidite in combination with iV-donor ligands for 
asymmetric hydrogenation of cyclic imine 14.61 The best result was obtained 
with the combination of (5)-MONOPHOS and an iV-donor ligand 30; but only 
a moderate enantioselectivity of 58% was obtained (Scheme 1.20). The 
reduction proceeded with 1 mol% catalyst under 40 bar H2 at room 
temperature and solvent-free conditions.
1 mol% [lr-((S)-MONOPHOS)(30)]+ 
40 bar H2, rt, 24 h
N
H14
58% ee
(s;-monophos
Scheme 1.20: Combination of phosphoradimite with TV-donor ligand for Ir-catalysed imine
hydrogenation.
24
Chapter 1: Introduction
Simultaneously and independently, Murai reported the synthesis of a new 
class of phosphoradimites.62 The application to the hydrogenation of imines 
with an iridium complex led to a more successful result, with enantioselectivity 
up to 73% for acyclic imine 20, which historically gave lower selectivities than 
cyclic imines, due to the easy interconversion of E- and Z-isomers of acyclic 
imines in solution (vide supra) (Scheme 1.21), The catalyst is formed in situ 
and the reaction takes place under a pressure of 80 bar H2 and room 
temperature in CH2CI2.
Scheme 1.21: Hydrogenation of acyclic imine with Ir-phosphoradimite complex.
Related chiral phosphoramidites 32 (Figure 1.12) were also applied for Ir- 
catalysed hydrogenation of N-H benzophenone imines, leading to protection- 
free chiral diaryhnethylamines.63 The use of chloride as counterion proved to 
be superior to non-coordinating counterions such as BF4". This was also 
observed previously with the Ir-f-BINAPHANE system (vide supra)56 The 
presence of bulky groups at the o/t/70-position of the aromatic ring was
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required to obtain high enantioselectivity. As a comparison, o-trifluomethyl, o- 
methyl and ^-methyl substituents led to 98, 82 and 31% ee, respectively 
(Figure 1.12),
;p-n
98% ee 82% ee 31% ee
Figure 1.12: Diarylmethylamines synthesised with Ir-32 catalyst.
hi addition to phosphoramidites, phosphites with the binol skeleton have 
also been applied in iridium hydrogenation. Reetz and co-workers reported 
heterocombinations of chiral phosphite 32 with different monophosphine 
ligands, showing a positive effect on the selectivity compared to the 
corresponding chiral homocombination.64 They first studied the combination of 
phosphite 33 and phosphonites with monophosphine ligands for the 
diastereoselective hydrogenation of imine 36. hi general, the optimal 
combination is composed of a relatively small monophosphine with the bulky 
phosphite 33. For hydrogenation of 36, the best result was obtained when 33 
and 34 were combined, obtaining a diastereoselectivity ratio of 378:1 (Scheme 
1.22). They then moved on to the enantioselective hydrogenation of A-benzyl 
imines, where the combinations were restricted to those ligands that had 
previously displayed the best enhancement of diastereoselectivity.
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Enantioselectivities up to 92% ee were reported. In terms of selectivity, this is 
one of the best results obtained for iV-benzylamines to date, although the 
reaction is earned out at high pressure and requires long reaction times.
1 mol% lr-33-34, CH2CI2) 
50 bar H2, rt, 48 h
Scheme 1.22: Hetero-combination of ligands applied to hydrogenation of imines.
In 2009, Ucariya reported the enantioselective hydrogenation of vV-benzyl 
imines with a cationic IrCp* (Cp*: pentamethyl cyclopentadienyl) ligated with 
the chiral sulfonylated diamine ligand 37 (Figure 1.13).65 Enantioselectivities 
up to 78% ee were obtained under 20 bar H2 at 30 °C. However, only racemic 
mixture is obtained when 20 is hydrogenated. Similarly to the hydrogenation of 
cyclic imines with cationic Rh-TsDPEN reported by our group (vide supra),30 
Ikariya observed positive effects of the silver salts, AgSbF6 being the best in 
terms of activity and selectivity.
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Figure 1,13: Chiral iV-tosylated diamine ligand for iridium catalysis.
More recently, Rueping reported the combination of an achiral IrCp*- 
diamine complex with a chiral A^-trifylphosphoramide for the asymmetric 
hydrogenation of quinolines.66 The inspiration for this work came from a 
previous work in this group, where the combination of a chiral IrCp*-diamine 
with chiral Bronsted acid had a synergetic effect on the enantioselectivity for 
the hydrogenation of imines and reductive amination of ketones, hi 
unpublished work, our group had explored similar combinations, achieving 
73% ee, in hydrogenation of />methoxy-jV-( 1 -phenylethylidene)aniline.67 This 
work is explained in more detail in the following chapter. Rueping and co­
workers envisioned that the chiral Bronsted acid 40 could induce chirality on 
the metal complex 38 (Scheme 1.23). Unfortunately, low enantioselectivity 
was observed for the hydrogenation of quinolines (up to 38% ee). More 
successful was the combination of the chiral 39 with 40. And interestingly, 40 
kinetically discriminates 39, with 40-(Ri?)-39 being more active and selective 
(Scheme 1.23).
28
Chapter 1: Introduction
1 mol% [Ir], 1 mol% 40, 
o-xylene, 100 bar H2, 20 °C
0=S=0
Ar: 2-Naphthyl R: 9-Phenanthryl
38 39 40
Time (h) Conv. (%) ee (%)
38 60 40 32
rac-39 24 >95 82
(S,S)-39 40 75 -68
(R,R)-39 24 >95 88
Scheme 1.23: Effect of the metal complex for the cooperative catalysis for the asymmetric
hydrogenation of quinolines.
1.3.3 Chiral ruthenium catalysts
Morris and co-workers introduced the Noyori type ruthenium 
diphosphine/diamine complexes (Figure 1.14) for the asymmetric 
hydrogenation of imines. Both iV-aryl and iV-alkyl acyclic imines were 
hydrogenated under mild conditions (3 bar H2 and 20 °C) at 0.2 mol% 41 in the 
presence of catalytic amounts of KO/Pr, resulting in moderate to good 
enantioselectivities (up to 71% ee).68 The presence of the base is essential for 
the effectiveness of the catalyst, suggesting that the true catalyst might be 
formed after the loss of HC1, possibly a dihydride species derived from 41 
(Figure 1.14).
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P,P: (R)-BINAP
41
P,P: (R)-TolBINAP
4342
Figure 1.14: Noyori’s type catalyst applied for asymmetric hydrogenation of imines.
Other groups also studied the effect of different diphosphine and diamine 
ligands in the Noyori type catalyst for asymmetric imine hydrogenation.69"70 
Cobley screened a wide library of diphosphine and diamine ligands for 
different imine substrates, unfortunately finding that every substrate requires an 
extensive screening and it is difficult to predict the best combination.69 For N- 
aryl imines, the complex 42, containing ligands (f^-Et-DuPHOS and {R,R)- 
DPEN, (Figure 1.14) gave the best selectivity of 91% ee, at 1 mol% catalyst, 
65 °C under 15 bar H2 in the presence of 1 eq of base in /PrOH. In the case of 
N-benzyl imine 6, the best combination of ligands was found to be (S)- 
TolBINAP and (S^-DPEN, forming complex 43 (Figure 1.14). For this 
substrate, only 5 mol% of base is used, as an increase of the amount of base 
favours the equilibrium mixture between 6 and its aldimine tautomer, which 
could be hydrogenated to give a racemic product (Figure 1.15).
6 Aldimine tautomer
Figure 1.15: Equilibrium of 4 and its aldimine tautomer.
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Jackson developed a new diphosphine ligand (7?,i?)~Ph-BPM 44 (Figure 
1*16) and then applied the complex [Ru((i?,7?)-Ph-BPM)(((S,)5,)-DPEN)C12] to 
enatioselective imine hydrogenation.70 Although only 3 substrates are reported, 
the catalyst is effective for vV-aryl and A-benzyl acyclic imines and a cyclic 
imine, displaying good selectivities (71-89% ee). There is a clear 
match/mismatch between the phosphine and the amine, as the opposite 
configuration on the amine showed inferior selectivity.
Ph Ph
Ph Rh
44
Figure 1.16: (/?,i?)-Ph-BPM ligand.
1.3.4 Other chiral metal catalysts
In 1992, Buchwald applied the ansa-titanocene system 45 developed by 
Brintzinger71 to the first example of asymmetric hydrogenation of imines 
(Scheme 1.24).72 The reaction occurs at -130 bar H2, 65 °C with 5 mol% 
catalyst loading. While the reduction of cyclic imines takes place with 
excellent enantioselectivity, only moderate to good enantioselectivities (up to 
76% ee) are obtained for the reduction of acyclic A-benzyl imines.
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MeO MeO
MeO'
5 mol% 45, THF,
133 bar H2, 65 °C, 48 h NHMeO'
98% ee
45
Scheme 1.24; Example of hydrogenation of cyclic imine by titanocene catalyst.
Brintzinger developed a different class of chiral ansa-titanocene catalyst 
46 (Figure 1.17), and also applied them for enantioselective imine 
hydrogenation.73 Although similar selectivity for both cyclic and acyclic imines 
is obtained to that reported by Buchwald, the catalyst activity is much higher, 
as only 0.1 mol% of titanium complex is required to complete the reaction in 
12 hours, at 150 bar H2 and 80 °C.
46
Figure 1.17: Chiral biphenyl-bridged titanocene complex developed by Brintzinger.
Corma and co-workers reported the first example of gold complex as a 
hydrogenation catalyst for the reduction of alkenes and imines,74 Only recently 
have gold complexes been studied in catalysis, which had always been thought 
as being chemically inert. The hydrogenation of 6 takes place with a dimeric
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gold(I) complex 47 with (£,i?)-Me-DuPHOS ligand, at only 0.2 mol% catalyst 
loading, 20 °C under a low pressure of 4 bar H2 (Scheme 1.25).
N' \ //
6
47
Scheme 1.25: Gold-catalysed asymmetric hydrogenation of 6.
1.4 Metal-catalysed asymmetric transfer hydrogenation of imines
In a transfer hydrogenation (TH) reaction, the hydrogen source is other 
than hydrogen gas.75 The most commonly used hydrogen sources are /PrOH 
and azeotropic mixture of formic acid/triethylamine. Metal-catalysed 
asymmetric transfer hydrogenation (ATH) of ketones has been widely reported 
in the literature, with an impressive number of successful examples for the 
synthesis of chiral secondary alcohols.11’76-81 However, ATH of imines has 
been less developed, despite the synthetic importance of chiral amines.23,82
1.4.1 Precious metal-catalysed ATH of imines
The first example of ATH of imines was reported by Noyori in 1996. 
Excellent enantioselectivities were reported for ATH of cyclic imines with 0.05 
mol% of Ru-TsDPEN catalyst, using a mixture of formic acid/triethylamine as
33
Chapter 1: Introduction
hydrogen source under mild conditions (Scheme 1.26).83 The reduction of 
acyclic imines is somewhat less stereoselective. For example, ATH of 6 led to 
only 77% ee. The presence of triethylamine is essential; in the absence of 
triethylamine, the Ru-TsDPEN complex catalysed the decomposition of formic 
acid into H2 and CO2.84’85
MeO
MeO'
Ru-TsDPEN
Scheme 1.26: ATH of an isoquinoline 48 with Ru-TsDPEN catalyst.
Since this discoveiy, this Ru-TsDPEN system has been applied for 
synthesis of key intermediates of important drugs,86'89 such as neuromuscular 
blocker GW 043086 or opiate analgesic morphine87 (Figure 1.18). Furthermore, 
derivatives of the Ru-TsDPEN catalyst have been developed for ATH of other 
cyclic imines.90'93
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MeO
OMe
MeO'
MeO. OMe
MeO
OMe
HO.
N—
morphine
Figure 1.18: Structures of GW 0430 and morphine.
Deng and co-workers developed the first ATH of cyclic imines in water. 
They had previously reported the ATH of ketones in water,94 and then 
expanded it to imines. The reaction takes place using HC02Na as hydrogen 
source, under mild conditions, with 1 mol% Ru catalyst, which is formed with 
water-soluble ligand 49, a derivative of Ts-DPEN (Figure 1.19), and in the 
presence of a surfactant, 48 could be reduced to completion after 10 hours with 
95% ee, A variety of cyclic imines were reduced, including 3,4-dihydro-p- 
carbolines and A-sulfonylimines. Attempts at ATH of 6 led to complete 
decomposition of the substrate, however.
H2N NHTs
49
Figure 1.19: Water-soluble ligand 49.
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Zhou and co-workers developed the ATH of quinolines with an h-fiS)- 
SegPHOS catalyst and Me-Hantzsch ester (Me-HEH) as hydrogen source 
(Scheme 1.27).95 Although good enantioselectivities are reported (81-87% ee), 
the use of Me-HEH as the hydrogen source necessitates long reaction times 
(42-79 hours).
2 mol% lr-(S)“SegPHOS, 5 mol% l2, 
Me-HEH, Toluene/Dioxane, rt, 42 h
PPh2
PPho
(Sj-SegPHOS
R02C co2r
N 
H
Me-HEH: R: Me
'N 
H
87% ee
Scheme 1.27: ATH of quinolines with Me-HEH as hydrogen source.
The first example of ATH of quinolines in water was developed within 
the Xiao group.96 Enantioselectivities in the range of 89-98% ee were reported 
for a wide range of quinolines. The conditions were optimised for 50. The 
reaction takes place in water, at 40 °C with 1 mol% catalyst loading and 
azeotropic HCOOH/EtaN as hydrogen source (Scheme 1.28). A buffer system 
(HOAc/NaOAc) was required to maintain the pH of the reaction media at an 
optimal value of 5. It is understood that this reduction follows an ionic 
pathway,97 98 where the corresponding iminium cation is the actual species 
reduced. Therefore a pH where 50 can be protonated is required (pKa of 
protonated 50 is 5.4).
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1 mol% 51, HCOONa 
HOAc/NaOAc buffer, 
40 °C, 6-24 h
Ar
Ar: 4-fBu-C6H4
51
89-98% ee
Scheme 1.28: ATH of quinolines in water.
1.4.2 Fe-catalysed ATH of imines
The homogeneous catalysed asymmetric reduction of imines is dominated 
by Ir, Ru, Rli, and Ti complexes. However, cheap metal catalysts are more 
desirable from an economical and environmental point of view, hi this regard, 
recent papers have attempted the iron-catalysed asymmetric reduction of 
imines, although this area is still relatively unexplored.
Morris et al reported the ATH of ketones with a Fe-PNNP catalyst (Figure 
1.20), using r'PrOH as the hydrogen source in the presence of a strong base 
KCfBu." They also reduced an aldimine, which showed much lower activity, 
and unfortunately catalyst 52 was almost inactive for the reduction of a 
ketimine.100
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52 53
Figure 1.20: Fe-PNNP catalysts for ATH.
More successful are the results reported by Beller and co-workers for the 
ATH of A-(diphenylphosphinyl)ketimines.101 Complex 53 (Figure 1.20), 
previously reported by Morris,102 was proven to be the most selective for this 
reduction. These substrates possess the advantage of not undergoing E/Z 
isomerisation, characteristic of simple iV-aryl imines. This catalyst shows high 
activity, as the reaction goes to completion after 30 minutes with 1 mol% 
complex, at 45 °C in the presence of a strong base KOH and /PrOH. Excellent 
enantioselectivities (95-97% ee) were reported (Scheme 1.29).
P(0)Ph2 /P(0)Ph2
N HN
1 moI% 53,5 mol% KOH,
r1}_ T /PrOH, 45 °C, 30 min, ^ Rif- jT
95-97% ee
Scheme 1.29: ATH of A-(diphenylphosphinyl)ketimines.
1.5 Metal-catalysed asymmetric reductive amination
Direct asymmetric reductive amination (DARA) of proclhral ketones for 
the synthesis of a-chiral amines has been considered one of the key green 
chemistry research areas by the ACS GCI (Green Chemistry Institute)
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Pharmaceutical Roundtable.103 It represents a more eco-friendly pathway for 
the synthesis of chiral amines. This reductive amination procedure consists of a 
one-pot two-step reaction. Firstly, the inline is formed from the condensation 
of a prochiral ketone and an amine. This is followed by in situ asymmetric 
reduction of the corresponding inline (Scheme 1.30). The isolation of the inline 
intermediate is not required, which is historically known as a tedious and 
difficult process due to low stability of imines.
,/R3 .R,I X ^[Hl ARi R2 R1 R2 R-i R2
Scheme 1.30: General scheme for DARA.
Recently, there has been a significant development in asymmetric catalytic 
imine reduction. However, there are still only a few examples in the literature 
for DARA.104 105 Although it is considered of high importance in the 
pharmaceutical industry, this reaction possesses several challenges: 
competition reaction between ketone reduction and the imine reduction, and 
inhibition of the catalyst by the amine substrate or product.
1.5.1 Metal-catalysed DARA under hydrogenation conditions
The first enantioselective reductive amination was reported by Blaser in 
1999 for the synthesis of (Sfmetolachlor, which is the active ingredient in the 
herbicide Dual (Scheme 1.31).106 The idea was to improve the optimised 
industrial process, where the isolated imine is hydrogenated at 80 bar H2 and
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50 °C with an Ir-XYLIPHOS complex formed in situ.52'53,107 This imine 
hydrogenation takes place at an excellent S/C ratio of 106, with initial turnover 
frequency (TOP) of 1.8 x 106 h"], 3-4 horns reaction time and around 80% <?e. 
During the study of the one-pot process, they determined that addition of a 
strong acid such as trifluoroacetic acid, tetra butyl ammonium iodide (TBAI) 
and a cosolvent was required. Cyclohexane was shown to be the best cosolvent 
in terms of activity and enantioselectivity, probably due to the low solubility of 
water and 2-methyl-5-ethylaniline (MEA) in the organic solvent, which are 
known to deactivate the Ir-XYLIPHOS catalyst.31,108'109 The reaction is 
complete after 14 hours with a S/C ratio of 10,000 and enantioselectivity of 76- 
78% ee. Although this new process avoids isolation of the imine intermediate, 
the activity of the catalyst drops considerably; hence the imine hydrogenation 
process is still the pathway of choice from the economical point of view, 
the economical point of view.
NH2 0.01 mol% Ir-XYLIPHOS, TBAI, 
CH3SO3H, cyclohexane,
80 bar H2, 50 °C, 14 h
MEA 76% ee
(S)-Metolachlor
Scheme 1.31: Reductive animation with Ir-XYLIPHOS catalyst.
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In 2003, Zhang and co-workers reported the DARA of aryl ketones with 
Ir-f-BINAPHANE catalyst110 (Scheme 1.32), which they previously proved to 
be effective for the asymmetric hydrogenation of imines.32 Preliminary studies 
concluded that the formation of the imine was the rate-limiting step. Therefore, 
different substances were used as additives to promote the imine formation. 
The presence of Ti(0‘Pr)4 clearly accelerates the reaction, while other additives 
such as 4 A molecular sieves (MS), MgS04 or TsOH did not show any positive 
effect. Optimised conditions were found to be 1 mol% of the catalyst, 10 mol% 
I2 and 1.5 eq of Ti(OlPr)4 at room temperature and ~65 bar H2. Excellent 
enantioselectivities were obtained for a range of aryl ketones in the presence of 
jp-anisidine. The enantioselectivity dropped for more sterically hindered 
ketones: from phenyl methyl ketone, to phenyl ethyl ketone to phenyl w-butyl 
ketone, the enantioselectivity dropped from 94 and 85 to 79% ee. The different 
methyl-substituted acetophenones led to a similar trend, where the 
enantioselectivity dropped considerably from /7-methylacetophenone with 96% 
ee, to 89% ee for w-methylacetophenone to a low 44% ee for 0- 
methylacetophenone. The main drawback of this catalyst is its ineffectiveness 
for the DARA of aliphatic ketones.
o
Rn-
R’ +
h2n
1 moI% Ir-f-BINAPHANE, 
10 mol% l2, Ti(0/Pr)4l 
CH2CI2, -65 bar H2, rt, 10 h
44-96% ee
Scheme 1.32: DARA of ketones with Ir-f-BINAPHANE catalyst.
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More recently, Rubio-Perez and co-workers reported DARA of ketones 
with an air-stable chiral Pd-BINAP catalyst (Scheme 1.33).111 The comparison 
of different diphosphine ligands showed that a larger bite angle increased the 
performance of the catalyst. The optimised conditions were found to be 2.5 
mol% catalyst, ~55 bar H2 at 70 °C in chloroform in the presence of 5 A MS. 
The reaction performs well for a series of aliphatic ketones with good yields 
and good to excellent enantioselectivities. The presence of substituents in the 
aniline increases the enantioselectivity and the catalyst still performs well when 
substituted or sterically hindered aliphatic ketones are employed. When 2,3- 
butanedione is used, the catalyst proved to be chemoselective to the 
monoaminated product, but product is almost racemic (10% ee). GC-MS 
experiments showed the catalyst is selective for imine reduction over the 
ketone, as no alcohol product is observed. When moving to DARA of aromatic 
ketones, the catalyst is still active; but only low enantioselectivities are 
obtained (up to 43% ee).
10-99% ee
Scheme 1.33: Reductive amination by chiral Pd-BINAP catalyst.
Kadyrov and Borner screened a library of 96 ligands for the rhodium 
catalysed DARA of a-ketoacids utilised in the synthesis of chiral
aminoacids.112 Best results were obtained when the diphosphine (R,R)-
DeguPHOS ligand was used, at 1 mol% catalyst loading, 60 bar H2 and room
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temperature (Scheme 1.34). Although excellent enantioselectivity (98%) was 
obtained for DARA of phenyl pyruvic acid with benzylamine, most of the 
products reported only had moderate ee (-50%).
Ox
[TXOOH
(f?,R)-DeguPHOS
Scheme 1.34: Rh-catalysed DARA of a-keto acids.
Apart from chiral a-amino acids, chiral j3-amino esters and amides can be 
synthesised following a reductive amination procedure. Bunlaksananusorn 
reported the DARA of (3-keto esters with a Ru-diphosphine complex under 
hydrogenation conditions. Under 30 bar H2 and 80 °C with 1 mol% catalyst 
loading, a series of aryl-substituted (3-keto ester was reductively animated with 
excellent yields and high enantioselectivities (Scheme 1.3 5).113 Steric effects 
on the phenyl ring can lower the chemoselectivity, resulting in the formation of 
P-hydroxyester. Only one example of alkyl p-keto ester was reported: 
reductive amination of ethyl acetylacetonate yielded the corresponding 
ammonium salt with 96% ee.
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Scheme 1.35: DARA of p-keto esters.
More recently, Steinhuebel reported the first DARA of P-keto amides to 
the unprotected chiral p-amino amides.114 A variety of alkyl- and aryl- 
substituted p-keto amides were converted to the corresponding p-amino 
amides in high yields and excellent enantioselectivities (95-99% ee) under 30 
bar H2 at 80 °C with 1 mol% catalyst loading of Ru-DMSegPHOS (Ru-55) 
complex. The addition of ammonium salicylate (NH4SA) eliminates the dimer­
like by-product. This methodology was also applied for the synthesis of 
sitagliptin by DARA of 56 (Scheme 1.36). Sitaghptin is a potent DPP-IV 
inhibitor for the treatment of type-II diabetes.115
1 mol% Ru-55,
I NH4SA CF3H2OH, 
,N 20 bar H2, 80 °C, 15 h
sitagliptin
55
Scheme 1.36: Synthesis of sitagliptin by reductive amination.
44
Chapter 1: Introduction
1.5.2 Metal-catalysed DARA under TH conditions
There are only a few examples of DARA with homogeneous catalyst 
under TH conditions, i.e. using an organic molecule rather than H2 as the 
hydrogen source. Kadyrov reported the DARA of ketones with a Ru-tolBINAP 
complex under TH conditions (Scheme 1.37).116 The reductive animation with 
ammonium salt of formic acid as a reducing agent is known as the Leuckart- 
Wallach (LW) reaction.117 When investigating the effect of additives, the 
author found that acids accelerated the reaction; however lower 
enantioselectivities were obtained. The opposite occurred with the addition of 
ammonia: higher ee but lower activity were acquired. Under the best conditions 
(5-10 eqs. of HCOONH4 in NHs/MeOH at 60-85 °C), the DARA of aromatic 
ketones proceeded with excellent enantioselectivities. However, the catalyst is 
not effective for aliphatic ketones, with low conversion and enantioselectivity 
being reported. To our knowledge, this is the only example of intermolecular 
DARA under TH conditions.
O 1 mol% Ru-(R)-TolBINAP, 
HCOONH4i NHa/MeOH, 
85 0C, 20-48 h
NH2
86-95% ee
Scheme 1.37: DARA of aromatic ketones under TH conditions.
Noyori developed an excellent Ru(II)-TsDPEN catalyst for ATH of imines 
under acidic conditions {vide supra). In particular', isoquinolines were reduced 
with excellent yields and enantioselectivities.118 Wills and co-workers extended 
this work to a one-pot reductive amination process, where /Boc-protected
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amine 58 undergoes deprotection, intramolecular cyclization and further 
reduction of C=N bond (Scheme 1.38).119 The reaction takes place in 
sequenced steps: the deprotection occurs under formic acid conditions; then, 
triethylamine is added to the azeotrope mixture, followed by Ru-TsDPEN 
complex, as well as anhydrous acetonitrile. For those examples where 
preformed imines were used, the selectivity was comparable. However, most of 
the examples reported are essentially racemic.
1) HCOOH, 16 h MeO.
2) 0.5 mol% Ru-TsDPEN, 
HCOOH/Et3N, MeCN, 20 h .. NH
Scheme 1.38: Intramolecular DARA under TH conditions.
1.6 Organo-catalysed DARA
MacMillan repotted the first example of organocatalytic DARA. A chiral 
Bronsted phosphoric acid is used as catalyst with Et-HEH as reductant. This 
type of strong chiral phosphoric acids was initially introduced by the Japanese 
groups of Akiyama120'121 and Terada122'124 for the asymmetric addition to 
aldimines. On the other hand, it had been previously shown that imines can be 
reduced with HEH in the presence of achiral Bronsted acid catalyst.125 Prior to 
this publication, the groups of List126 and Rueping127 simultaneously reported 
the organocatalytic imine reduction with Et-HEH, with the same type of chiral 
phosphoric acid, although List’s results were somehow superior.126
A series of aromatic and aliphatic ketones were reductively animated with 
derivatives of aniline in the presence of 10 mol% of chiral phosphoric acid 59
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and Et-HEH. Very good yields and enantioselectivities are reported, albeit with 
long reaction times (24-96 horn's) (Scheme 1.39). The combination of Et-HEH 
with phosphoric acid is chemoselective for imines over other reducible groups, 
such as ketones, nitro and alkene. This organocatalytic procedure was extended 
by List and co-workers to the DARA of ketones with benzylamine128 and 
DARA of a-branched aldehydes.129
O
HoN
Ts 10 mol% 59, Et-HEH, 
5 A MS, benzene, 
// 40 °C, 72 h
Ts
N
HN
//
>0
90% ee
Scheme 1.39: Example of organocatalytic DARA.
The catalytic cycle is thought as follows: the imine is formed in situ, and 
subsequently protonated by the chiral 59. The resulting iminium cation has a 
lower LUMO than the corresponding imine; therefore it is easier to be reduced 
by Et-HEH. The iminium cation is stabilised by hydrogen-bonding with the 
chiral phosphate, which makes the iminium cation facially-biased towards the 
incoming hydride.130'131
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1.7 Mechanistic considerations for the metal-catalysed inline 
hydrogenation
Only a few studies of the mechanism of homogeneous hydrogenation of 
imines have been reported. Two main pathways can be considered for the 
metal-catalysed inline hydrogenation, the so-called classic and ionic pathways. 
A simplified representation of the classic pathway involves coordination of 
hydrogen, oxidative addition, and coordination of the substrate prior to hydride 
transfer, followed by reductive elimination (Scheme 1.40).
,€lL,,AA ,XU
M: Rh(l), Ir (I)
H2
CrH8n16
Oxidative
addition
H2 Coordination, 
oxidative addition
RHN-CHR'R"
Reductive
elimination
,rH+
s N.
I A\
M’ CR’R"
IX
H
Hydride
transfer
Scheme 1,40: General scheme for inline hydrogenation following a classic pathway; L: ligand;
S: solvent.
Wilkinson132 and James133 studied independently the mechanism for imine
hydrogenation with rhodium-phosphine complexes. Wilkinson determined that
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alcohol solvents were required, while other polar but non-hydrogen bonding 
were unsuitable.132 This suggests that hydrogen bonding may be important. 
Intramolecular hydrogen bonding between the alcohol solvent and the inline 
promotes T]2-C,N-bonding of the imine (Figure 1.21). Attempts to reduce the 
corresponding iminium cation failed, however. The iminium cation would have 
little tendency to bond to the metal centre, supporting the idea that the 
coordination of the imine substrate is required prior to hydride transfer.
PhaRr,
V
H
l3r"''. I .ovS R1N*CR2R3,-S ph3p'"<,. I
Rh- 2 3 ' ^Rh-;' CRgR
Ph3p^ I Ph3p'
rwh\ r~i+
O '[sj-Ri I
2r'3
H
H H
Figure 1.21: Intramolecular hydrogen bonding between alcohol solvent and imine substrate.
Later on, studies undertaken by James indicate that imine binding is 
probably the first step. When rhodium catalysts containing chelating 
phosphines are used, imine binding is a more facile process than the hydride 
formation.133 The use of methanol as the solvent seems to be essential. It 
reiterates the idea that the alcohol is probably bound to the metal and it 
facilitates the change from the rj1 to r\ binding of the imine group.
Buchwald et al. also reported mechanistic and kinetic studies on imine 
hydrogenation with their titanocene catalyst.134 Scheme 1.41 summarises their 
suggested catalytic cycle, which follows the classic pathway. They proposed 
the Ti-hydride species 60 as the active catalyst. The imine coordinates to the 
metal centre through the C=N double bond; this is followed by 1,2-hydride 
migration on the imine carbon atom to form the amido-titanium(III) complex
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61. H2 coordinates to the metal centre, followed by elimination of the amine 
product via a four-centre transition state 62, regenerating the active Ti-hydride 
60 (A classic inner-sphere mechanism).
Scheme 1.41: Catalytic cycle proposed by Buchwald for the titanocene catalyst 60.
In contrast to the classic pathway shown in the previous examples, the 
ionic pathway involves no imine coordination, which is represented in Scheme 
1.42. This catalytic cycle is usually present when the catalyst is a half­
sandwich type complex. After the formation of the active metal species, the 
actual catalytic cycle is made up of 3 steps: coordination of a H2 molecule, 
heterolytic cleavage of H2 into a hydride and a proton and subsequent transfer 
of hydride to the iminium cation. This pathway involves the protonation of the
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imine substrate prior to the hydride transfer and does not require the 
coordination of the substrate to the metal complex (outer-sphere mechanism).
+
' Hydrogen 
coordination
Proton ' 
transfer
Scheme 1.42: Catalytic cycle for an ionic pathway.
The concept of ionic hydrogenation for reduction of imines was introduced 
by Norton and co-workers in 2001.135 Although only moderate 
enantioselectivities were reported for a methyl aryl pyrrolidinium (up to 60% 
ee), they reported the first example of catalytic asymmetric ionic 
hydrogenation. According to Norton’s experiments, the increase of the H2 
pressure does not affect either the conversion or the enantioselectivity.97,135 
This supports the hydride transfer to be the turnover-limiting and enantiofacial­
determining step. They also followed the reaction by ^ NMR, observing the 
formation of monohydride but not dihydrogen or dihydride species, 
corroborating the hydride transfer as the turnover-limiting step, hi this regard, 
they studied the effect of the chelate ring size on the hydride transfer step.136
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They determined that the smaller the ring, i.e. the smaller the bite angle, the 
higher the reaction rate. From a steric point of view, the iminium cation has 
more space to approach the hydride with a smaller chelate ring. From an 
electronic point of view, the ability to transfer the hydride is mainly determined 
by the energy of the LUMO for the 16e species formed after the hydride 
transfer.137 This type of complex prefers a pyramidal geometry, where a 
smaller chelate ring will force some additional bending that raises the LUMO 
energy.
Stoichiometric experiments were run by the groups of Fan138 and Norton135 
supporting the ionic mechanism: Fan reported no reduction of 50 even in the 
presence of excess of the hydride; however, the corresponding protonated 
species reacts smoothly to give the tetrahydroquinoline product. In Norton’s 
experiments it has been determined that the hydride transfer rate is first order 
for both the Ru-hydride and the iminium cation, being second order overall.135
Ikariya’s group also reported mechanistic studies for the asymmetric 
hydrogenation of 6 with Ir-37.65 The role of activation of the imine substrate is 
addressed with respect to the silver salt, as the presence of excess of AgSbFf, 
improves not only the activity, but also the enantioselectivity. The substrate is 
activated by a strong interaction between the imine nitrogen and the Lewis 
acidic silver centre, observed by a characteristic downfield shift in the imine 
carbon in 13C{1H} NMR experiments, when equimolecular amount of AgSbFg 
is added to the imine. Therefore, the silver salt has a dual role: formation of the 
cationic species for the iridium complexes, as well as enhancement of 
enantioselectivity by activation of the imine, presumably because N-Ag bond
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facilitates the hydride attack to the Re face of the imine.
As shown in a previous section (1.3.2), several groups have reported the 
asymmetric hydrogenation of imines mediated by an Ir-PHOX catalyst. 
Hopmann and co-workers reported a comprehensive quantum chemical study 
to determine the preferred Ir-PHOX imine hydrogenation mechanism.139 
Scheme 1.43 shows the possible mechanism, which goes through an Ir(III) 
catalytic cycle. Firstly, oxidative addition takes place, changing the iridium 
from Ir(I) to Ir(III). Then, it is assumed that an initial coordination of the imine 
to the iridium will occur (Step A). A six-coordinated dihydride-Ir-(III) species 
63 is formed by binding of an additional ligand (solvent or H2) (Step B). The 
substrate is then replaced by a H2 molecule (Step C), followed by proton 
transfer to the imine substrate (step D). Finally, the hydride tram to the 
phosphine ligand is fransferred from the Ir(III)-trihydride to the iminium cation 
(Step E). The hydride transfer is the rate-limiting and enantio-determining step. 
Interestingly, based on their results, the proposed mechanism is similar to the 
ionic pathway shown by Norton. Although the coordination of the substrate is 
involved in the catalytic cycle, it is actually the protonated imine that is the 
species to be reduced.
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+
Oxidative
addition
Imine
Coordination
A
w - Amine 
+ Imine
VH
R
Scheme 1.43: Mechanism proposed for the imine hydrogenation with Ir-PHOX type catalyst.
1.8 Aims of the thesis
This introduction has summarised the best methodologies reported in the 
literature for the synthesis of chiral amines. In particular, it focuses on the most 
efficient and selective metal catalysts for asymmetric imine hydrogenation. The 
groups of Zhang, Blaser and Andersson, among others, have designed excellent 
ligands and complexes, and applied them to imine hydrogenation, achieving 
excellent results. However, there is still a need for highly efficient and selective 
catalysts capable of reducing a wider range of C=N double bonds under mild 
conditions.
We hope it can be seen that this thesis goes some way to achieving this 
goal, as new strategies for the synthesis of chiral amines have been developed. 
Chapter 2 presents an efficient catalyst for DARA of aliphatic ketones, where
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the catalysis is effected by the cooperative action of a cationic Ir(III)-diamine 
complex and its phosphate counterion.
Chapter 3, 4 and 5 were developed naturally from the challenges found in 
Chapter 2. This cooperative catalysis was not effective for the DARA of 
ketones with aliphatic amines. Chapters 3 and 4 were born from the efforts to 
overcome this problem. Chapter 3 presents the synthesis and application of 
cyclometallated iridium-imine complexes for the hydrogenation of imines. 
These catalysts are effective for imines from aromatic and aliphatic ketones, as 
well as aromatic and aliphatic amines. Chapter 4 reports our efforts to develop 
chiral versions of cyclometallated iridium complexes and their application for 
the hydrogenation of A-benzylimines.
Whilst this cooperative catalysis provides excellent enantioselectivity for 
the synthesis of a-chiral amines, only moderate enantioselectivity could be 
achieved when the same methodology was applied to the DARA of a-branched 
aldehydes, which would lead to p-chiral amines. Besides, these a-branched 
aldehydes are not commercially available and require prior synthesis and 
tedious purification. Chapter 5 provides a novel methodology for the synthesis 
of P-chiral amines, by a one-pot three-step hydroaminomethylation procedure, 
where a readily accessible styrene is selectively hydroformylated to the 
corresponding a-branched aldehyde and in situ reductively aminated to 
provide the P-chiral amine with good enantioselectivity.
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Chapter 2
Metal-Bronsted Acid Cooperative Catalysis for Asymmetric 
Reductive Amination
2.1 Introduction
Transition metal catalysis has been established as one of the most useful 
and powerful tools in organic chemistry.1 On the other hand, organocatalysis, 
i.e. small organic molecules acting as catalysts, has become a rapidly growing 
area in synthetic organic chemistry in the past decade.2 Very recently, the 
combination of transition metal catalysis and organocatalysis has gained a lot 
of attention. It could potentially provide an attractive way for unprecedented 
tiansformations, which are not possible with either a transition metal catalyst or 
organocatalyst alone.3 hi particular, the combination of transition metals with 
Bronsted acids has proven to be very successful, especially for asymmetric 
reactions.3
An example of this novel dual catalysis was reported by Rueping and co­
workers for the alkynylations of a-imino esters.4 hi this regard, a chiral 
Bronsted acid enantioselectively activates the substrate; then silver-catalysed 
alkynylation of the activated species takes place. Chiral amino acids were 
synthesised with good yields and excellent enantioselectivities under mild 
reaction conditions (Scheme 2.1). No product formation was observed if only 
the Brousted acid or the silver acetate was used.
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88% ee
10 mol% 1a, 5 mol% AgOAc, 
Toluene, rt, 12 hEtOoC'
1
1a: R: 9-phenanthryl
Scheme 2.1: Asymmeti'ic metal-Brensted acid catalysed alkynylation of imines.
The concept of dual catalysis has also been applied to asymmetric 
multicomponent reactions. Gong and co-workers reported the enantioselective 
three-component reaction of diazo compoimds and alcohols with imines in the 
presence of an achiral rhodium complex and a chiral Bronsted acid.5 hi 
previous work within this group, they had observed that this three component 
reaction catalysed by Rli2(OAc)4 was accelerated by proton donors.5’6 
Following this observation, they decided to incorporate a chiral Bronsted acid 
to develop the corresponding asymmetric version for that reaction. In a similar 
way to Rueping’s work, the role of the chiral acid is the activation of the imine 
substrate by ion-pairing. An asymmetric Mannich reaction would then take 
place between the iminium cation and an oxonium ylide, formed in situ from a 
diazoacetate and an alcohol initiated by rhodium catalyst (Scheme 2.2). This 
procedure allows for the synthesis of (3-chiral-a-hydroxyl acid derivatives with 
a quaternary carbon stereogenic centre with good yields and 
enantioselectivities up to 99% ee.
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Ph'
93% ee
Scheme 2.2: Combination of Rli2(OAc)4 and chiral Brousted acid catalyst for a three-
component reaction.
On the basis that the imine could be generated in situ from the 
corresponding aldehyde and amine, Rueping’s group then extended the 
reaction to a four-component reaction, where the extra step comes from the in 
situ imine formation.7 hi this transformation the phosphoric acid 1 would play 
a dual role: it would not only activate the imine by formation of iminium, but 
also accelerates the imine formation step.
List and co-workers also used a cooperative catalysis approach for the 
synthesis of quaternary carbon stereogenic centres. They combined a Pd(0) 
catalyst with chiral Bronsted acid lb for the a-allylation of a-branched 
aldehydes with an allyl amine (Scheme 2.3).8 The acid catalyst acts as a proton 
donor as well as an anionic ligand for the cationic jr-allyl Pd(II) complex 
intermediate, inducing asymmetry. Enantioselectivities in the range of 70-95% 
were reported. This methodology was effective for the synthesis of a natural 
product, (Hyl-cuparene.
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CHO
Ph
Ph^N
H
3 mol% Pd(PPh3)4l 1.5 mol% 1b, 
5 A MS, MTBE, 40 0C, 24 h
1b: R: 2,4,6-(2-C2H7)3-C6H2
('+)-Cuparene
Scheme 2.3: Cooperative catalysis for asymmetric a-allylation of aldehydes.
Previous work within the group showed that cooperative catalysis of Ir- 
diamine complex with chiral phosphoric acid was effective for the asymmetric 
hydrogenation of acyclic imines, with excellent yields and enantioselectivities 
reported.9 Initially, the group was studying the enantioselective hydrogenation 
of imines with a Noyori-Ikariya type M-diamine catalyst. While excellent 
results were reported for the reduction of cyclic imines,10 only low 
enantioselectivities were obtained for the hydrogenation of 2 (up to 22% ee 
with 4) (Scheme 2.4).9
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1 mol% 4, DCM-H20,
Solvent
4
Scheme 2,4: Asymmetric hydrogenation of acyclic inline with Rh-diamine catalyst.
Previous to these studies, the groups of Macmillan,11 Rueping12 and List13 
have shown that chiral phosphoric acid catalysts such as 1 can induce excellent 
ee's in imine reduction12'13 and in DARA11,14 with HEH, although the reaction 
times are generally long (up to 3 days). As in most Bronsted acid-catalysed 
reactions {vide supra), the phosphoric acid activates the imine via protonation 
and induces chirality by ion-pairing the resulting phosphate anion and iminium 
cation. Inspired by this work and by successful examples of cooperative 
catalysis in the literature, we wondered whether a more versatile catalyst for 
imine hydrogenation could be constructed by the cooperative action of a In­
activating metal complex and a chiral phosphoric acid.
A synergistic effect between the chiral metal complex and the chiral 
Bronsted acid was indeed demonstrated. The Ir-diamine complex 5 alone led to 
a low ee of 22%, while the combination of chiral Bronsted acid with achiral Ir- 
diamine complex achieved 73% ee}5 However, the cooperative catalysis of a 
chiral Bronsted acid with a chiral Ir-diamine complex provided excellent yields
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and enantioselectivities (up to 98% ee) for a wide range of imines (Scheme 
2.5).9
1 mol% 5, 1 mol% 1b, Toluene,
97% ee
Scheme 2.5: Combination of chiral Bronsted acid with chiral Ir complex for asymmetric
hydrogenation of imines.
The key elements of this cooperative catalysis are illustrated in Scheme 
2.6. H2 is activated by the metal complex and heterolytically cleaved, forming 
an iminium cation (by imine protonation) and an Ir-hydride complex, hi a non­
polar solvent, the iminium cation ion-pairs, via hydrogen bonding, with the 
chiral phosphate anion,1113 and is reduced by hydride transfer from the metal 
complex (Scheme 2.6). The protonation activates the C=N double bond 
towards attack by the hydride while ion-pairing aids its enantiodiscrimination 
by the metal catalyst. This ionic hydrogenation pathway, which involves no 
coordination of the C=N double bond to the metal, has previously been 
demonstrated by Norton and co-workers by using iminium tetrafluoroborate 
salts (See also Scheme 1.42).16'17
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Scheme 2.6: Asymmetric hydrogenation of imines via metal-counteranion cooperative
catalysis.
The excellent results reported prompted us to extend the application of this 
cooperative catalysis to DARA of ketones. As mentioned in Chapter 1, this is a 
more desirable approach for the synthesis of chiral amines, because the tedious 
isolation of imine intermediate is avoided. However, the catalyst must be 
highly selective for the reduction of C=N over C=0 double bonds, as the 
ketone is present in the reaction media in excess. The development of 
cooperative catalysis applied to DARA of ketones was undertaken by two PhD 
students with one focusing on aromatic ketones,15 while the other on aliphatic 
ketones. Herein it is described the DARA of aliphatic ketones, for which only 
few catalysts have been reported.11’18
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2.2 Results and Discussion
2.2.1 DARA of aliphatic ketones
Pi.
H2
Pi
6 7
6a: X: Cl 
6b: X: 7-H 
6c: X: 1b-H
Figure 2.1: Structures of chiral Ir(III) catalysts 6 and achiral phosphoric acid 7.
We started with optimization of the DARA conditions by considering the 
model reaction of 4-methylpentan-2-one 8 with /?-anisidine. Table 2.1 
summarises the results. While the complex 6a (Figure 2.1) was inactive in the 
DARA of 8 (entry 1), exchange of the chloride for a non-coordinating 
counteranion such as SbFg and PF^’ allows the reaction to occur’, but with low 
ee’s (15 and 35%, respectively) (entries 2 and 3). Changing to the pseudo- 
chiral anion 7-H, the enantioselectivity rose to 47% (entry 4). This prompted us 
to search for an Ir(III)-diamine complex containing a chiral counteranion.
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Table 2.1: Optimisation of conditions for the DARA of 8."
Entry [Ir] Additive Conv. (%)b Ee(%)c
1 6a - N.R. (17 h) -
2 6a AgSbF6 (2 mol%) 42 (17 h) 15 (R)
3 6a AgPF6 (2 mol%) 60 (17 h) 35 (R)
4 6b - 11 (17 h) 47 (R)
5 6b 7 (5 mol%) 28 (17 h) 46 (R)
6 6c - 19 84 (S)
7 6c lb (1 mol%) 42 85 (S)
8 6c lb (5 mol%) 60 86 (S)
9 6c lb (8 mol%) 67 89 (S)
10 6c 4 A MS (50 mg) 30 85 (S)
11 6c 4 A MS (100 mg) 50 86 (S)
12 6c 4 AMS 59 86 (S)
13 6c 4 A MS (200 mg) 59 86 (S)
14 6c lb (1 mol%), 4 A MS 58 85 (S)
15 6c lb (5 mol%), 4 A MS 63 86 (S)
16 6c lb (8 mol%), 4 A MS 72 86 (S)
17d 6c 4 A MS 57 (24 h) 91 (S)
18 5 - 5 -
19 5 4 A MS 7 -
20 5 lb (8 mol%) 50 n (S)
21 5 lb (8 mol%), 4 A MS 60 74 (S)
22 6c 4 A MS >99 (12 h) 87 (S)
"Reaction conditions: 0.55 mmol of 8, 0.5 mmol of jP-anisidine, 1 mol% of 
catalyst, 2 mL of toluene, 5 bar of H2, 35 °C, 150 mg of 4 A MS when added 
unless specified, 6 hours unless specified, Conversion of jo-anisidine, 
determined by 'H NMR analysis of the crude product. cDetermined by HPLC 
analysis; d 20 °C.
Thus, as reported before,9,19 when we moved to the chiral phosphate Ib-H 
(6c) a 19% conversion and a much higher enantioselectivity of 84% were
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observed in 6 hours reaction time (entry 6). Aiming to boost the conversion and 
ee, we then studied the effect of extra acid lb and molecular sieves on the 
DARA. As can be seen, additional lb indeed resulted in a faster reaction; but 
its effect on the enantioselectivity was less significant than that for DARA of 
aromatic ketones19 (entries 6 vs 7-9). In a similar way, the presence of 
molecular sieves (MS) increased the reaction rate but not the enantioselectivity 
(entries 6 vs 10-13). We presume that the presence of the MS benefits the 
ketimine formation by removal of water from the reaction media. Furthermore, 
we were pleased to discover that in the presence of the MS, the acid lb is no 
longer critical to the DARA rate and ee (entry 12 vs 16), an observation that is 
in contrast to what was observed in the DARA of aromatic ketones.19
The observations above point to an easier ketimine formation in the 
DARA of aliphatic ketones, hi the case of aromatic ketones, the reaction 
appears to be limited by this step and hence necessitates both a Bronsted acid 
and MS, which can catalyse the ketone-amine condensation and help shift the 
resulting equilibrium by removing water.9,19 Scheme 2.7 illustrates a 
competition reaction between an aromatic (acetophenone) and an aliphatic 
ketone, which led to the predominant DARA of 8, showing that aromatic 
ketones are essentially inactive under the conditions employed. When dealing 
with the aliphatic ketones, we also noted that there was no competition 
between hydrogenation of ketones over imines; the ketones were not reduced 
under the DARA conditions.
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r ■OMe
O
Ph
+
O
h2n
OMe
1mol% 6c,
V 4 A MS, toluene, j 
f 5 bar H2i 35 °C, 8 h
Ph
HN'
A
3
3% conv,
HN
OMe
8
J
9a
^ 75% conv.
Scheme 2.7: Competitive DARA of an aromatic and an aliphatic ketone with /?-anisidine.
A quick screening on the ligand showed that catalyst 6c surpassed 5 in 
terms of activity and enantioselectivity (entry 16 vs 21). In addition, the effect 
of temperature was also studied. Although a slight increase in the 
enantioselectivity was observed (entry 17), lowering the temperature to 20 °C 
afforded only a 57% conversion after 24 hours. Finally, we confirmed that the 
reaction went to completion in 12 hours reaction time (entry 22). Hence, the 
optimum reaction conditions are catalyst 6c and MS (150 mg), and we deemed 
the addition of extra lb unnecessary, avoiding the use of an expensive chiral 
acid (entry 22).
Next, we explored the application of the optimised reaction conditions to a 
variety of aliphatic ketones and aromatic amines. As can be seen, a wide range 
of aliphatic ketones were readily aminated with p-anisidine and w-anisidine 
(Table 2.2) and relatively more electron-deficient anilines (Table 2.3) under 5 
bar of H2 at 35 °C. The amines 9, 10 and 11 were obtained with good yields 
and excellent enantioselectivities in general. Notably, the catalyst tolerates
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other reducible functional groups in the substrates, such as terminal (9i) and 
internal alkenes (9j, lOh, lie) and highly strained cyclopropyl ring (9h, lOi, 
Ilf).
Table 2.2 presents the results for the DARA with p-anisidine and m- 
anisidine. Compared to our results reported for inline hydrogenation at 20 °C 
(9a, 9e, 9i),9 the enantioselectivity is slightly lower, but with the advantage of 
not isolating the imines.
The product 9c was previously obtained in 84% ee,20 via the reduction of 
the corresponding enantiomerically pure a-sulfinylketimine followed by 
desulfmylation. 9e appeared in the DARA with the Pd-(i?)-BINAP, showing a 
slightly lower ee (76%).18 The amine 9i was obtained by Macmillan et al in 
90% ee in DARA with HEH, but requiring a long reaction time (96 hours).11 
Finally, the amine 9j has also been reported, as the product of the 
hydrosilylation of the corresponding imine with 90% ee?]
With the sterically more demanding w-anisidine, both the yields and ee’s 
remained good, albeit lower than those with p-anisidine in most cases (Table 
2.2). This lowering in ee may stem from a less favoured interaction of the 
iminium ion with either the metal catalyst or the counteranion or both. Worthy 
of particular mention is the amine 10c, where the catalyst is capable of 
differentiating an isopropyl and a methyl group, affording an excellent 90% ee. 
The amines lOe, lOh and lOi have been previously reported as products for a 
tandem intermolecular hydroamination-transfer hydrogenation of alkynes.22 
Although similar enantioselectivities were achieved, much longer reaction 
times appear to be necessary (up to 72 hours).
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In general, the products arising from the DARA of alkyl-methyl ketones 
with /7-anisidine and w-anisidine are obtained with good yields and excellent 
ee’s. However, the enantioselectivity dropped significantly when alkyl-ethyl 
ketones were aminated (9f, 9g, lOf, lOg). Clearly, the catalyst is unable to 
discriminate efficiently an ethyl from a butyl or pentyl group. This problem 
might be addressed by modifying the chiral counteranion.
Table 2,2: DARA of aliphatic ketones with />anisidine and w-anisidine.a
O
11 +
R1 R2 H2N
R, 1 mol% [Ir], toluene, 
5 bar H2i 35 °C
Ri R2
R3 - p-OMe R3 = m-OMe
Ketone Product Yield Product Yield
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“Reaction conditions: 0.55 mmol of ketone, 0.5 mmol of ^-anisidine, 1 mol% of 6c, 2 mL of 
toluene, 150 mg of 4 A MS, 5 bar of H2, 35 °C, 12-20 hours. bDetermined by HPLC; S 
configuration, assigned by comparison with the literature.11 c~ 2% d.e.
We then investigated DARA of aliphatic ketones with aniline and more 
electron-deficient analogues. Amines 11 were obtained with good yields and 
enantioselectivities (Table 2.3). Of particular note is that />bromoaniline also 
reacted, giving rise to a decent yield and enantioselectivity, albeit in a longer 
reaction time (llh). Other aliphatic ketones were also aminated with p- 
bromoaniline as well as />chloroaniline, affording 70-90% yields. However, 
we have not been able to find suitable conditions to separate the enantiomers 
by HPLC; so they are not included in this chapter. Compounds 11a and lib 
were previously obtained in DARA with the [PdBr2((A)-BINAP)]catalyst,18
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with only a 51% and 10% ee, respectively. A poor enantioselectivity (17%) 
was also observed for the amine 11b in the hydrogenation of the corresponding 
imine with a cationic Ir(I) complex containing a chiral 
phosphanodihydrooxazole ligand.23 Similarly, the amine lid was previously 
obtained in only 18% ee in the literature.24
Table 2.3: DARA with aniline and/?-bromoaniline.a
Entry Product Yield (%) Ee (%)b
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Br
70 84
'Same conditions as those in Table 2.2, except with 0.5 mmol aniline.
’Determined by HPLC. c0.5 mmol />bromoaniline, 30 hours.
To further appreciate how steric effects affect the cooperative DARA, we 
compared the amination of the ketones in Figure 2.2 with /7-anisidine. As can 
be seen, with increasing steric hindrance near the carbonyl carbon, the DARA 
becomes slower, and no amination was observed with the sterically most 
demanding te/Y-butylmethyl ketone, even after 24 hours. This reduction in rate 
is most likely a result of increased difficulty in hydride transfer. The 
enantioselectivity is, however, more difficult to explain, as it does not follow 
the trend of reaction rate and is highest with a sterically bulky ketone (entries 2 
vs 1 and 3, Table 2.2). This is probably a reflection of the enantioselectivity 
being controlled by both the h(III) catalyst and its counteranion. The former is 
responsible for hydride delivery and would be expected to respond to steric 
effects in the manner observed.
Figure 2.2: Conversion observed in the DARA with 1 mol% 6c at 5 bar H2 and 35 °C in 8
hours.
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2.2.2 DARA with aliphatic amine
After the excellent results obtained for DARA with aromatic amines,19’25 
we then decided to extend the scope to DARA with aliphatic amines. The 
benzyl protecting group can be easily removed by hydrogenolysis with Pd/C, 
offering an attractive route for the synthesis of chiral primary amines.26 There 
are only few examples in the literature for the asymmetric hydrogenation of N- 
benzyl imines where high enantioselectivity is reported.27'30 There are even 
fewer examples for the DARA with vV-benzyl amines. As mentioned in Chapter 
1, Kadyrov and Bonier reported the Rh-catalysed DARA of a-keto acids for 
the synthesis of cc-TV-benzylamino acids with moderate to good 
enantioselectivities (50-91% e<?).31 List et al reported the organocatalytic 
DARA of ketones with benzylamine using la as the catalyst, with 
enantioselectivities in the range of 26-88% ee.26
We applied the optimised conditions for DARA with vV-aryl amines. To 
our disappointment, treatment of acetophenone with benzylamine in those 
conditions gave almost no conversion to amine 12 (Scheme 2.8).
1 mol% 5, 5 mol% 1b, 
4 A MS, toluene,
5 bar H2, 35 °C, 17h
O
No reaction
Scheme 2.8: Attempt of DARA with an aliphatic amine using metal-Bronsted acid bifunctional
catalyst 5.
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We reasoned that the high basicity of benzylamine (pKa: 9.34)32 could 
lead to deactivation of the catalyst, presumably by either coordination to the 
vacant site or by deprotonation of the ligand leading to the inactive Ibeamido 
complex. To support this idea, we compared the DARA of acetophenone with 
/7-anisidine in the absence and in the presence of benzylamine. When 
benzylamine is present, there is negligible conversion to any of the possible 
hydr ogenation products, supporting the idea of the catalyst being poisoned by 
the amine (Scheme 2.9).
Scheme 2.9: Competition reaction of DARA between aromatic and aliphatic amine.
We then considered changing the solvent in order to discourage the 
deactivation of the catalyst by benzylamine. The results are shown in Table 
2.4. Neither DCM (entry 2) nor a variety of alcohol solvents (entries 3-5) 
allowed the imine reduction. Only when CF3CH2OH (TFE) was used as 
solvent, the reduction of the imine occurred (entry 6). Unfortunately, the amine 
product was obtained as a racemic mixture. The modification of the chiral 
ligand in the complex did not show any improvement (entries 6-9), even when 
the ligand possessed an extra stereogenic centre (entry 9).
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Table 2,4: Solvent and catalyst effect on the DARA of acetophenone with benzyl amine.3
O
1 mol% [Ir], 5 mol% 1b, 
NH2 4 A MS, solvent,
5 bar H2, 35 °C, 17 h
Ar
HIST /
12
13a: Ar: a.S-tCFaMCeHg) 
13b: R: 2-(S)-Camphor
Entry [It] Solvent Yield 15 (%)c Ee (%)d
1 6c Toluene 11 N.D.
2 6c DCM N.R. -
3 6c MeOH 6 N.D.
4 6c 1,3-Propanediol N.R. -
5 6c Isopropanol N.R. -
6 6c TFE 91 0
7b 5 TFE 52 0
8b 13a TFE 44 0
9b 13b TFE 42 0
"Reaction conditions: 0.3 mmol of acetophenone, 0.25 mmol of benzylamine, 1
mol% of catalyst, 5 mol% of lb, 2 mL of toluene, 150 mg of 4 A MS, 5 bar of H2, 
35 °C, 17 horn’s. *8 h. CN.R., no reaction. dN.D., not determined.
The lack of enantiodiscrimination suggests that neither the chiral 
counterion nor the chiral ligand participate in the reduction step. It is 
understood that the counterion ion-pairs with the imine substrate by hydrogen 
bonding; as expected, a polar protic solvent would not favour the ion-pairing. 
Furthermore, we propose that the chiral ligand may be displaced in the metal 
complex by the imine intermediate, which might coordinate to the metal centre
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by cyclometallation. A parallel work developed within the group showed that 
an Ir-imine cyclometallated complex was the active catalyst in the reductive 
amination by transfer hydrogenation.33
2.2.3 DARA of a-branched aldehyde
With the excellent results obtained for DARA of ketones in hand for the 
synthesis of a-chiral amines, we then decided to explore the potential of this 
metal-Bronsted acid cooperative catalysis for the DARA of a-branched 
aldehydes. This would result in a new methodology for the synthesis of [3- 
chiral amines. To our knowledge, this methodology has only previously 
described by List and co-workers, using lb as the organocatalyst and Et-HEH 
as the hydrogen source.14
As a starting point for our study, we applied the DARA conditions for 
aliphatic ketones to the reaction of a—branched aldehyde 14 with />anisidine. 
However, only 70% conversion and 20% ee were obtained after miming the 
reaction overnight (Scheme 2.10). To improve this preliminary result, we 
studied the effect of acid catalyst, metal centre, ligand, solvent and temperature 
for DARA of a-branched aldehyde 14 with p-anisidine. The results are 
outlined below.
1 mol% 5,
4 A MS.Toluene,
5 bar H2, 35 °C, 17 h
14 15
20% ee
Scheme 2.10: Catalyst applied for the DARA of a-branched aldehyde 11.
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The effect of the metal centre was studied. [RhCp*Cl2]2 showed to be 
superior over the iridium analogue and [RuO-cymene)Cl2]2 (Table 2.5). 
Enamine 16 is not reduced in the presence of the ruthenium dimer (entry 1) and 
only 10% ee was obtained when [IrCp*Cl2]2 was used as a catalyst (entry 2). 
The effect of the chiral diamine ligand was then studied using rhodium as the 
metal centre (Table 2.5, entries 4-7). More electron-deficient ligands provided 
an increase in enantioselectivity (entries 6 and 7). However, this increase was 
insignificantly beneficial (entries 4, 5 vs 6, 7).
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Table 2.5: Effect of metal centre.'
H
1 mol% catalyst,
5 mol% 1 b, toluene, 
5 bar H2, 35 °C, 17h 'OMe14
15
+
H2N
■OMe
OMe
Ar
l
16
0=S=0
I Rh ^
H2
17 X: Ib-H
17a: Ar: 4-MeO(C6H4)
17b: Ar: 2,4,6-(C3H7)3(C6H2) 
17c: Ar: 2-naphthyl 
17d: Ar: 3,5-(CF3)2(C6H3)
Entry Catalyst Conv. to 15 (%)b
Conv. to
16 (%)b
EelS
(%)c
1 [Ru(p-cymene)Cl2]2 2 71 N.D.
2 [IrCp*Cl2]2 74 16 10
3 [RhCp*Cl2]2 70 28 30
4 17a 69 31 35
5 17b 83 17 36
6 17c 84 16 39
7 17d 85 15 42
"Reaction conditions: 0.3 mmol of 14, 0.25 mmol of /j-anisidine, 1 mol%
of catalyst, 5 mol% of lb, 2 mL of toluene, 5 bar of H2, 35 0C, 17 hours. 
bDetermined by !H NMR. determined by HPLC; N.D., not determined.
Table 2.6 shows the effect of the presence of Bronsted acid in the reaction. 
As observed for DARA of aromatic ketones, the presence of acid had a positive 
effect on the conversion (entries 2-4). It was understood that the acid would 
catalyse the inline formation, as well as the imine reduction. However, the 
enamine intermediate is formed without the need of acid catalysis (entry 1),
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suggesting that the Breasted acid exclusively catalyses the reduction step. 
Although best results were obtained when 10 mol% of lb was used (entry 4), 
we continued the following screening with only 5 mol%, to ensure the catalyst 
loading remains low.
Table 2.6: Effect of Bransted acid.8
Entry mol% lb Conv. to 15 (%)b
Conv. to 16 
(%)b
Ee 15 
(%)c
1 - 0 91 N.D.
2 1 22 75 24
3 5 70 28 30
4 10 90 8 34
aReaction conditions were the same as those in Table 2.6 except 1 mol% 
[RhCp*Cl2]2 and 0-10 mol% lb. determined by 'H NMR, determined by 
HPLC; N.D., not determined.
We then run a solvent screening (Table 2.7). Water and THF do not 
facilitate the reduction of 16 (entries 1 and 2). Methanol, a polar protic solvent, 
led to a racemic mixture of the imine (entry 3). It is understood that the 
corresponding anion of lb forms an ion-pair with the iminium cation by 
hydrogen bonding, and polar protic solvents do not facilitate the ion-pairing. 
Halogenated solvents provided higher selectivity compared to toluene (entries 
6-9 vs 10). However, the best enantioselectivity was obtained with an aprotic 
solvent MTBE (entry 11), although only 53% ee was reached. The presence of
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MS and reaction at lower temperature were also studied. However, the 
enantioselectivity remained moderate (up to 53% ee). Therefore, a scope of 
substrates was not developed.
Table 2.7: Solvent screening.
1 mol% 17b, 5 mol% 1b, 
5 bar H2, 35 °C, 17 h
Entry3 Solvent Conv. to IS (%)b
Conv. to 
16 (%)b
Ee 15
(%)c
1 h2o 0 100 N.D.
2 THF 11 77 N.D.
3 MeOH 73 11 < 1
4 MeCN 40 60 16
5 DCM 74 19 46
6 DCE 56 44 39
7 CHCls 72 23 45
8 CH2Br2 50 43 46
9 Chlorobenzene 79 21 40
10 Toluene 79 21 36
11 MTBE 82 17 53
“Reaction conditions were the same as those in Table 2.6 except 1 
mol% 17b. bDetermined by ‘H NMR. determined by HPLC; N.D., 
not determined.
2.3 Conclusions and future work
In conclusion, we have developed an efficient catalyst for DARA of 
ketones. The corresponding catalyst, formed by the combination of a chiral 
metal complex and a chiral phosphate counteranion, allows excellent yields
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and enantioselectivities for a wide range of aliphatic ketones and aromatic 
amines. In conjunction with the work on aromatic ketones also developed 
within the group, this catalyst appears to be one of the best for DARA. The 
reaction works at low hydrogen pressure and mild temperature. Investigations 
into the mechanism of the reaction are currently undergoing by other members 
of this research group.
Several limitations have been found, however. Only moderate 
enantioselectivities are obtained for the DARA of a-branched aldehydes. It is 
more difficult to induce selectivity on these substrates, as the chiral centre 
formed does not form part of the double bond reduced. In addition, the DARA 
with aliphatic amines is not possible under the general conditions developed 
due to deactivation of the catalyst. The reaction can only take place in TFE; but 
only racemic mixtures were obtained.
The publication of this cooperative Ir-phosphate catalysis for the DARA of 
ketones has prompted other research groups to extend this chemistry to other 
substrates and/or greener and cheaper catalysts. As shown in Chapter 1, 
Rueping and co-workers studied the asymmetric hydrogenation of quinolines 
with the combination of a racemic Ir-complex and a chiral phosphoramide. 
However, only moderate enantioselectivities (up to 82% ee) were reported 
(Scheme 2.11).34
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1 mol% 18, 1 mol% 19, 
o-xylene,
100 bar H?, 20 °C, 24 h
82% ee
o=s=o
R: 9-phenanthryl
18 19
Sclieme 2.11: Asymmetric hydrogenation of quinolines with racemic metal catalyst and chiral
N-triflylphosphoramides.
More recently, Beller and co-workers reported the asymmetric 
hydrogenation of acyclic imines by the cooperative catalysis of Knolker’s 
complex 20 and phosphoric acid lb, with high enantioselectivities reported 
(Scheme 2.12).35 This leads to a cheaper and more eco-friendly cooperative 
catalyst for the synthesis of chiral amines by asymmetric hydrogenation.
20
92% ee
Scheme 2.12: Asymmetric hydrogenation of imines with cooperative Fe-complex and chiral
phosphoric acid.
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2.4. Experimental
General procedure for the synthesis of complex 5 and its derivatives
Ar
I
ArAr
o=s=o
KQH, PCM
H H2
X: 1b-H 
5
Ar: 2,416-(2-C3H7)3C6H2
21 22
To an oven-dried Schlenk tube equipped with stir bar was added 
[IrCp*Cl2]2 (0.3 mmol) and (0.6 mmol). The Schlenk tube was then
degassed 3 times with N2. Freshly distilled DCM was added (2 mL). An excess 
of aqueous solution of KOH was then added.36 The reaction mixture was left 
stirring at room temperature for 3 hours. The mixture was washed with H20 (2 
x 5 mL). The organic layer was dried over MgS04, filtered through celite and 
concentrated to afford the crude product. 16e amido Ir complex (S,S)-22 was 
used in the following step without further purification.
A solution of lb (113 mg, 0.15 mmol) in freshly distilled DCM (5 mL) 
was added dropwise into a solution of the corresponding (S,S)-22 (0.15 mmol) 
in DCM (5 mL) under a nitrogen atmosphere at room temperature over a 
period of 30 minutes. After the solution was stirred for another 30 minutes, the 
solvent was removed in vacuo. The resulting red solid was used for 
hydrogenation without further purification. 6c complex was synthesised 
following a similar method.
General procedure for the DARA of ketones:
To a glass liner equipped with a stir bar was added 4 A MS (150 mg), 
aliphatic ketone (0.55 mmol), amine (0.5 mmol), catalyst (5 pmol) and distilled
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toluene (2 mL). The glass liner was then placed into an autoclave, followed by 
degassing with H2 three times. The hydrogenation was carried out at 5 bar H2 
with stirring at 1000 rpm, 35 °C for 12-30 hours. The hydrogen gas was then 
carefully released in a fume hood and the solution was filtered, transferred to a 
flask, and concentrated to afford the crude product. Flash chromatography 
purification with a column of silica gel eluted with petroleum ether/ethyl 
acetate (15/1) yielded the desired amine product.
2.5. Analytical data
Compounds 5, 6c, 9b, 9f-h, 9k, lOa-d, lOf-g, lOj, lle-h are new compounds.
5
5 was obtained as a red solid according to the general procedure.
Mp = 210°C dec.
^ NMR (CDC13, 400 MHz) 5 0.92 (d, J= 6.8 Hz, 12H), 1.11 (d, J= 6.8 Hz, 
12H), 1.16 (d, 12 Hz, 12H), 1.18 (d, J= 12 Hz, 6H), 1.24 (d, 7.2 Hz,
12H), 2.02 (s, 15H), 2.54-2.62 (m, 2H), 2.68-2.79 (m, 2H), 2.85-2.91 (m, 2H), 
2.94 (bis, 1H), 3.73-3.80 (m, 2H), 3.93-3.95 (m, 1H), 5.36 (br, 1 H), 6.83 (s, 
2H), 6.99 (s, 2H), 7.03 (s, 2H), 7.09-7.17 (m, 8H), 7.21-7.30 (m, 6H), 7.40 (t, J 
= 6.8 Hz, 2H), 7.77 (s, 2H), 7.85 (d, J= 8.0 Hz, 2H);
13C NMR (CDCI3, 100 MHz) S 10.8, 23.8, 24.1, 24.5, 24.7, 25.5, 26.9, 29.7, 
31.1, 31.2, 34.4, 34.7, 73.2, 81.7, 85.7, 120.3, 121.0, 123.0, 124.9, 125.8,
126.7, 127.0, 127.3, 127.8, 128.3, 128.4, 130.7, 132.0, 133.2, 133.3, 133.4,
133.7, 134.5, 146.5, 147.4, 148.0, 148.6, 150.8, 151.0;
31P NMR (CDCI3, 162 MHz) 8 7.0;
IR (neat) 3660 (w), 2977 (s), 2889 (m), 2364 (w), 2337 (w), 1388 (m), 1095 
(s), 964 (m) cm'1;
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HRMS (ES) for [C39H52N202SmIr]+ [M - CsoEfeCUPf: Calcd: 805.3379; 
Found: 805.3391.
6c
6c was obtained as a red solid according to the general procedure.
Mp = 205°C dec.
^ NMR (CDC13, 400 MHz) 5 0.94 (d, J= 6.8 Hz, 12H), 1.12 (d, J= 6.8 Hz, 
6H), 1.20 (d, J= 12 Hz, 6H), 1.26 (d, 6.8 Hz, 12H), 1.99 (s, 6H), 2.00 (s,
6H), 2.06 (s, 15H), 2.16 (s, 3H), 2.58-2.64 (m, 2H), 2.70-2.79 (m, 2H), 2.86- 
2.93 (m, 2H), 2.99 (brs, 1H), 3.95 (s, 1H), 4.00 (s, 1H), 5.17 (br, 1H), 7.00 (s, 
2H), 7.04 (s, 2H), 7.13-7.31 (m, 12H), 7.40-7.44 (m, 4H), 7.99 (s, 2H), 7.86 (d, 
J= 8.0 Hz, 2H);
13C NMR (CDCI3, 100 MHz) 8 9.3, 15.7, 16.4, 17.7, 22.3, 22.9, 23.2, 23.9, 
25.3, 29.6, 33.1, 77.9, 78.8, 84.1, 119.2, 121.3, 123.0, 124.0, 124.8, 124.9,
125.8, 126.0, 126.1, 126.5, 128.9, 130.2, 131.4, 131.6, 131.9, 132.0, 133.9,
135.8, 143.7, 145.9, 146.1, 146.8;
31P NMR (CDCI3, 162 MHz) 5 6.9;
IR (neat) 3652 (w), 2977 (s), 2889 (m), 2360 (w), 2333 (w), 1384 (m), 952 
(m), 632 (s) cm'1;
HRMS (ES) for [C35H44N202S193Ir]+ [M - CsoHseC^Pf: Calcd: 749.2753; 
Found: 749.2733.
OMe
4-Metlioxy-7V-(4-methylpentan-2-yl)aniline.9 The product (94 mg, 91% yield, 
87% ee) was obtained according to the general procedure as a colourless oil 
from 4-methylpentan-2-one (55 mg, 0.55 mmol) and p-anisidine (62 mg, 0.5 
mmol) in 12 h;
JH NMR (400 MHz, CDCI3) 8 0.83 (d, /= 6.6 Hz, 3H), 0.85 (d, 6.6 Hz,
3H), 1.05 (d, J = 6.3 Hz, 3H), 1.15 (dt, J = 13.7, 6.9 Hz, 1H), 1.37 (dt, J = 
13.7, 6.9 Hz, 1H), 1.62-1.72 (m, 1H), 2.92 (brs, 1H), 3.31-3.39 (m, 1H), 3.66 
(s, 3H), 6.45-6.49 (m, 2H), 6.67-6.71 (m, 2H);
13C NMR (100 MHz, CDC13) 8 21.5, 22.9, 23.4, 25.5, 47.4, 48.0, 56.2, 115.1, 
115.4, 142.3, 152.2;
IR (neat) 3656 (w), 2977 (m), 2885 (w), 1512 (s), 1234 (m), 1037 (m), 818 (m) 
cm'1;
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HRMS for C13H22NO [M+H]+: Calcd: 208.1701; Found: 208.1705;
HPLC (Chiralcel OD-H, hexane:isopropanol = 99:1, flow rate 0.5 mL/min, X ~ 
254 rnn): tR = 13.5 min (minor), tR = 14.6 min (major).
4-Methoxy-A^-(3-methylpentan-2“yl)aniline. Mixtm’e of diastereoisomers 
51:49. The product (85 mg, 82% yield, 96% ee) was obtained according the 
general procedure as a colourless oil from (+/-)-3-methylpentan-2-one (55 mg, 
0.55 mmol) andp-anisidine (62 mg, 0.5 mmol) in 20 h;
^ NMR (400 MHz, CDC13) 5 0.84-0.94 (m, 6H), 1.03 (d, /= 8.6 Hz, 1.5H), 
1.07 (d, /= 7.6 Hz, 1.5H), 1.13-1.25 (m, 1H), 1.42-1.63 (m, 2H), 3.31-3.40 (m, 
1H), 3.74 (s, 3H), 6.55-6.58 (m, 2H), 6.74-6.78 (m, 2H);
13C NMR (100 MHz, CDC13) 5 12.3(7), 12.4(3), 14.0, 15.7, 16.0, 17.6, 25.2, 
27.0, 38.6, 39.5, 53.5, 54.1, 56.2,115.2, 115.4, 142.5,152.2;
HRMS for C13H22NO [M+Hf: Calcd: 208.1701; Found: 208.1697;
HPLC (Chiralcel OD-H, hexane:isopropanol = 99:1, flow rate 0.5 mL/min, X = 
254 nm): tR = 12.0 min (dl, minor), tR = 12.9 min (d2, minor), tR = 13.8 (dl, 
major), tR = 14.8 (d2, major).
4-Methoxy-iV-(pentan-2-yl)aniline.20 The product (85 mg, 88% yield, 90% ee) 
was obtained according to the general procedure as a colourless oil from 2- 
pentanone (47 mg, 0.55 mmol) andp-anisidine (62 mg, 0.5 mmol) in 20 h;
NMR (400 MHz, CDC13) 5 0.92 (t, J= 7.1 Hz, 3H), 1.14 (d, J= 6.3 Hz, 
3H), 1.33-1.45 (m, 3H), 1.50-1.57 (m, 1H), 3.11 (brs, 1H), 3.38 (sextet, J= 6.3 
Hz, 1H), 3.74 (s, 3H), 6.53-6.57 (m, 2H), 6.75-6.79 (m, 2H);
13C NMR (100 MHz, CDC13) 5 14.6, 19.8,21.2,39.9, 49.6, 56.2, 115.1, 115.4, 
142.4, 152.2;
HRMS forCi2H2oNO [M+H]+: Calcd: 194.1545; Found: 194.1539;
HPLC (Chiralcel OD-H, hexanedsopropanol = 99:1, flow rate 0.5 mL/min, X = 
254 nm): tR = 15.1 min (minor), tR = 15.8 min (major).
4-Methoxy-/V-(hexan-2-yl)amline.37 The product (85 mg, 82% yield, 93% ee) 
was obtainedaccording to the general procedure as a colourless oil from 2- 
hexanone (55 mg, 0.55 mmol) andp-anisidine (62 mg, 0.5 mmol) in 20 h;
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^ NMR (400 MHz, CDC13) 5 0.90 (t, J= 7.1 Hz, 3H), 1.15 (d, 6.3 Hz,
3H), 1.30-1.42 (m, 5H), 1.53-1.59 (m, 1H), 3.36 (sextet, J= 6.3 Hz, 1H), 3.74 
(s, 3H), 6.53-6.57 (m, 2H), 6.75-6.79 (m, 2H);
13C NMR (100 MHz, CDC13) 5 14.5, 21.2, 23.2, 28.8, 37.4, 49.9, 56.3, 115.1, 
115.4, 142.5, 152.2;
HRMS for C]3H22NO [M+H]+: Calcd: 208.1701; Found: 208.1705;
HPLC (Chiralcel OD-H, hexane:isopropanol = 99:1, flow rate 0.5 mL/min, X = 
254 mn): tR = 14.1 min (minor), tR = 14.7 min (major).
.OMe
9e
7^-(Heptan-2-yl)-4-methoxyaniline.9,18 The product (87 mg, 79% yield, 91% 
ee) was obtainedaccording to the general procedure as a colourless oil from 2- 
heptanone (63 mg, 0.55 mmol) andp-anisidine (62 mg, 0.5 mmol) in 20 h;
^ NMR (CDCI3, 400 MHz) 5 0.89 (t, /= 6.8 Hz, 3H), 1.14 (d, J= 6.3 Hz, 
3H), 1.24-1.32 (m, 4H), 1.34-1.43 (m, 3H), 1.50-1.59 (m, 1H), 3.12 (brs, 1H), 
3.32-3.39 (m, 1H),3.74 (s, 3H), 6.53-6.57 (m, 2H), 6.75-6.79 (m, 2H);
13C NMR (CDCI3, 100 MHz) 5 14.4, 21.2, 23.1, 26.3, 32.3, 37.6, 50.0, 56.3, 
115.1, 115.4, 142.4, 152.3;
IR (neat) 3656 (w), 2978 (s), 1512 (s), 1462 (m), 1381 (m), 1234 (s), 1153 (m), 
818 (m) cm*1;
HRMS for C14H24NO [M+Hf: Calcd: 222.1858; Found: 222.1852;
HPLC (Chiralcel OB-H, hexane:isopropanol = 99:1, flow rate 1.0 mL/min, X = 
254 nm): tR = 9.3 min (major), tR = 10.6 min (minor).
A^-(Heptan-3-yl)-4-methoxyaniline. The product (105 mg, 95% yield, 49% ee) 
was obtainedaccording to the general procedure as a colourless oil from 3- 
heptanone (63 mg, 0.55 mmol) andp-anisidine (62 mg, 0.5 mmol) in 20 h;
^ NMR (CDCI3, 400 MHz) 5 0.89 (t, J = 7.1 Hz, 3H), 0.91 (t, J = 7.5 Hz, 
3H), 1.26-1.59 (m, 8H), 3.18 (quintet, 6.0 Hz, 1H), 3.74 (s, 3H), 6.52-6.56 
(m, 2H), 6.74-6.78 (m, 2H);
13C NMR (CDCI3, 100 MHz) 5 10.4, 14.5, 23.3, 27.5, 28.6, 34.4, 55.5, 56.3, 
114.7, 115.4, 142.9, 151.9;
IR (neat) 3432 (w), 2981 (s), 2931 (m), 1601 (m), 1516 (m), 1458 (m), 1219 
(m), 1030 (m), 733 (s) cm*1;
HRMS for C14H24NO [M+Hf: Calcd: 222.1858; Found: 222.1850;
HPLC (Chiralcel OB-H, hexane:isopropanol = 99:1, flow rate 0.5 mL/min, X = 
254 nm): tR = 14.0 min (major), tR = 15.8 min (minor).
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OMe
4-Methoxy-Af-(octaii-3-yl)anilme. The product (94 mg, 80% yield, 71% ee) 
was obtainedaccording to the general procedure as a colourless oil from 3- 
octanone (71 mg, 0.55 mmol) andp-anisidine (62 mg, 0.5 mmol) in 20 h;
^ NMR (CDCls, 400 MHz) 5 0.86-0.93 (m, 6H), 1.27-1.59 (m, 10H), 3.14 
(brs, 1H), 3.18 (quintet, J = 5.9 Hz, 1H), 3.74 (s, 3H), 6.54 (d, J = 8.8 Hz, 
2H), 6.76 (d, J = 8.8 Hz, 2H);
13C NMR (CDC13, 100 MHz) 5 10.4, 14.5, 23.1, 26.1, 27.5, 32.5, 34.7, 55.5, 
56.3, 114.7, 115.3, 142.9, 151.9;
HRMS for Ci5H26NO[M+H]+: Calcd: 236.2009; Fomid: 236.2006;
HPLC (Chiralcel OB-H, hexane:isopropanol = 99:1, flow rate 1.0 mL/min, X = 
254 nm): 1r = 11.0 min (major), tR = 13.6 min (minor).
/OMe
HN
9h
N-( 1 -Cyclopropylethyl)-4-methoxyaniline. The product (86 mg, 90% yield, 
93% ee) was obtained according to the general procedure as a colourless oil 
from 1 -cyclopropylethanone (46 mg, 0.55 mmol) and p-anisidine (62 mg, 0.5 
mmol) in20h;
^ NMR (400 MHz, CDC13) 6 0.21-0.31 (m, 2H), 0.43-0.52 (m, 2H), 0.86- 
0.95 (m, 1H), 1.20 (d, J = 6.3 Hz, 3H), 2.82-2.89 (m, 1H), 3.74 (s, 3H), 6.56- 
6.60 (m, 2H), 6.74-6.78 (m, 2H);
13C NMR (100 MHz, CDCI3) 8 2.9, 3.6, 18.4, 20.7, 54.2, 56.2, 115.2, 115.5, 
142.6, 152.3;
HRMS for C12H18NO [M+H]+: Calcd: 192.1388; Found: 192.1381;
HPLC (Chiralcel OB-H, hexane:isopropanol = 99:1, flow rate 0.5 mL/min, X = 
254 mn): tR = 18.4 min (major), tR = 24.4 min (minor).
vV-(Hex-5-en-2-yl)-4-niethoxyaniline.9,11 The product (82 mg, 80% yield, 92% 
ee) was obtainedaccording to the general procedure as a colourless oil from 
hex-5-en-2-one (54 mg, 0.55 mmol) and /j-anisidinc (62 mg, 0.5 mmol) in 20 
h;
^ NMR (CDCI3, 400 MHz) 5 1.15 (d, J= 6.3 Hz, 3H), 1.38-1.47 (m, 1H), 
1.54-1.63 (m, 1H), 2.05-2.11 (m, 2H), 3.10 (brs, 1H), 3.33 (sextet, J= 6.3 Hz, 
1H), 3.67 (s, 3H), 4.88-4.92 (m, 1H), 4.96 (dq, J = 17.0, 1.7 Hz, 1H), 5.76 
(ddt, J= 17.0, 10.3, 6.7 Hz, 1FI), 6.46-6.50 (111, 2H), 6.68-6.72 (111, 2H);
13C NMR (CDCI3, 100 MHz) 8 21.2, 30.9, 36.7, 49.4, 56.2, 115.1, 115.2, 
115.4, 138.9, 142.3, 152.3;
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HRMS for Ci3H2oNO [M+H]+: Calcd: 206.1545; Found: 206.1547;
HPLC (Chiralcel OB-H, hexane:isopropanol = 99:1, flow rate 1.0 mL/min, X = 
254 nm): tR = 13.4 min (major), 1r = 15.8 min (minor).
4-Metlioxy-7/-(6-methylliept-5-en-2-yl)aniline.21 The product (104 mg, 89% 
yield, 95% ee) was obtained according to the general procedure as a colourless 
oil from 6-methylhept-5-en-2-one (69 mg, 0.55 mmol) and /7-anisidine (62 mg, 
0.5 mmol) in 20 h;
^ NMR (400 MHz, CDC13) 8 1.16 (d, J= 6.3 Hz, 3H), 1.39-1.48 (m, 1H), 
1.59 (s, 3H), 1.54-1.63 (m, 1H), 1.69 (d, /= 0.8 Hz, 3H), 2.05-2.10 (m, 2H), 
3.37 (sextet, J = 6.3 Hz, 1H), 3.74 (s, 3H), 5.10-5.14 (m, 1H), 6.53-6.57 (m, 
2H), 6.75-6.79 (m, 2H);
13C NMR (100 MHz, CDC13) 5 18.1, 21.2, 25.1, 26.1, 37.6, 49.5, 56.2, 115.1, 
115.3, 124.5, 132.4, 142.5, 152.3;
HRMS for C15H24NO [M+H]+: Calcd: 234.1858; Found: 234.1865;
HPLC (Chiralcel OB-H, hexane:isopropanol = 99:1, flow rate 0.5 mL/min, X = 
254 nm): tR = 21.6 min (major), tR = 26.9 min (minor).
iV-[4-(2H-l,3-Benzodioxol-5-yl)butan-2-yl]-4-methoxyaniline. The product 
(127 mg, 85% yield, 93% ee) was obtainedaccording to the general procedure 
as a colourless oil from 4-benzo[l,3]dioxol-5-yl-butan-2-one (106 mg, 0.55 
mmol) andp-anisidine (62 mg, 0.5 mmol) in 20 h;
!H NMR (400 MHz, CDC13) 8 1.18 (d, J = 6.4 Hz, 3H), 1.65-1.74 (m, 1H), 
1.78-1.87 (m, 1H), 2.64 (t, J= 7.9 Hz, 2H), 3.36-3.41 (m, 1H), 3.75 (s, 3H), 
5.92 (s, 2H), 6.53 (d, J= 8.5 Hz, 2H), 6.62 (d, J= 7.8 Hz, 1H), 6.67 (d, /= 1.6 
Hz, 1H), 6.72 (d, J= 7.8 Hz, 1H), 6.75-6.77 (m, 2H);
13C NMR (100 MFIz, CDC13) 8 21.3, 32.6, 39.5, 49.3, 56.2, 101.2, 108.6, 
109.3, 115.2, 115.4, 121.6, 136.4, 142.1,146.0, 148.0, 152.3;
HRMS for C]gH22N03 [M+H]+: Calcd: 300.1599; Found: 300.1590;
HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 1 mL/min, X = 
254 nm): tR = 28.7 min (major), tR = 38.6 min (minor).
3-Methoxy-/V-(4-methylpentan-2-yl)aniline. The product (75 mg, 72% yield, 
80% ee) was obtained according the general procedure as a colourless oil from
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4-inethyl-2-pentanone (55 mg, 0.55 mmol) and w-anisidine (62 mg, 0.5 mmol) 
in 20 h;
'H NMR (400 MHz, CDC13) 5 0.90 (d, 6.6 Hz, 3H), 0.94 (d, /= 6.6 Hz,
3H), 1.15 (d, J= 6.8 Hz, 3H), 1.25 (dt, J= 13.6, 6.8 Hz, 1H), 1.46 (dt,7= 13.6, 
6.9 Hz, 1H), 1.71-1.79 (m, 1H), 3.40 (brs, 1H), 3.46-3.54 (m, 1H), 3.76 (s, 3H), 
6.13 (t, J= 2.2 Hz, 1H), 6.21 (dd, J= 8.1, 2.2 Hz, 2H), 7.06 (t, J= 8.1 Hz, 1H); 
13C NMR (100 MHz, CDC13) 8 21.5, 23.0, 23.4, 25.5, 47.0, 47.3, 55.5, 99.3, 
102.2, 106.7, 130.4, 149.5, 161.3;
HRMS for C13H22NO [M+H]+: Calcd: 208.1701; Found: 208.1711;
HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X = 
254 nm): tR = 19.9 min (minor), tR = 21.9 min (major).
OMe
3-Methoxy-7V-(3-methylpentan-2-yl)anilme (10b). Mixture of diastereoisomers 
54:46.The product (85 mg, 82% yield, 96% ee) was obtained according the 
general procedure as a colourless oil from (+/-)-3-methylpentan-2-one (55 mg, 
0.55 mmol) and 7M-anisidine (62 mg, 0.5 mmol) in 20 h;
‘H NMR (400 MHz, CDC13) 8 0.86 (d, J = 6.8 Hz, 1.5H), 0.89 (t, J = 1A Hz, 
1.5H), 0.82-0.96 (m, 3H), 1.06 (d, J = 6.5 Hz, 1.5H), 1.10 (d, J = 6.5 Hz, 
1.5H), 1.13-1.23 (m, 1H), 1.44-1.65 (m, 2H), 3.40-3.45 (m, 1H), 3.53 (brs, 
1H), 3.76 (s, 3H), 6.13 (t, J= 2.2 Hz, 1H), 6.18-6.23 (m, 2H), 7.03-7.07 (m, 
1H);
13C NMR (100 MHz, CDC13) 8 12.3(6), 12.4(3), 14.2, 15.7, 16.3, 17.7, 25.3, 
26.9, 38.9, 39.6, 52.1, 52.7, 55.5, 99.2, 99.3, 101.9, 102.0, 106.6,(3), 106.6(7), 
130.4, 149.5, 149.7, 161.3;
HRMS for C13H22NO [M+H]+: Calcd: 208.1701; Found: 208.1700;
HPLC (Chiralcel OD-H, hexane:isopropanol = 99.5:0.5, flow rate 0.5 mL/min, 
X = 254 nm): tR = 46.7 min (dl, major), tR = 50.3 min (d2, major), tR = 55.6 
(dl, minor), tR = 58.2 (d2, minor).
HN OMe
10c
3-Methoxy-iV-(3-methylbutan-2-yl)aniline. The product (83 mg, 86% yield, 
90% ee) was obtained according the general procedure as a colourless oil from 
3-methylbutan-2-one (47 mg, 0.55 mmol) and w?-anisidine (62 mg, 0.5 mmol) 
in 20 h;
^ NMR (400 MHz, CDC13) 8 0.90 (d, J = 6.8 Hz, 3H), 0.96 (d, J = 8.0 Hz, 
3H), 1.09 (d, J = 6.5 Hz, 3H), 1.80-1.88 (m, 1H), 3.28-3.42 (m, 1H), 3.52 (brs, 
1H), 3.76 (s, 3H), 6.13 (t, J = 2.3 Hz, 1H), 6.18-6.23 (m, 2H), 7.05 (t, J = 8.1 
Hz, 1H);
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,3C NMR (100 MHz, CDC13) 8 17.0, 17.9, 19.6, 32.6, 53.8, 55.5, 99.3, 102.0, 
106.7, 130.4, 149.6, 161.3;
HRMS for C12H20NO [M+H]+: Calcd: 194.1539; Found: 194.1541;
HPLC (Chiralcel OB-II, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X = 
254 nm): tR = 10.9 min (minor), tR = 12.9 min (major).
OMe
3-Methoxy-7V-(pentan-2-yl)aniline. The product (74 mg, 77% yield, 91% ee) 
was obtained according the general procedure as a colourless oil from 2- 
pentanone (47 mg, 0.55 mmol) and m-anisidine (62 mg, 0.5 mmol) in 20 h;
^ NMR (400 MHz, CDC13) 5 0.92 (t, J = 7.1 Hz, 3H), 1.16 (d, J = 6.3 Hz, 
3H), 1.36-1.43 (m, 3H), 1.52-1.57 (m, 1H), 3.41-3.48 (m, 2H), 3.77 (s, 3H), 
6.13 (t, J = 2.3 Hz, 1H), 6.19 (ddd, J = 8.1, 2.3, 0.8 Hz, 1H), 6.23 (ddd, J = 
8.1,2.3,0.8 Hz, 1H), 7.06 (t,J =8.1 Hz, 1H);
13C NMR (100 MHz, CDC13) 8 14.5, 19.7, 21.2, 39.8, 48.7, 55.5, 99.5, 102.3, 
106.8, 130.4, 149.4,161.3;
HRMS for C13H22NO [M+H]+: Calcd: 194.1539; Found: 194.1540;
HPLC (Chiralcel OB-H, hexanensopropanol = 98:2, flow rate 0.5 mL/min, X ~ 
254 nm): tR = 14.4 min (minor), tR = 16.0 min (major).
OMe
7V-(Hexan-2-yl)-3-methoxyaniline.22 The product (88 mg, 85% yield, 92% ee) 
was obtained according the general procedure as a colourless oil from 2- 
hexanone (55 mg, 0.55 mmol) and w-anisidine (62 mg, 0.5 mmol) in 20 h;
^ NMR (400 MHz, CDC13) 8 0.90 (t, /= 7.1 Hz, 3H), 1.16 (d, 7= 6.3 Hz, 
3H), 1.30-1.45 (m, 5H), 1.52-1.58 (m, 1H), 3.43 (sextet, J= 6.3 Hz, 1H), 3.46 
(brs, 1H), 3.77 (s, 3H), 6.13 (t, J= 2.3 Hz, 1H), 6.18-6.24 (m, 2H), 7.06 (t, J = 
8.1 Hz, 1H);
13C NMR (100 MHz, CDC13) 8 14.5, 21.2, 23.2, 28.8, 37.3, 49.0, 55.5, 99.5, 
102.3, 106.8, 130.4, 149.3, 161.3;
HRMS for C13H22NO [M+H]+; Calcd: 208.1696; Found: 208.1696;
HPLC (Chiralcel OB-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X = 
254 nm): tR = 13.5 min (minor), tR = 15.5 min (major).
HN OMe
iV-(Heptan-3-yl)-3-methoxyaniline. The product (90 mg, 81% yield, 61% ee) 
was obtained according the general procedure as a colourless oil from 3- 
heptanone (63 mg, 0.55 mmol) and /n-anisidine (62 mg, 0.5 mmol) in 20 h;
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^ NMR (400 MHz, CDC13) 8 0.89 (t, /= 7.0 Hz, 3H), 0.91 (t, /= 7.4 Hz, 
3H), 1.24-1.63 (m, 8H), 3.25 (quintet, J= 6.0 Hz, 1H), 3.45 (brs, 1H), 3.77 (s, 
3H), 6.12 (t, 2.2 Hz, 1H), 6.17-6.22 (m, 2H), 7.05 (t, J= 8.1 Hz, 1H);
13C NMR (100 MHz, CDCI3) 8 10.5, 14.5, 23.3, 27.7, 28.6, 34.5, 54.5, 55.5, 
99.1, 101.8, 106.5, 130.4, 150.0, 161.3;
HRMS for C14H24NO[M+H]+: Calcd: 222.1852; Found: 222.1851;
HPLC (Chiralcel OB-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X = 
254 nm): tR ~ 12.6 min (minor), tR = 15.9 min (major).
"OMe
10g
3-Methoxy-A^-(octan-3-yl)aniline. The product (98 mg, 83% yield, 64% ee) 
was obtained according the general procedure as a colourless oil from 3- 
octanone (71 mg, 0.55 mmol) and w-anisidine (62 mg, 0.5 mmol) in 20 h;
’H NMR (400 MHz, CDCI3) 8 0.87 (t, J = 7.0 Hz, 3H), 0.91 (t, J = 7.5 Hz, 
3H), 1.25-1.61 (m, 10H), 3.22-3.28 (m, 1H), 3.44 (brs, 1H), 3.77 (s, 3H), 6.12 
(t, /= 2.2 Hz, 1H), 6.17-6.22 (m, 2H), 7.05 (t, J= 8.1 Hz, 1H);
13C NMR (100 MHz, CDC13) 8 10.5, 14.5, 23.1, 26.1, 27.7, 32.4, 34.8, 54.5, 
55.5, 99.1,101.8, 106.5, 130.4, 150.0, 161.3;
HRMS for C15H26NO[M+H]+: Calcd: 236.2009; Found: 236.2008;
HPLC (Chiralcel OJ, hexane:isopropanol = 99.5:0.5, flow rate 0.5 mL/min, X 
= 254 nm): tR = 21.2 min (major), tR = 25.2 min (minor).
OMe
l-(2,6-Dimethylhept-5-enyl)-3-methoxybenzene.22 The product (78 mg, 67% 
yield, 82% ee) was obtained according the general procedure as a colourless oil 
from 6-methylhept-5-en-2-one (69 mg, 0.55 mmol) and w-anisidine (62 mg, 
0.5 mmol) in 20 h;
^ NMR (400 MHz, CDC13) 8 1.17 (d, J= 6.3 Hz, 3H), 1.43-1.50 (m, 1H), 
1.55-1.64 (m, 1H), 1.59 (s, 3H), 1.69 (d, J= 0.8 Hz, 3H), 2.07 (q, J= 1A Hz, 
2H), 3.44 (sextet, J= 6.3 Hz, 1H), 3.51 (brs, 1H), 3.76 (s, 3H), 5.10-5.14 (m, 
1H), 6.13 (t, J= 2.2 Hz, 1H), 6.19 (dd, 8.0, 2.2 Hz, 1H), 6.23 (dd, J= 8.0, 
2.2 Hz, 1H), 7.05 (t, J= 8.0 Hz, 1H);
13C NMR (100 MHz, CDC13) 8 18.1, 21.2, 25.1, 26.1, 37.5, 48.6, 55.5, 99.4, 
102.3, 106.8, 124.4, 130.4, 132.5, 149.4, 161.3;
HRMS for Ci5H24NO[M+H]+: Calcd: 234.1858; Found: 234.1857;
HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X = 
254 nm): tR = 20.5 min (minor), tR = 21.6 min (major).
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HN OMe
10i
N~( 1 -Cyclopropylethyl)-3-methoxyamline.22 The product (59 mg, 62% yield, 
82% ee) was obtained according the general procedure as a colourless oil from 
1-cyclopropylethanone (46 mg, 0.55 mmol) and w-anisidine (62 mg, 0.5 mmol) 
in 20 h;
^ NMR (400 MHz, CDC13) 5 0.23-0.34 (m, 2H), 0.43-0.53 (m, 2H), 0.89- 
0.96 (m, 1H), 1.22 (d, J=6.3 Hz, 3H), 2.92-2.99 (m, 1H), 3.76 (s, 3H), 6.15 (t, 
J= 2.2 Hz, 1H), 6.20-6.25 (m, 2H), 7.05 (t, 8.1 Hz, 1H);
13C NMR (100 MHz, CDC13) 8 3.0, 3.5, 18.2, 20.6, 53.0, 55.5, 99.6, 102.5, 
106.9, 130.3, 149.5,161.2;
HRMS for C12H18NO [M+H]+: Calcd: 192.1383; Found: 192.1386;
HPLC (Chiralcel OD-H, hexane:isopropanol = 99.5:0.5, flow rate 1 ml ./min % 
- 254 nm): tR = 37.0 min (major), tR = 38.0 min (minor).
77-(4-(Benzo[d][l ,3]dioxol-5-yl)butan-2-yl)-3-methoxyaniline. The product 
(120 mg, 80% yield, 91% ee) was obtained according the general procedure as 
a colourless oil from 4-benzo[l,3]dioxol-5-yl-butan-2-one (106 mg, 0.55 
mmol) and «7-anisidine (62 mg, 0.5 mmol) in 20 h;
^ NMR (400 MHz, CDC13) 8 1.19 (d, J = 6.3 Hz, 3H), 1.66-1.75 (m, 1H), 
1.77-1.86 (m, 1H), 2.63 (t, J = 7.8 Hz, 2H), 3.45 (sextet, J - 6.3 Hz, 1H), 5.91 
(s, 2H), 6.09 (t, J = 2.2 Hz, 1H), 6.14-6.17 (m, 1H), 6.22-6.25 (m, 1H), 6.62 
(dd, J = 7.8, 1.6 Hz, 1H), 6.67 (d, 7 = 1.6 Hz, 1H), 6.72 (d, J = 7.8 Hz, 1H), 
7.05 (t, J =8.1 Hz, 1H);
13C NMR (100 MHz, CDC13) 8 21.3, 32.6, 39.5, 48.2, 55.5, 99.4, 101.2, 102.4, 
106.7, 108.6, 109.3, 121.5, 130.4, 136.2, 146.0,148.0,149.3, 161.3;
HRMS forC]8H22N03 [M+H]+: Calcd: 300.1588; Found: 300.1600;
HPLC (Chiralcel OD-H, hexane:isopropanol = 90:10 flow rate 1 mL/min, % = 
254 nm): tR = 25.5 min (major), tR = 29.2 min (minor).
HN
11a
7V-(4“Methylpentan-2-yl)aniline.18,38 The product (71 mg, 80% yield, 88% ee) 
was obtained according to the general procedure as a colourless oil from 4- 
methylpentan-2-one (55 mg, 0.55 mmol) and aniline (47 mg, 0.5 mmol) in 20 
li;
^ NMR (400 MHz, CDC13) 8 0.91 (d, J= 6.6 Hz, 3H), 0.94 (d, J= 6.6 Hz, 
3H), 1.16 (d, J= 6.3 Hz, 3H), 1.26 (dt, 13.7, 6.9 Hz, 1H), 1.47 (dt,J= 13.7,
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6.9 Hz, 1H), 1.70-1.80 (m, 1H), 3.39 (brs, 1H), 3.47-3.57 (m, 1H), 6.56-6.59 
(m, 2H), 6.65 (tt, J = 7.3, 1.0 Hz, 1H), 7.13-7.20 (m, 2H);
13C NMR (100 MHz, CDC13) 5 21.5, 23.1, 23.4, 25.5, 46.9, 47.4, 113.5, 117.2, 
129.8, 148.2;
HRMS for C12H20N [M+H]+: Calcd: 178.1596; Found: 178.1590;
HPLC (Chiralcel OB-H, hexane:isopropanol = 99.5:0.5, flow rate 0.5 mL/min, 
X = 254 nm): tR = 7.7 min (minor), tR = 8.6 min (major).
11b
7V-(Pentan-2-yl)aniline.39 The product (75 mg, 92% yield, 94% ee) was 
obtainedaccording to the general procedure as a colourless oil from 2- 
pentanone (47 mg, 0.55 mmol) and aniline (47 mg, 0.5 mmol) in 20 h;
'H NMR (400 MHz, CDC13) 8 0.93 (t, /= 7.1 Hz, 3H), 1.17 (d, /= 6.2 Hz, 
3H), 1.35-1.46 (m, 3H), 1.50-1.60 (m, 1H), 3.45 (brs, 1H), 3.47 (sextet, J = 6.2 
Hz, 1H), 6.55-6.58 (m, 2H), 6.65 (tt, ./= 7.3, 1.0 Hz, 1H), 7.13-7.20 (m, 2H);
C NMR (100 MHz, CDCI3) 5 14.5, 19.7, 21.2, 39.9, 48.6, 113.5, 117.1, 
129.7, 148.3;
HRMS for CnHisN [M+H]+: Calcd: 164.1439; Fomid: 164.1440;
HPLC (Chiralcel OJ, hexane:isopropanol = 99.5:0.5, flow rate 0.5 mL/min, X 
= 254 nm): tR = 28.8 min (major), tR = 34.8 min (minor).The ee was 
determined by weighing the HPLC peaks, as the peak corresponding to the 
minor enantiomer was too small and wide to be integrated.
11c
iV-(hexan-2-yl)aniline.40 The product (75 mg, 85% yield, 95% ee) was 
obtainedaccording to the general procedure as a colourless oil from 2-hexanone 
(55 mg, 0.55 mmol) and aniline (47 mg, 0.5 mmol) in 20 h;
‘H NMR (400 MHz, CDC13) 8 0.90 (t, J= 7.1 Hz, 3H), 1.16 (d, J= 6.3 Hz, 
3H), 1.28-1.47 (m, 5H), 1.53-1.56 (m, 1H), 3.41-3.48 (m, 2H), 6.55-6.58 (m, 
2H), 6.65 (tt, .7=7.3, 1.0 Hz, 1H), 7.13-7.18 (m, 2H);
13C NMR (100 MHz, CDC13) 8 14.5, 21.2, 23.2, 28.8, 37.4, 48.8, 113.5, 117.1, 
129.7, 148.1;
HRMS forCi2H2oN [M+H]+: Calcd: 178.1596; Found: 178.1590;
HPLC (Chiralcel OB-H, hexane:isopropanol = 99.5:0.5, flow rate 0.25 
mL/min, X = 254 nm): tR = 18.2 min (minor), tR = 19.1 min (major).
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AKHeptan-2-yl)aniline.24’41 The product (79 mg, 83% yield, 92% ee) was 
obtainedaccording to the general procedure as a colourless oil from 2- 
heptanone (63 mg, 0.55 mmol) and aniline (47 mg, 0.5 mmol) in 20 h;
'H NMR (400 MHz, CDCI3) 5 0.88 (t, J= 7.0 Hz, 3H), 1.17 (d, J= 6.3 Hz, 
3H), 1.26-1.46 (m, 7H), 1.53-1.59 (m, 1H), 3.41 (brs, 1H), 3.44 (sextet, J= 6.3 
Hz, 1H), 6.55-6.58 (m, 2H), 6.65 (tt, 7= 7.3, 1.0 Hz, 1H), 7.13-7.18 (m, 2H); 
13C NMR (100 MHz, CDC13) 5 14.4, 21.2, 23.1, 26.2, 32.3, 37.6, 48.9, 113.5, 
117.1, 129.7, 148.3;
HRMS for Ci3H22N [M+H]+: Calcd: 192.1752; Found: 192.1754;
HPLC (Chiralcel OB-H, hexane:isopropanol = 99.5:0.5, flow rate 0.5 mL/min, 
X = 254 nm): tR = 8.8 min (minor), tR = 9.7 min (major).
11e
7/-(6-Methylhept-5-en-2-yl)aniliiie. The product (93 mg, 91% yield, 91% ee) 
was obtainedaccording to the general procedure as a colourless oil from 6- 
methylhept-5-en-2-one (69 mg, 0.55 mmol) and aniline (47 mg, 0.5 mmol) in 
20 h;
'H NMR (400 MHz, CDC13) 5 1.17 (d, 7= 6.3 Hz, 3H), 1.42-1.51 (m, 1H), 
1.59 (s, 3H), 1.55-1.64 (m, 1H), 1.69 (d, 7= 1.0 Hz, 3H), 2.08 (q, 7= 7.2 Hz, 
2H), 3.43 (brs, 1H), 3.46 (sextet, 7= 6.3 Hz, 1H), 5.10-5.14 (m, 1H), 6.55-6.58 
(m, 2H), 6.65 (tt, 7= 7.4, 1.0 Hz, 1H), 7.13-7.17 (m, 2H);
13C NMR (100 MHz, CDC13) 5 18.1, 21.2, 25.1, 26.1, 37.6, 48.5, 113.5, 117.2, 
124.4, 129.7,132.4, 148.2;
HRMS for C14H22N [M+H]+: Calcd: 204.1752; Found: 204.1749;
HPLC (Chiralcel OJ, hexane:isopropanol = 99:1, flow rate 0.5 mL/min, X = 
254 nm): tR = 15.3 min (major), tR = 19.4 min (minor).
11f
N-{ 1 -Cyclopropylethyl)aniline. The product (73 mg, 91% yield, 92% ee) was 
obtainedaccording to the general procedme as a colourless oil from 1- 
cyclopropylethanone (46 mg, 0.55 mmol) and aniline (47 mg, 0.5 mmol) in 20 
h;
JH NMR (400 MHz, CDC13) 5 0.22-0.33 (m, 2H), 0.44-0.53 (m, 2H) 0.88-0.97 
(m, 1H), 1.22 (d, 7= 6.5 Hz, 3H), 2.97 (quintet, 7= 6.5 Hz, 1H), 3.66 (brs, 
1H), 6.57-6.60 (m, 2H), 6.66 (tt, 7= 7.3, 1.0 Hz, 1H), 7.13-7.18 (m, 2H);
13C NMR (100 MHz, CDC13) 5 3.0, 3.5, 18.3, 20.6, 52.9, 113.6, 117.3, 129.6, 
148.3;
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IR (neat) 3660 (w), 2977 (m), 2888 (w), 1601 (m), 1504 (m), 1315 (w), 748 
(s), 690 (m) cm'1;
HRMS for CnHjeN [M+H]+: Calcd: 162.1283; Found: 162.1286;
HPLC (Chiralcel OJ, hexane:isopropanol = 99.5:0.5, flow rate 0.5 mL/min, X 
= 254 imi): tR = 32.4 min (major), tR = 37.3 min (minor). The ee was 
determined by weighing the HPLC peaks, as the peak corresponding to the 
minor enantiomer was too small and wide to be integrated.
HN
Hg
7V-[4-(2H“l,3-Benzodioxol-5-yl)butan-2-yl]aniline. The product (128 mg, 95% 
yield, 91 % ee) was obtained according to the general procedure as a colourless 
oil from 4-(benzo[l,3]dioxol-5-yl-butan-2-one (106 mg, 0.55 mmol) and 
aniline (47 mg, 0.5 mmol) in 20 h;
‘H NMR (400 MHz, CDCI3) 5 1.20 (d, /= 6.3 Hz, 3H), 1.67-1.76 (m, 1H), 
1.78-1.87 (m, 1H), 2.64 (t, J= 7.8 Hz, 2H), 3.42 (brs, 1H), 3.47 (sextet, J= 6.3 
Hz, 1H), 5.91 (s, 2H), 6.52-6.55 (m, 2H), 6.62 (dd, J= 7.9, 1.7 Hz, 1H), 6.64- 
6.68 (m, 2H), 6.72 (d, J= 7.9 Hz, 1H), 7.12-7.17 (m, 2H);
,3C NMR (100 MHz, CDClj) 8 21.3, 32.6, 39.5, 48.2, 101.2, 108.6, 109.3, 
113.6, 117.4, 121.5, 129.7, 136.2, 146.0, 147.9, 148.0;
HRMS for C17H20NO2 [M+H]+: Calcd: 270.1494; Found: 270.1503;
HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 1 mL/min, X = 
254 nm): tR = 22.4 min (major), tR = 24.8 min (minor).
Ar-(4-(Benzo[d][l,3]dioxol-5-yl)butan-2-yl)-4-bromoaniline. The product (122 
mg, 70% yield, 84% ee) was obtained according the general procedure as a 
colourless oil from 4-(benzo[l,3]dioxol-5-yl-butan-2-one (106 mg, 0.55 mmol) 
and/7-bromoaniline (86 mg, 0.5 mmol) in 30 h;
‘H NMR (400 MHz, CDC13) 5 1.18 (d, 6.1 Hz, 3H), 1.66-1.84 (m, 2H),
2.62 (t,J= 7.5 Hz, 2H), 3.36-3.43 (m, 1H), 3.43 (brs, 1H), 5.92 (s, 2H), 6.39 
(d, 8.6 Hz, 2H), 6.60 (d, J= 7.8 Hz, 1H), 6.65 (s, 1H), 6.72 (d, J= 7.8 Hz,
1H), 7.21 (d, .7=8.6 Hz, 2H);
13C NMR (100 MHz, CDC13) 5 21.1, 32.5, 39.3, 48.2, 101.2, 108.6, 108.7, 
109.3, 115.1, 121.5, 132.4, 136.0, 146.1, 146.9, 148.0;
HRMS for Ci7H1979BrN02 [M+PI]+: Calcd: 348.0599; Found: 348.0592;
HPLC (Chiralcel OJ, hexane:isopropanol = 90:10, flow rate 1 mL/min, X = 
254 nm): tR = 46.8 min (major), tR = 65.6 min (minor).
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HN'"'
u
A^-Benzyl-1 -phenylethanamine.30 The product (95 mg, 90% yield) was obtained 
according to the general procedure as a colourless oil, with catalyst 6c in TFE, 
from acetophenone (66 mg, 0.55 mmol) and benzylamine (53 mg, 0.5 mmol);
NMR (400 MHz, CDC13) 5 1.29 (d, J= 6.6 Hz, 3H), 3.51 (d, A of AB, Jab 
= 13.1 Hz, 1H), 3.58 (d, B of AB, JAb = 13.1 Hz, 1H), 3.73 (q, /= 6.6 Hz, 1H), 
7.13-7.27(m, 10H);
13C NMR (100 MHz, CDC13) 5 23.4, 50.6, 56.4, 125.7, 125.8, 125.9, 127.1, 
127.3,127.4, 139.5, 144.4;
HRMS for CtsHisN [M+H]+: Calcd: 212.1434; Found: 212.1430;
HPLC (Chiralcel OD-H, hexane:isopropanol = 99.9:0.1, flow rate 1 mL/min, A, 
= 220 nm): tR = 16.6 min, tR = 20.5 min.
4-Methoxy-iV-(2“pheiiylpropyl)aniline.14 The product (111 mg, 92% yield, 53% 
ee) was obtained according to the general procedure as a colourless oil;
^ NMR (400 MHz, CDC13) 5 1.32 (d, J = 7.0 Hz, 3H), 3.00-3.08 (m, 1H), 
3.19 (dd, A of ABX, Jab = 12.2 Hz, JAx = 8.3 Hz, 1H), 3.30 (dd, B of ABX, 
Jab = 12.2 Hz, JBx = 6.1 Hz, 1H), 3.74 (s, 3H), 6.52-6.56 (m, 2H), 6.74-6.77 
(m, 2H), 7.21-7.25 (m, 3H), 7.30-7.35 (m, 2H);
13C NMR (100 MHz, CDC13) 5 19.8, 39.2, 52.0, 55.8, 114.4, 114.9, 126.6, 
127.3, 128.7, 142.4, 144.6, 152.1;
HRMS for C16H20NO [M+H]+: Calcd: 242.1539; Found: 242.1537;
HPLC (Chiralcel OJ, hexane dsopropanol = 90:10, flow rate 0.5 mL/min, X = 
254 nm): tR = 19.6 min (minor), tR = 23.1 min (major).
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Chapter 3
Achiral Cycloinetallated Complexes for Imine
Hydrogenation
3.1 Introduction
The term Cyclometallation Reaction was introduced by Trofimenko in 
1973 when he studied the formation of Pd-C bond with a series of Pd 
complexes and derivatives of benzylamine.1 It is defined as “the intramolecular 
reaction of a transition metal complex with an organic ligand where a metal- 
carbon a bond is formed”.2 The reaction may occur as follows. The ligand 
coordinates to the metal, followed by cyclometallation. The metal-carbon 
formation is facilitated by the presence of a good leaving basic group in the 
complex, which combines with the hydrogen atom that has been eliminated 
from the metallated carbon atom (Scheme 3.1).
+ M-X
Scheme 3.1: General scheme of cyclometallation reaction.2 E: donor group; X: leaving group.
A typical cyclometallation reaction refers to the coordination of a 
heteroatom to a metal centre. C-H activation then takes place, giving rise to a 
covalent metal-carbon bond. The dative bond is normally derived from 
heteroatoms such as nitrogen in the ligand. Five-membered rings are usually 
regioselectively formed, as it is more stable than four- and six-membered 
rings.3
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Although cyclometallated reactions were not “baptised” until 1973, the 
first example of a cyclometallated reaction was reported by Cope and Siekman 
in 1965.4 They synthesised cyclometallated Pt and Pd dimer complexes from 
the reaction of azobenzene with K2PtCl2 or PdCl2, respectively (Figure 3.1). 
Since then, a wide variety of these organo transit ion metal compounds have 
been synthesised by cyclometallation. They can be highly active in catalytic 
reactions and have presented catalytic activity for a number of transformations, 
such as reduction,5 8 dehydrogenation9"12 and cross-coupling reactions.13"16
/ Cl
Figure 3.1: First example of synthesis of cyclometallated complexes.
The use of cyclometallated complexes as catalysts for the reduction of 
unsaturated functional groups has also been demonstrated. Baratta and co­
workers reported the first application of a cyclometallated metal complex in 
catalytic transfer hydrogenation.5 They reported the synthesis of ruthenium 
complex 1 containing a simple P,C ligand and a 2-(aminomethyl)pyridine 
ligand. 1 was found to be very active for the reduction of ketones with TOF up 
to 63,000 If1 (Scheme 3.2). The reaction takes place at 82 °C in 2-propanol, 
which acts as both the solvent and hydrogen source. It is noteworthy that this 
catalyst is chemoselective for ketones over olefins. Thus, ketone 2 is
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selectively converted into its corresponding alcohol without reduction or 
isomerisation of the C=C double bond (Scheme 3.2).
O 0.05 mol% 1, 2 mol% NaOH, OH
1
Scheme 3.2: First application of a cyclometallated metal complex for transfer hydrogenation.
Subsequently, Ramesh et al. studied the TH of benzophenone with a series 
of cyclometallated ruthenium(III) complexes containing 2-(arylazo)phenol 
ligands 3 (Figure 3.2), halide and triphenylphosphine.6 The reduction takes 
places at 82 °C with 1 mol% catalyst in the presence of 2.5 mol% KOH in 
/PrOH. Although this type of complex catalyses the reduction of benzophenone 
with high conversion, its activity did not suipass that of the complex previously 
reported by Baratta.
R: Cl, Me, OMe, OEt, H 
3
Figure 3.2: 2-(Arylazo)phenol ligand.
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Ikariya and co-workers also reported the application of a cyclometallated 
complex to catalytic TH of ketones.7 They synthesised a series of 16e amido 
complexes 4, containing the metal/NH bifunctionality. These complexes were 
readily and reversibly converted into the corresponding metal hydride. Due to 
this reversibility they were successfully applied to the TH of acetophenone 
with /PrOH or formic acid (Scheme 3.3). Acetophenone was fully reduced after 
1 hour with 1 mol% catalyst loading. Therefore, this catalyst was shown to be 
more effective than the classical Ir-Ts-diamine. Asymmetric reduction was also 
attempted with catalyst 5. Although only moderate enantioselectivities were 
obtained, the tunability of the ligands makes improvement in selectivity very 
promising.
/PrOH, rt, 1 h
4: 96% yield
TBDMSO.
^ N'
H H S
Scheme 3,3: Asymmetric transfer hydrogenation of acetophenone with Ir-metallacycle
catalysts.
Although still in their infancy, cyclometallated complexes have showed to 
be effective for the reduction of polar C=0 bonds. Furthermore, the presence of 
a robust cyclometallated metal-carbon bond apparently allows the formation of 
a long-lived catalytic species.6 The combination of both features prompted us 
to apply this type of complex for the reduction of C=N double bonds. It would
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be very desirable, from an industrial point of view, to design a highly active as 
well as stable catalyst for the reduction of imines.
3.2 Results and discussion
3.2.1 Optimisation of conditions
A series of cyclometallated Ir-imine complexes were synthesised from 
[IrCp*Cl2]2 and aryl imines, following a procedure developed by Davies and 
co-workers (Scheme 3.4).17 Mechanistic studies developed by Jones et al. 
suggest that the cyclometallation follows an electrophilic C-H activation 
mechanism.18 The proposed mechanism involves the formation of cationic 16e 
species [IrCp*(OAc)]+, followed by imine coordination and C-H cleavage. The 
rate-determining step is considered to be the C-H cleavage.
Scheme 3.4: Synthesis of cyclometallated Ir-imine complexes.
Recently, our group applied this type of Ir-cyclometallated complexes for 
imine reduction and reductive amination under TH conditions.8 Although non- 
chiral, this type of complexes shows high chemoselectivity and activity for the 
reduction of C=N bond, with initial TOP up to 1.9 x 10'4 h"1 (Scheme 3.5). 
Moreover, they are effective for a wide range of substrates, including 
derivatives of aromatic and aliphatic ketones and amines, hr addition, these
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complexes are very easy to synthesise and are air-stable. These features 
prompted us to investigate their application for imine reduction under 
hydrogenation conditions. The use of H2 as the hydrogen source would provide 
a much cleaner, more scalable reaction.
OMe
Scheme 3,5: Ir-metallacycle complex for TH of imines.5
The initial hydrogenation experiments were carried out on substrate 7 at 
room temperature under 5 bar of H2 for 2 hour's. Firstly, the activity of catalyst 
6a was compared in a series of solvents, which shows that TFE is the solvent 
of choice (Table 3.1). It is understood that the active catalytic system is the 
cationic 16e species, formed after removal of the chloride ligand. TFE has high 
polarity and low nucleophilicity.19 Therefore, it helps the dissociation and 
solvation of the chloride ion, while having minimal interaction with the 
cationic 16e species.
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Table 3.1: Screening of solvents for the hydrogenation of 7.
^PMP -j i^qio^ 6a,
Jj! 1.5 mL solvent,
5 bar H2, 25 °C, 2 h
Entry Solvent Conversion (%)a
1 TFE >99
2 MeOH 7
3 EtOH 2
4 DMSO N.R.
5 DMF N.R.
6 DCM N.R.
7
a • j i
Toluene
1T T T. TX x-r.
N.R.
8 Determined by ‘H NMR.
One of the main features of these cyclometallated complexes is the 
modular nature of the ligand, as different substituents can be added in either the 
aryl ketone ring or the TV-aryl ring. Therefore, the electronic effects of different 
substituents were then studied for catalytic activity (Table 3.2). The reaction 
with 0.1 mol% of [IrCp*Cl2]2, a precursor for this type of cyclometallated 
complexes, was first run. The substrate could act as a ligand, forming the 
cyclometallated complex in situ. However, no reaction was obseived (Entry 1). 
In comparison, 51% conversion was observed when the catalyst had been 
previously synthesised (entry 4), suggesting that the reaction conditions do not 
promote the cyclometallation and it is necessary to pre-prepare the catalyst. 
When changing the /va/rz-substituents at the ketone ring, electron-deficient 
groups clearly enhance the activity (entries 2-6). However, the position of the 
substituent has a significant effect on the catalyst: the nitro group at the meta-
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position led to a much lower conversion (entry 7 vv 8). The /?-MeO group in the 
aniline ring proves to be important for good activity as well (entry 6 vs 9). This 
substituent makes the nitrogen atom more electron-donating, therefore a better 
Lewis base (higher HOMO), favouring coordination of the nitrogen to the 
metal centre. The best result was obtained with complex 6f, with 87% 
conversion being observed after 30 minutes, at 0.2 mol% catalyst loading, 
room temperature and under 5 bar H2.
Table 3.2: Ligand effect on hydrogenation of 7.
n'pmp HN'PMP
0.2 mol% [Ir], 1.5 mL TFE, 
5 bar H2, 25 0C, 30 min
N—Ir
Entry [Ir] R R’ Conv. (%)a
1 [IrCp*Cl2]2 - - 1
2 6b p-iBu OMe 9
3 6c p-OMe OMe 21
4 6d H OMe 51
5 6e p-Br OMe 54
6 6a p-CN OMe 74
7 6f p~N02 OMe 87
8 6g/6hb JTI-N02 OMe 26
9
Qt-x . j. 
6i
1... ITT XT* ^
p-CN H 37
“Determined by HNMR. Mixture of regioisomers: 6g:6h 7:1, see
analytical data.
114
Chapter 3: Achiral Cyclometallated Complexes for Imine Hydrogenation
Having identified the best ligand, our attention turned to optimisation of 
the reaction conditions to enhance the activity. The increase of the hydrogen 
pressure had a positive effect on the activity, as can be seen from Table 3.3 
(entry 1 vs 2 and 3; entry 4 vs 5). While 76% conversion was obtained after 15 
minutes under 5 bar H2 (entry 1), a similar conversion (65%) was obtained 
after only 5 minutes under 20 bar H2 (entry 5). An increase in temperature also 
led to higher activity, suggesting that the catalyst is stable at high temperatures. 
Therefore, the optimal conditions chosen for examining the substrate scope 
were 20 bar of hydrogen, 75 °C and a low catalyst loading of 0.05 mol% (entry 
6).
Table 3.3: Effect of pressure and temperature on hydrogenation of 7.
n'pmp hn'pmp
6f, 1,5 mL TFE, Hg
7
Entry 6f(mol%)
h2
(bar)
temp.
(°C)
t
(min)
Conv.
(%)a
1 0.2 5 25 15 76
2 0.2 10 25 15 80
3 0.2 20 25 15 95
4 0.2 10 25 5 24
5 0.2 20 25 5 65
6
a-r-x 
0.05
 J 1T T T. T
20 75 30 >99
“Determined by ‘H NMR.
3.2.2 Scope of substrates
With the optimal conditions determined, a series of imine substrates were 
hydrogenated to demonstrate the high activity and versatility of this catalyst. At 
a S/C ratio of 2,000 a wide range of imines were efficiently hydrogenated, with
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reaction times ranging from 5 to 75 minutes, showing the high activity and 
versatility of the catalyst. Table 3.4 presents the results for the hydrogenation 
of imines derived from aromatic ketones and an aldehyde. The catalyst 
tolerates functional groups with different electronic properties on the ketone 
(entries 1-7), although longer reaction times were required for electron- 
deficient ketimines (entries 1 and 2 vs 3 and 4). Substitution on the ketone is 
not restricted to the para-position, as the catalyst also tolerates meta- (entry 7), 
di- (entry 6) or even more sterically demanding o/Y/vo-substitution (entry 8). In 
this regard, it is worth to note that the catalyst is effective for the synthesis of 
sterically hindered amine 8i. Cyclic imines can also be hydrogenated with 
excellent yields, albeit requiring longer reaction time (entry 10). Aldimines are 
particularly active under the conditions developed. Thus even at S/C of 4,000, 
amine 8k was isolated in 91% yield after only 5 minutes (entry 11), resulting in 
a TOP of4.4x 105h_1.
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Table 3.4: Ii-metallacycle hydrogenation of imines derived from aromatic ketones/aldehyde.3
Entry Product t (min) Yield (%)b
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.OMe
9 60 93
10 120 95
Cy 8j
.OMe
llc 5 91
12 60 78
“Reaction conditions: 1 mmol of inline, 0.05 mol% 6f, 1.5 mL
CF3CH2OH, 20 bar H2, 75 °C, 5-75 minutes, isolated yields. c0.025 
mol% 6f.
Imines derived fi*om aliphatic ketones were also hydrogenated. The results 
are summarised in Table 3.5. Although aliphatic ketimines tend to be more 
reactive than the aromatic ketimines,8 lower yields were recorded. This is due 
to low stability of the aliphatic ketimines. Again, the catalyst tolerates electron- 
donating and electron-deficient groups in the aniline ring (entries 1 and 3,4), as 
well as more sterically hindered anilines (entries 2 and 4).
Worthy of note is the excellent chemoselectivity exhibited by the catalyst. 
Thus, C=N double bonds were reduced selectively in the presence of other 
reducible groups, such as internal and external alkenes (entries 5 and 6, 
respectively). The moderate yield obtained for inline 8r is probably due to the 
instability of the corresponding imine. No reduction of the C=C double bond 
was observed in the crude NMR.
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Table 3.5: Ir-metallacycle hydrogenation of imines derived from aliphatic ketones/aldehyde.3
Entry Substrate t (min) Yield (%)b
“Same conditions as those in Table 3.4. bIsolated yields. c0.025 mol% 6f.
Finally, Table 3.6 shows the effectiveness of the catalyst for the 
hydrogenation of JV-benzyl imines. The corresponding amines can then be 
easily debenzylated by hydrogenolysis with Pd/C. This provides a simple route 
for the synthesis of primary amines.20 The catalyst is chemoselective of C=N 
bond as the benzyl group remains intact. Both aromatic and aliphatic ketone-
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derived vV-benzyl imines can be effectively hydrogenated under the optimised 
conditions with good yields.
Table 3.6: Ir-metallacycle imine hydrogenation of N-benzyl imines.3
Entry Substrate t (min) Yield (%)b
75 81
90 85
60 73
aSame conditions as those in Table 3.4. bIsolated yields.
3.2.3 Mechanisitic considerations
We propose that the hydrogenation with this type of catalyst takes place 
through an ionic pathway. As mentioned in Chapter 1, this pathway involves 
three main steps: hydrogen coordination (or hydrogen activation) (Step A), 
heterolytic cleavage of fE into H and H‘ (Step B); and hydride transfer (Step 
C) (Scheme 3.6).
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Scheme 3,6: Suggested catalytic cycle for Ir-metallacycle catalysed imine hydrogenation.
During the optimisation of conditions, it was shown that the increase of 
pressure had a positive effect on the activity, suggesting that either the H2 
coordination or H2 cleavage would possibly be the rate-determining step. We 
decided to undertake some kinetic experiments to gain a deeper insight into this 
catalytic cycle, particularly about the rate-determining step.
Firstly, we studied the effect of the concentration of the imine substrate on 
the reaction rate. For this purpose, we determined the initial rate of the reaction 
at different concentrations of substrates. As can be seen from the graph 
(Scheme 3.7), there is negligible variation on the rate when the concentration 
of substrate increases. This suggests that the reaction rate is zero order with 
respect to the imine substrate; therefore it may not participate in the rate- 
limiting step.
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Scheme 3.7: Effect of the substrate concentration on the reaction rate.
In a similar way, we plotted the initial rate against different concentrations 
of catalyst. Scheme 3.8 shows the results obtained. The rate remains very low 
with limited change at very low concentrations of catalyst. We rationalise that 
impurities from the hydrogen gas highly affect the performance of the catalyst 
at very low concentrations. From 0.17 mM, there is a significant change on the 
initial rate when the concentration of catalyst increases. Therefore, the catalyst 
is involved in the rate-limiting step. This result, combined with H2 pressure 
effect, suggests that either the coordination of H2 or heterolytical cleavage of 
H2 is the slowest step for this reduction. The heterolytical cleavage of H2 
requires a base to take the proton. If we assume that the substrate acts as a base 
and forms the corresponding iminium by protonation, then it should be first 
order with respect to the substrate. The fact that it is not the case suggests that 
rate-determining step may be hydrogen coordination. However, it has to be
122
Chapter 3: Achiral Cyclometallated Complexes for Imine Hydrogenation
taken into account that the amine product could also be involved in this step; so 
a final conclusion cannot be drawn.
Scheme 3.8: Effect of the catalyst concentration on the reaction rate.
3.3 Conclusions
Cyclometallated iridium complexes have shown to be highly active and 
chemoselective for the reduction of imines under hydrogenation conditions. 
The combination of air-stability, ease of synthesis and a simple work-up for the 
hydrogenation procedure makes this catalyst very attractive for industrial 
application.
Evidences from the kinetic studies suggest that the reaction rate is 
independent of the concentration of substrate, but dependent of both hydrogen 
gas and concentration of catalyst. These results support the idea of coordination 
of H2 to the cyclometallated complex as the rate-limiting step.
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3.4 Experimental
General procedure for the synthesis of cyclometallated complexes17"18 
An oven-dried Schlenk tube containing a stir bar was charged with [IrCp*Cl2]2 
(1 eq), imine ligand (2 eqs) and NaOAc (10 eqs.). Following degassing will N2 
three times, freshly distilled CH2CI2 was then injected. The resulting mixture 
was stirred at room temperature overnight. The reaction mixture was then 
filtered through celite and concentrated in vacuo. The resulting solid was 
washed with diethyl ether/hexane.
Preparation of stock solution of cyclometallated iridium complexes
0.025 mmol of iridium complex was weighed and transferred to a 5 mL 
volumetric flask. 5 111L TFE was added, giving a 5 mM solution of catalyst.
Typical procedure for imine hydrogenation with achiral cyclometallated 
complexes
A glass liner containing a stir bar was charged with an imine (1 mmol) and 
TFE was added (0.5 111L, except for substrates 8k and 8s with 1 mL). The 
mixture was stirred until the imine was dissolved. 1 mL (0.5 mL for substrates 
8k and 8s) of stock solution containing the catalyst was then added. The glass 
liner was then placed into an autoclave followed by degassing with H2 three 
times. The hydrogenation was carried out at 20 bar H2 with stirring at 75 °C for 
5-75 minutes. The stirring was then stopped, and the autoclave allowed to cool 
down to room temperature. The hydrogen gas was then carefully released in 
the fumehood, the solution transferred to a flask and concentrated in vacuo to
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afford the crude product. Flash chromatography purification with a column of 
silica gel eluted with petroleum ether/ethyl acetate (20:1 to 5:1) yielded the 
desired amine product.
3.5 Analytical data
Compounds 6b, 6e-i and 8n-q are new compounds.
N—In
The product was obtained as a deep red solid according to the cyclometallation 
procedure in 17 h;8
NMR (400 MHz, 253 K, CDC13) 5 1.44 (s, 15H), 2.47 (s, 3H), 3.88 (s, 3H), 
6.82-6.83 (m, 1H), 6.93 (d, J= 5.8 Hz, 1H), 7.02 (d, 7= 5.9 Hz, 1H), 7.33 (d, J 
= 7.6 Hz, 1H), 7.56 (d, 7.6 Hz, 1H), 7.77 (d, J= 7.8 Hz, 1H), 8.05 (s, 1H);
13C NMR (100 MHz, 253 K, CDC13) 5 8.8, 17.5, 55.7, 90.0, 112.5, 114.3, 
115.1, 120.1, 123.1, 125.2, 128.2, 138.2, 138.3, 143.6, 151.8, 157.9, 167.4, 
180.9;
Anal Calcd for CzeHisCUrNsO: C, 51.01; H, 4.61; N, 4.58. Found: C, 51.02; 
H, 4.65; N, 4.42.
MeO
N—Ir
The product was obtained as a bright yellow solid according to the 
cyclometallation procedure in 17 h;
NMR (400 MHz, 253 K, CDC13) 5 0.94 (d, J= 6.7 Hz, 3H), 0.97 (d, 7= 6.5 
Hz, 3H), 1.43 (s, 15H), 1.91-1.98 (m, 1H), 2.43 (s, 3H), 2.57-2.57 (m, 2H), 
3.87 (s, 3H), 6.79 (d, 7= 5.4 Hz, 1H), 6.84 (d, 7= 7.5 Hz, 1H), 6.89 (d, 7= 5.4 
Hz, 1H), 6.98 (d, 7= 6.7 Hz, 1H), 7.45 (d, 7- 7.5 Hz, 1H), 7.60 (s, 1H), 7.80 
(d, 7= 6.7 Hz, 1H);
13C NMR (100 MHz, 253 K, CDC13) 5 8.8, 17.1, 22.7, 23.0, 30.8, 46.1, 55.6, 
88.9, 112.2, 114.8, 122.8, 123.5, 125.0, 128.3, 136.0, 144.2, 145.5, 146.0, 
157.3, 167.7, 181.2;
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Anal Calcd for Cs^ClIrNO: C, 54.15; H, 5.80; N, 2.18. Found: C, 54.66; H, 
5.90; N, 2.06.
N—lr
The product was obtained as a bright yellow solid according to the 
cyclometallation procedure in 17 h;8
‘H NMR (400 MHz, 253 K, CDC13) 5 1.44 (s, 15H), 2.41 (s, 3H), 3.87 (s, 
3H), 3.93 (s, 3H), 6.61 (dd, J= 8.5, 2.4 Hz, 1H), 6.81 (d, 8.4 Hz, 1H), 6.90
(d, J= 8.4 Hz, 1H), 6.98 (d, J= 8.4 Hz, 1H), 7.35 (d, 7 = 2.4 Hz, 1H), 7.49 (d, 
7- 8.5 Hz, 1H), 7.80 (d, J= 8.4 Hz, 1H);
13C NMR (100 MHz, 253 K, CDC13)5 8.8, 17.1,55.2, 55.6, 89.0, 107.6, 112.2, 
114.8, 119.1, 123.8, 125.2, 130.2, 141.2, 144.2, 157.3, 161.9, 170.3, 180.1; 
Anal Calcd for C26H3]ClIrN02: C, 50.60; H, 5.06; N, 2.27. Found: C, 50.60; 
H, 4.93; N, 2.16.
N—lr.
The product was obtained as a bright yellow solid according to the 
cyclometallation procedure in 17 h;8
^ NMR (400 MHz, 253 K, CDC13) 5 1.44 (s, 15H), 2.46 (s, 3H), 3.88 (s, 3H), 
6.82 (d, 7= 8.0 Hz, 1H), 6.91 (d, 7= 8.0 Hz, 1H), 6.99-7.01 (m, 1H), 7.05 (t, 7 
= 7.3 Hz, 1H), 7.26 (d, 7= 7.3 Hz, 1H), 7.54 (d, J= 7.5 Hz, 1H), 7.80 (d, 7 = 
8.0 Hz, 1H), 7.84 (d, 7= 7.5 Hz, 1H);
13C NMR (100 MHz, 253 K, CDC13) 5 8.8, 17.2, 55.6, 89.1, 112.3, 115.0, 
121.5, 121.6, 123.5, 128.6, 132.2, 135.1, 144.1, 147.7, 157.4, 167.9, 181.6; 
Anal Calcd for C25H29Clh-NO: C, 51.14; H, 4.98; N, 2.39. Found: C, 51.41; H, 
5.04; N, 2.22.
MeO
N—lr.
The product was obtained as a bright orange solid according to the 
cyclometallation procedure in 17 h;
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'H NMR (400 MHz, 253 K, CDClj) 6 1.43 (s, 15H), 2.43 (s, 3H), 3.88 (s, 3H), 
6.82 (d, J= 8.4 Hz, 1H), 6.91 (d, J= 8.4 Hz, 1H), 7.00 (d, J= 8.3 Hz, 1H), 
7.18 (dd, J= 8.2, 1.8 Hz, 1H), 7.39 (d, J= 8.3 Hz, 1H), 7.79 (d, J= 8.2 Hz, 
1H), 7.91 (d, .7=1.8 Hz, 1H);
,3C NMR (100 MHz, 253 K, CDCI3) 5 8.7, 17.3, 55.6, 89.4, 112.3, 114.9, 
124.5, 127.5, 130.0, 137.2, 143.8, 145.1, 146.5, 152.6, 157.6, 170.1, 180.9; 
Anal Calcd for C25H2sBrIi*NO: C, 45.08; H, 4.24; N, 2.10. Found: C, 44.98; H, 
4.25; N, 2.02.
MeO
N—In.
The product was obtained as a black solid according to the cyclometallation 
procedure in 17 h;
lTl NMR (400 MHz, 253 K, CDC13) 5 1.46 (s, 15H), 2.52 (s, 3H), 3.89 (s, 3H), 
6.84-6.86 (m, 1H), 6.94-6.96 (m, 1H), 7.03 (d, 8.6 Hz, 1H), 7.64 (d, J= 8.5
Hz, 1H), 7.79 (d, J= 7.8 Hz, 1H), 7.89 (dd, 8.5, 2.2 Hz, 1H), 8.63 (d, J = 
2.2 Hz, 1H);
13C NMR (100 MHz, 253 K, CDC13) 5 8.81, 55.7, 90.1, 112.5, 115.1, 117.1, 
123.1, 124.4, 128.7, 129.2, 143.6, 148.8,153.5, 157.9, 168.4, 180.5;
HRMS for C25H28ClIrN2Na03 [M+Naf: Calcd: 653.1292; Found: 653.1268; 
Anal Calcd for C25Hi5ClIrN203: C, 47.50; H, 4.46; N, 4.43. Found: C, 47.94; 
H, 4.51; N, 4.40.
N—In
N—lr
The product was obtained as a red solid according to the cyclometallation 
procedure in 17 h; Product exists as a mixture of regioisomers, 6g:6h, 7:1;
^ NMR (400 MHz, 253 K, CDC13) 5 1.41 (s, 1.9H), 1.44 (s, 13.1H), 2.35 (s, 
0.4H), 2.55 (s, 2.6H), 3.86 (s, 0.4H), 3.88 (s, 2.6H), 6.80 (d, J= 8.6 Hz, 0.3H), 
6.85 (d, 8.0 Hz, 0.8H), 6.95 (d, 8.8 Hz, 1.2H), 7.02 (d, J = 8.2 Hz,
0.8H), 7.66 (t,J= 8.0 Hz, 0.2H), 7.72 (d, J= 8.0 Hz, 0.8H), 7.96 (d, J= 8.4 
Hz, 0.8H), 8.06 (dd,J= 8.4, 1.5 Hz, 0.8H), 8.35 (d, J= 1.5 Hz, 1H), 8.82 (s, 
0.1H);
13C NMR (100 MHz, 253 K, CDC13) 5 8.8 (M), 9.0 (m), 17.4 (M), 17.7 (m), 
55.6 (m), 55.7 (M), 90.2 (m), 90.6 (M), 112.5, 114.2, 115.2, 121.0, 122.2,
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123.2, 123.3, 124.4, 125.1, 126.0, 129.6, 133.2, 135.7, 141.1, 142.7, 143.3, 
143.5, 148.1, 148.6,156.2, 157.9, 163.7, 173.9, 180.8, 181.1, 181.9;
Anal Calcd for CisHisClM^: C, 47.50; H, 4.46; N, 4.43. Found: C, 47.44; 
H, 4.37; N, 4.41.
N—In
The product was obtamed as a deep red solid according to the cyclometaliation 
procedure in 17 h;
’H NMR (400 MHz, 253 K, CDC13) 5 1.42 (s, 15H), 2.49 (s, 3H), 6.88 (d,
7.6 Hz, 1H), 7.27-7.31 (m, 1H), 7.35 (d, J= 8.0 Hz, 1H), 7.45 (d, J= 7.5 Hz, 
1H), 7.52 (d, J = 7.8 Hz, 1H), 7.59 (d, J = 8.0 Hz, 1H), 7.80 (d, J = 7.8 Hz, 
1H), 8.06 (s, 1H);
13c NMR (100 MHz, 253 K, CDCI3) 5 3.9, 12.8, 85.2, 109.6, 115.3, 117.3, 
118.3, 120.5, 122.2, 123.2, 123.6, 125.6, 133.6, 145.4, 146.9, 162.9, 176.1; 
Anal Calcd for Cas^eClIrNO;,: C, 51.58; H, 4.50; N, 4.81. Found: C, 51.58; 
H, 4.44; N, 4.64.
4-Methoxy-7V-(l-phenylethyl)aniline.21'22 The product (209 mg, 92% yield) 
was obtained as a colourless oil according to the hydrogenation procedure in 30 
min;
^ NMR (400 MHz, CDC13) 5 1.49 (d, 6.7 Hz, 3H), 3.69 (s, 3H), 4.41 (q, J
= 6.7 Hz, 1H), 6.44-6.48 (m, 2H), 6.66-6.70 (m, 2H), 7.19-7.23 (m, 1H), 7.29- 
7.32 (m, 2H), 7.35-7.37 (m, 2H);
13C NMR (100 MHz, CDC13) 6 25.5, 54.7, 56.1, 115.0, 115.2, 126.3, 127.2, 
129.0, 142.0, 145.9, 152.3;
HRMS for CisHisNO [M+H]+: Calcd: 228.1383; Found: 228.1384;
Anal Calcd for C15H17NO: C, 79.26; H, 7.54; N, 6.16. Found: C, 79.48; H, 
7.74; N, 5.82.
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4-Methoxy-7V-( 1 -p-tolylethyl)amline.21,23 The product (205 mg, 85% yield) was 
obtained as a colourless oil according to the hydrogenation procedure in 30 
min;
^ NMR (400 MHz, CDC13) 5 1.47 (d, J= 6.1 Hz, 3H), 2.31 (s, 3H), 3.69 (s, 
3H), 4.38 (q, J= 6.1 Hz, 1H), 6.45-6.49 (m, 2H), 6.67-6.71 (m, 2H), 7.12 (d, J 
= 7.9 Hz, 2H), 7.24 (d, J= 7.9 Hz, 2H);
13C NMR (100 MHz, CDC13) 5 21.0, 25.1, 53.9, 55.7, 114.5, 114.7, 125.8, 
129.3, 136.3, 141.6, 142.4, 151.8;
HRMS for C16H20NO [M+H]+: Calcd: 242.1540; Found: 242.1539;
Anal Calcd for C16H19NO: C, 79.63; H, 7.94; N, 5.80. Found: C, 79.03; H, 
8.14; N, 5.88.
OMe
4-Methoxy-JV-( 1 -(4-nitrophenyl)ethyl)aniline.21,23 The product (242 mg, 89% 
yield) was obtained as a yellow oil according to the hydrogenation procedure in 
60 min;
!H NMR (400 MHz, CDC13) 5 1.52 (d, J= 6.8 Hz, 3H), 3.69 (s, 3H), 3.84 (brs, 
1H), 4.49 (q, J= 6.8 Hz, 1H), 6.38-6.42 (m, 2H), 6.67-6.71 (m, 2H), 7.52-7.56 
(m, 2H), 8.16-8.19(m, 2H);
13C NMR (100 MHz, CDC13) 5 25.4, 54.4, 56.1, 114.9, 115.2, 124.5, 127.1, 
141.1, 147.4, 152.7, 153.9;
HRMS for Ci5H17N203 [M+H]+: Calcd: 273.1239; Found: 273.1241;
Anal Calcd for CisH^Os: C, 66.16; H, 5.92; N, 10.29. Found: C, 65.80; H, 
5.95; N, 10.12.
HN
4-(l-(Phenylaniino)ethyl)benzonitrile.24 The product (197 mg, 89% yield) was 
obtained as a colourless oil according to the hydrogenation procedure in 75 
min;
]H NMR (400 MHz, CDC13) 5 1,52 (d, J= 6.8 Hz, 3H), 4,04 (bis, 1H), 4.51 (q, 
/= 6.8 Hz, 1H), 6.43 (dd, J= 8.6, 0.9 Hz, 2H), 6.68 (tt, J= 7.3, 0.9 Hz, 1H), 
7.07-7.12 (m, 2H), 7.47-7.50 (m, 2H), 7.60-7.62 (m, 2H);
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13C NMR (100 MHz, CDCI3) 5 25.3, 53.8, 111.2, 113.7, 118.3, 119.3, 127.0, 
129.6, 133.0, 147.0, 151.4;
HRMS for C15H15N2 [M+H]+: Calcd: 223.1230; Found: 223.1232;
Anal Calcd for C15H14N2: C, 81.05; H, 6.35; N, 12.50. Found: C, 81.02; H, 
6.34; N, 12.73.
HN ^
8e
A-(l-(Naphthalen-2-yl)ethyl)aniline.21’25 The product (215 mg, 87% yield) was 
obtained as a colourless oil according to the hydrogenation procedure in 45 
min;
^ NMR (400 MHz, CDC13) 6 1.57 (d, J- 6.7 Hz, 3H), 4.10 (brs, 1H), 4.62 (q, 
6.7 Hz, 1H), 6.54 (dd, J= 8.6, 1.0 Hz, 2H), 6.63 (tt, 7.3, 1.0 Hz, 1H), 
7.04-7.09 (m, 2H), 7.39-7.46 (m, 2H), 7.48 (dd, 8.5, 1.6 Hz, 1H), 7.77-7.81 
(m, 4H);
13C NMR (100 MHz, CDC13) 5 25.5, 54.2, 113.8, 117.8, 124.7, 124.9, 125.9, 
126.4, 128.1, 128.3, 128.9, 129.6, 133.2, 134.0, 143.2, 147.8;
HRMS for Ci8H18N [M+H]+: Calcd: 248.1434; Found: 248.1436;
Anal Calcd for Ci8Hi7N: C, 87.41; H, 6.93; N, 5.66. Found: C, 87.31; H, 6.96; 
N, 5.55.
A-(l-(3,4-Dimethoxyphenyl)ethyl)-4-methoxyaniline.21,23 The product (264 
mg, 92% yield) was obtained as a colourless oil according to the hydrogenation 
procedure in 60 min;
!H NMR (400 MHz, CDC13) 5 1.49 (d, J= 6.6 Hz, 3H), 3.70 (s, 3H), 3.85 (s, 
3H), 3.86 (s, 3H), 4.35 (q, /= 6.6 Hz, 1H), 6.47-6.51 (m, 2H), 6.68-6.72 (m, 
2H), 6.81 (d, J= 6.7 Hz, 1H), 6.88-6.92 (m, 2H);
13C NMR (100 MHz, CDC13) 6 25.5, 54.6, 56.1, 56.2(6), 56.2(9), 109.6, 111.7, 
115.1, 115.2, 118.2, 138.5, 142.0, 148.2, 149.6, 152.4;
HRMS for Ciy^iNOsNa [M+Na]+: Calcd: 310.1419; Found: 310.1430;
Anal Calcd for C17H2]N03: C, 71.06; H, 7.37; N, 4.87. Found: C, 71.10; H, 
7.10; N, 4.35.
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4-Methoxy-Af-( 1 -(3-nitrophenyl)ethyl)aniIine.21,23 The product (247 mg, 91% 
yield) was obtained as a yellow oil according to the hydrogenation procedure in 
60 min;
'H NMR (400 MHz, CDC13) 5 1.51 (d, J= 6.7 Hz, 3H), 3.67 (s, 3H), 4.49 (q, J 
= 6.7 Hz, 1H), 6.41-6.45 (m, 2H), 6.67-6.71 (m, 2H), 7.45 (t, /= 7.9 Hz, 1H), 
7.70 (d, ^ = 7.7 Hz, 1H), 8.06 (ddd, 8.1, 2.3, 1.0 Hz, 1H), 8.24 (t,J=2.3 
Hz, 1H);
13C NMR (100 MHz, CDC13) 5 25.5, 54.3, 56.1, 115.0, 115.2, 121.4, 122.5, 
130.1, 132.7, 141.2, 148.6, 149.1, 152.7;
HRMS for Ci5Hi7N203 [M+Hf: Calcd: 273.1239; Found: 273.1235;
Anal Calcd for Ci5Hi6N203: C, 66.16; H, 5.92; N, 10.29. Found: C, 65.62; H, 
6.17; N, 10.21.
4-Methoxy-iV-( 1 -o-tolylethyl)aniline.21,26 The product (222 mg, 92% yield) was 
obtained as a colourless oil according to the hydrogenation procedure in 45 
min;
'H NMR (400 MHz, CDC13) 6 1.41 (dd, J = 6.6, 1.1 Hz, 3H), 2.40 (d, J~- 0.9 
Hz, 3H), 3.63 (d, J = 0.9 Hz, 3H), 3.72 (bis, 1H), 4.57 (q, J = 6.5 Hz, 1H), 
6.35-6.40 (m, 2H), 6.64-6.67 (m, 2H), 7.07-7.14 (m, 3H), 7.40 (d, J= 7.3 Hz, 
1H);
I3C NMR (100 MHz, CDClj) S 19.5, 23.6, 51.0, 56.2, 114.8, 115.3, 125.2, 
127.0(8), 127.1(2), 131.1, 135.1, 142.0, 143.5, 152.4;
HRMS forC]6H2oNO [M+H]+: Calcd: 242,1539; Found: 242,1535;
Anal Calcd for Ci6Hi9NO: C, 79.63; H, 7.94; N, 5.80. Found: C, 78.52; H, 
8.25; N, 5.89.
4-Methoxy-7V-(l-plienylpentyl)aniline.27 The product (251 mg, 93% yield) was 
obtained according to the hydrogenation procedure yellow oil in 60 min;
‘H NMR (400 MHz, CDCI3) S 0.87 (t, 7= 7.0 Hz, 3H), 1.21-1.41 (m, 4H), 
1.68-1.82 (m, 2H), 3.65 (s, 3H), 4.20 (t, J= 6.8 Hz, 1H), 6.43-6.47 (m, 2H), 
6.64-6.68 (m, 2H), 7.16-7.21 (m, 1H), 7.26-7.33 (m, 4H);
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13c NMR (100 MHz, CDC13) 5 14.5, 23.1, 29.0, 39.2, 56.2, 59.5, 114.9, 115.2, 
126.9, 127.3, 129.0, 142.3, 145.1, 152.3;
HRMS for C18H24NO [M+H]+: Calcd: 270.1852; Found: 270.1847;
Anal Calcd for Ci8H23NO: C, 80.26; H, 8.61; N, 5.20. Found: C, 80.02; H, 
8.86; N, 5.48.
1-Cyclohexyl-1,2,3,4-tetrahydroisoquinoline.28 The product (251 mg, 93% 
yield) was obtained as a colourless oil according to the hydrogenation 
procedure in 60 min;
% NMR (400 MHz, CDC13) 5 1.06-1.19 (m, 3H), 1.28-1.42 (m, 3H), 1.65- 
1.73 (m, 3H), 1.80-1.84 (m, 1H), 1.88-1.92 (m, 1H), 2.15 (brs, 1H), 2.65 (dt, J 
= 15.6, 4.4 Hz, 1H), 2.78-2.86 (m, 1H), 2.88-2.95 (m, 1H), 3.23-3.30 (m, 1H), 
3.91 (d, J= 4.4 Hz, 1H), 7.04-7.14 (m, 4H);
13C NMR (100 MHz, CDCI3) 5 26.8, 27.0, 27.1, 27.5, 30.7, 31.4, 42.8, 43.4, 
61.2, 125.9, 126.0, 126.5, 129.6, 136.7, 138.9;
HRMS for C,5H22N [M+H]+: Calcd: 216.1747; Found: 216.1747;
Anal Calcd for C15H21N: C, 83.67; H, 9.83; N, 6.50. Found: C, 80.83; H, 9.50; 
N, 6.23.
OMe
8k
iV-Benzyl-4-methoxyaniline.8’29 The product (194 mg, 91% yield) was obtained 
according to the hydrogenation procedure as a colourless oil in 5 min;
!H NMR (400 MHz, CDC13) 8 3.73 (s, 3H), 4.27 (s, 2H), 6.58-6.61 (m, 2H), 
6.75-6.79 (m, 2H), 7.23-7.28 (m, 1H), 7.31-7.38 (m, 4H);
I3C NMR (100 MHz, CDC13) 5 49.7, 56.2, 114.5, 115.3, 127.6, 128.0, 129.0, 
140.1, 142.9, 152.6;
HRMS for Ci4H]6NO [M+H]+: Calcd: 214.1226; Found: 214.1227;
Anal Calcd for C14H15NO: C, 78.84; H, 7.09; N, 6.57. Found: C, 78.57; H, 
7.26; N, 6.77.
N-( 1 -Phenylethyl)cyclohexanamine.8 The product (159 mg, 78% yield) was 
obtained according to the general procedure as a colourless oil in 60 min;
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^ NMR (400 MHz, CDC13) 5 0.98-1.17 (m, 5H), 1.32 (d, /= 6.6 Hz, 3H), 
1.54-1.55 (m, 1H), 1.63-1.71 (m, 3H), 1.96-2.00 (m, 1H), 2.23-2.30 (m, 1H), 
3.95 (q, 6.6 Hz, 1H), 7.20-7.25 (m, 1H), 7.27-7.33 (m, 4H);
13C NMR (CDCb, 100 MHz) 5 25.4, 25.5, 25.7, 26.6, 33.6, 35.0, 54.0, 54.8, 
126.9, 127.1, 128.8, 146.7;
HRMS for C14H22N [M+Hf: Calcd: 214.1752; Found: 214.1755;
Anal Calcd for CI4H2iN: C, 82.70; H, 10.41; N, 6.89. Found: C, 82.86; H, 
10.42; N, 6.96.
OMe
4-Methoxy-iV-(pentan-2-yl)aiiiline.30 The product (152 mg, 79% yield) was 
obtained according to the general procedure as a colourless oil in 30 min;
'B. NMR (400 MHz, CDC13) 5 0.92 (t, 7.1 Hz, 3H), 1.14 (d, /= 6.2 Hz,
3H), 1.34-1.44 (m, 3H), 1.50-1.57 (m, 1H), 3.37 (sextet, J= 6.2 Hz, 1H), 3.74 
(s, 3H), 6.53-6.58 (m, 2H), 6.75-6 J9 (m, 2H);
13C NMR (100 MHz, CDC13)S 14.1, 19.3, 20.8,39.4, 49.3, 55.8, 114.7, 114.9, 
141.9, 151.8;
HRMS for C12H20NO [M+H]+: Calcd: 194.1539; Found: 194.1534;
Anal Calcd for Ci2Hi9NO: C, 74.57; H, 9.91; N, 7.25. Found: C, 73.95; H, 
10.20; N, 7.20.
HN
8n
2-Ethyl-iV-(pentan-2-yl)aniline. The product (136 mg, 71% yield) was obtained 
according to the general procedure as a colourless oil in 30 min;
^ NMR (400 MHz, CDC13) 8 0.93 (t,J= 7.2 Hz, 3H), 1.19 (d, 7- 6.3 Hz, 
3H), 1.24 (t, 7= 7.5 Hz, 3H), 1.36-1.49 (m, 3H), 1.54-1.63 (m, 1H), 2.45 (q, 7 
- 7.5 Hz, 2H), 3.38 (brs, 1H), 3.49-3.57 (m, 1H), 6.62 (d, 7= 8.4 Hz, 1H), 6.66 
(td, 7= 7.4, 1.0 Hz, 1H), 7.06 (dd, 7= 7.4, 1.5 Hz, 1H), 7.10 (td, 7= 7.7, 1.5 
Hz, 1H);
13C NMR (100 MHz, CDC13) 5 12.8, 14.2, 19.4, 20.9, 23.9, 39.6, 47.9, 110.3, 
116.3, 126.9, 127.2, 128.0, 144.9;
HRMS for C]3H22N [M+H]+: Calcd: 192.1747; Found: 192.1747;
Anal Calcd for CnH2^ C, 81.61; H, 11.06; N, 7.32. Found: C, 81.63; H, 
11.48; N, 7.61.
HN
rBr
\ 80
l-Bromo-4-(2,4-dimethylpentyl)benzene. The product (182 mg, 71% yield) 
was obtained according to the general procedure as a colourless oil in 40 min;
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‘H NMR (400 MHz, CDCI3) 5 0.90 {&,J= 6.6 Hz, 3H), 0.93 (d, J= 6.6 Hz, 
3H), 1.13 (d, .7=6.2 Hz, 3H), 1.25 (dt,J=13.7, 6.9 Hz, 1H), 1.44 (dt, .7=13.7, 
6.9 Hz, 1H), 1.67-1.78 (m, 1H), 3.39 (brs, 1H), 3.42-3.50 (m, 1H), 6.42-6.46 
(m, 2H), 7.20-7.25 (m, 2H);
13C NMR (100 MHz, CDCI3) 5 21.3, 23.0, 23.3, 25.5, 47.0, 47.1, 108.5, 114.9, 
132.3, 147.1;
HRMS for C12Hi9BrN [M+H]*: Calcd: 256.0695; Found: 256.0696;
Anal Calcd for C^H^BrN: C, 56.26; H, 7.03; N, 5.47. Found: C, 56.63; H, 
7.23; N, 5.82.
2-Bromo-AL(4-methylpentan-2-yl)amline. The product (207 mg, 81% yield) 
was obtained according to the general procedure as a colourless oil in 30 min; 
'H NMR (400 MHz, CDCI3) 5 0.91 (d, J= 6.6 Hz, 3H), 0.96 (d, 6.6 Hz,
3H), 1.19 (d, 6.2 Hz, 3H), 1.33 (dt, J= 13.9, 6.9 Hz, 1H), 1.52 (dt, J= 13.9,
7.0 Hz, 1H), 1.72-1.82 (m, 1H), 3.50-3.60 (m, 1H), 4.09 (brd, J= 7.3 Hz, 1H), 
6.51 (ddd, 7=7.8, 7.3, 1.3 Hz, 1H), 6.63 (dd, 7= 7.9, 1.3 Hz, 1H), 7.15 (ddd, 7 
= 7.9, 7.3, 1.5 Hz, 1H), 7.40 (dd, 7= 7.8, 1.5 Hz, 1H);
13C NMR (100 MHz, CDC13) 5 21.4, 23.0, 23.3, 25.5, 47.1, 110.2, 111.9, 
117.4, 128.8, 132.9, 144.8;
HRMS for C^HigBrN [M+H]+: Calcd: 256.0695; Found: 256.0690;
Anal Calcd for C^H^BrN: C, 56.26; H, 7.03; N, 5.47. Found: C, 56.37; H, 
7.41; N, 5.79.
2-Methyl-iV’-(6-methylhept-5-en-2-yl)aniline. The product (145 mg, 67% yield) 
was obtained according to the general procedure as a colourless oil in 20 min; 
'H NMR (400 MHz, CDC13) 5 1.20 (d, 7= 6.3 Hz, 3H), 1.46-1.55 (m, 1H), 
1.58 (s, 3H), 1.59-1.66 (m, 1H), 1.69 (d, 7= 0.8 Hz, 3H), 2.06-2.13 (m, 2H), 
2.11 (s, 3H), 3.30 (brs, 1H), 3.52 (sextet, 7= 6.3 Hz, 1H), 5.12-5.16 (m, 1H), 
6.58-6.62 (m, 2H), 7.03 (d, 7= 7.1 Hz, 1H), 7.10 (td, 7= 7.8, 1.2 Hz, 1H);
13C NMR (100 MHz, CDC13) 5 17.6(0), 17.6(5), 20.9, 24.7, 25.7, 37.3, 47.8, 
110.0, 116.1, 121.6, 124.0, 127.1, 130.2, 132.0, 145.5;
HRMS for C15H24N [M+H]+: Calcd: 218.1901; Fomid: 218.1903;
Anal Calcd for CjsfeN: C, 82.89; H, 10.67; N, 6.44. Found: C, 82.56; H, 
10.92; N, 6.82.
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Af-(Hex-5-en-2-yl)-4-methoxyaniline.22,30 The product (98 mg, 48% yield) was 
obtained according to the general procedure as a colourless oil in 30 min;
!H NMR (400 MHz, CDC13) 5 1.08 (d, 7 = 6.3 Hz, 3H), 1.38-1.47 (m, 1H), 
1.53-1.62 (m, 1H), 2.05-2.11 (m, 2H), 3.40 (sextet, 7 = 6.3 Hz, 1H), 3.74 (s, 
3H), 4.89 (d, 7= 10.1 Hz, 1H), 4.95 (dd, 7= 17.0, 1.6 Hz, 1H), 5.75 (ddt, 7 = 
17.0, 10.3, 6.7 Hz, 1H), 6.45-6.49 (m, 2H), 6.67-6.71 (m, 2H);
13C NMR (100 MHz, CDC13) 5 21.1, 30.8, 36.6, 49.6, 56.2, 115.2, 115.3(2), 
115.3(5), 138.8, 142.0, 152.4;
HRMS for C13H20NO [M+H]+: Calcd: 206.1539; Found: 206.1540;
Anal Calcd for Ci3H19NO: C, 76.06; H, 9.33; N, 6.82. Found: C, 76.18; H, 
9.50; N, 7.00.
OMe
8s
A-(Cyclohexylmethyl)-4-methoxyaniline.31 The product (180 mg, 82% yield) 
was obtained according to the general procedure as a colourless oil in 5 min;
!H NMR (400 MHz, CDC13) 5 0.89-1.06 (m, 2H), 1.15-1.34 (m, 3H), 1.54- 
1.64 (m, 1H), 1.68-1.85 (m, 5H), 2.93 (d, J= 6.6 Hz, 2H), 3.46 (brs, 1H), 3.72 
(s, 3H), 6.59 (d, 7= 8.8 Hz, 2H), 6.78-6.82 (m, 2H);
13C NMR (100 MHz, CDC13) 8 26.0, 26.6, 31.3, 37.6, 51.7, 55.9, 113.9, 114.9, 
143.0, 151.8;
HRMS for CMH22NO [M+H]+: Calcd: 220.1696; Found: 220.1692;
Anal Calcd for C14H21NO: C, 76.67; H, 9.65; N, 6.39. Found: C, 76.60; H, 
9.81; N, 6.07.
HN'" \ //
u "
A-Benzyl-l-phenylethanamine.8 The product (171 mg, 81% yield) was 
obtained according to the general procedure as a colourless oil in 75 min;
^ NMR (400 MHz, CDC13) 5 1.29 (d, 7= 6.6 Hz, 3H), 3.51 (d, A of AB, 7Ab 
= 13.1 Hz, 1H), 3.58 (d, B of AB, 7AB = 13.1 Hz, 1H), 3.73 (q, 7= 6.6 Hz, 1H), 
7.13-7.27(m, 10H);
13C NMR (100 MHz, CDC13) 5 23.4, 50.6, 56.4, 125.7, 125.8, 125.9, 127.1, 
127.3, 127.4, 139.5, 144.4;
HRMS for CisHjgN [M+H]+: Calcd: 212.1434; Found: 212.1429;
Anal Calcd for C15H17NO: C, 85.26; H, 8.11; N, 6.63. Found: C, 85.56; H, 
8.19; N, 6.50.
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vV-Benzyl-1 “(4-methoxyphenyl)ethanamine.32 The product (205 mg, 85% yield) 
was obtained according to the general procedure as a colourless oil in 90 min; 
^ NMR (400 MHz, CDC13) 5 1.34 (d, J= 6.5 Hz, 3H), 3.58 (d, A of AB, Jab 
= 13.1 Hz, 1H), 3.65 (d, B of AB, JAB = 13.1 Hz, 1H), 3.77 (q, J= 6.5 Hz, 1H), 
3.81 (s, 3H), 6.87-6.91 (m, 2H), 7.21-7.34 (m, 7H);
13C NMR (100 MHz, CDCH) 5 24.9, 52.0, 55.7, 57.2, 114.2, 127.2, 128.1, 
128.5, 128.8, 138.1, 141.2, 159.2;
HRMS for Ci6H2oNO [M+Hf: Calcd: 242.1539; Found: 242.1543;
Anal Calcd for C16H19NO: C, 79.63; H, 7.94; N, 5.80. Found: C, 79.13; H, 
8.37; N, 5.84.
VJ'
8v
JV-Benzylheptan-2-amine.8’33 The product (150 mg, 73% yield) was obtained 
according to the general procedure as a yellow oil in 60 min;
^ NMR (400 MHz, CDC13) 5 0.88 (t,J= 6.9 Hz, 3H), 1.08 (d, /= 6.2 Hz, 
3H), 1.22-1.34 (m, 8H, including NH), 1.42-1.52 (m, 1H), 2.60-2.71 (m, 1H), 
3.74 (d, A of AB, JAB = 12.9 Hz, 1H), 3.83 (d, B of AB, Jab = 12.9 Hz, 1H), 
7.22-7.27 (m, 1H), 7.31-7.35 (m, 4H);
13C NMR (100 MHz, CDC13) 8 14.5, 20.7, 23.1, 26.1, 32.5, 37.4, 51.8, 52.9, 
127.2, 128.6, 128.8, 141.2;
HRMS for C14H24N [M+Hf: Calcd: 206.1903; Found: 206.1903;
Anal Calcd for C14H23N: C, 81.89; H, 11.29; N, 6.82. Found: C, 81.62; H, 
11.02; N, 6.37.
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3.6 'H and ,3C NMR spectra of complex 6f
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Chapter 4
Chiral Cyclometallated Ir-Oxazoline Complexes for 
Asymmetric Imine Hydrogenation
4.1 Introduction
Chapter 3 showed excellent results for the hydrogenation of imines with 
achiral cyclometallated iridium complexes, where both //-aryl and N- 
alkylimines can be hydrogenated in TFE. This prompted us to develop chiral 
cyclometallated iridium complexes for the asymmetric hydrogenation of N- 
alkyl imines. This type of substrates proved to be one of the main limitations 
for the cooperative chiral Ir-phosphate catalysis described in Chapter 2, as the 
catalyst is ineffective for DARA with aliphatic amines. This chapter describes 
the efforts towards highly enantioselective hydrogenation of A-alkyl imines 
with chiral Ir-oxazoline catalysts synthesised by cyclometallation of an iridium 
metal centre with oxazoline ligands.
Chiral oxazoline-containing ligands have proven highly versatile in 
asymmetric catalysis. They are present in a wide variety of catalytic 
applications, as for example hydrosilylation,1"2 aldol condensation,3'6 allylation 
of aldehydes,7 allylic substitution8'13 and Michael additions (Scheme 4.1).14'15
o oh1 + H2SiR'2 PMLn; X
R 2)H30+ R
O On + x ml-
R H
O OH
Hydrosilylation Aldol condensation
O
I MLn
R H “
O O O R' O
A + R—A.
Allylation of aldehydes Michael addition
Scheme 4.1: Example of catalytic applications of chiral oxazoline ligands.
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Pyridinooxazoline16"17 (PyOX) 1, bisoxazoline18 2, N,N,N- 
bis(oxazolinylphenyl)amine19'21 (BOPA) 3, bisoxazolinopyridine22 (PyBOX) 4 
and PHOX ligands are some of the most widely used oxazoline-containing 
ligands (Figure 4.1). PHOX ligands, in particular, have been proven very 
efficient ligands for the asymmetric hydrogenation of imines,23"30 as presented 
in the introduction of this thesis. Additionally, the wide use of chiral-oxazoline 
ligands for asymmetric transformations was mentioned above. Therefore, the 
introduction to this chapter will only present relevant examples of chiral metal- 
oxazoline catalysts used for catalytic asymmetric reduction.
2 3 4
Figure 4.1: Examples of oxazoline-containing ligands.
Brunner studied the asymmetric hydrosilylation of acetophenone with a 
rhodium catalyst containing a derivative of ligand l.16 This is one of the first 
examples of an oxazoline-containing ligand applied to asymmetric 
hydrosilylation. The best enantioselectivity was obtained when 1 had R = Me, 
although only 48% ee was reported.
Nishiyama and co-workers reported iron31"32 and cobalt31 catalysts 
containing a BOPA ligand 3 for the hydrosilylation of ketones. Alcohol 
products are obtained with good yields and enantioselectivities, with 2-5 mol%
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catalyst loading, at 65 °C, albeit with long reaction times (24-96 hours) 
(Scheme 4.2).
n nw
Fe: 73% ee 
Co: 93% ee
3a: R: CHPh2 
3b: R: Rh
Scheme 4.2: Asymmetric hydrosilylation of ketones with Fe or Co-BOPA catalysts.
PyBOX ligands were first prepared by Nishiyama in 1989.33 Since then, 
the use of these ligands has increased exponentially. They are effective chiral 
ligands in a wide variety of transformations.22 hi the area of asymmetric 
reduction, Nishiyama and co-workers reported the first asymmetric 
hydrosilylation of ketones with rhodium-PyBOX catalysts33 and further 
developed this work in the following years.2,34 By using 1 mol% of a Rli- 
PyBOX 4a catalyst with the aid of AgBF4, a wide range of aromatic and 
aliphatic methyl ketones were reduced with high enantioselectivities (68-99% 
ee) (Scheme 4.3).2 The presence of the silver salt is essential to activate the 
catalyst, enabling the formation of the corresponding cationic rhodium species, 
which then can react smoothly with the silane.
O 1)1 mol% [Rh(4a)Cl3], OH
Ph2SiH2, AgBF4, 
THF, 0 0C, 26 h 
2) H30+
4a: R: /Pr 95% ee
Scheme 4.3: Asymmetric hydrosilylation of ketones with a Rh-PyBOX catalyst.
142
Chapter 4: Chiral Cyclometallated Ir-Oxazoline Complexes for Asymmetric Imine Hydrogenation
More recently, Jayashankaran and co-workers reported the synthesis of 
PyBOX-derived ligands 5 and studied their application in the rhodium- 
catalysed hydrosilylation of ketones (Scheme 4.4).35 These new ligands contain 
a remote substituent, at the /wra-position of the pyridine. Although far away 
from the catalytic centre, it is connected through an extended Tt-conjugation, so 
it influences the electronic environment at the metal centre. The reaction is 
completed after 20 hours in THF at 10 °C. Enantioselectivities smpassed in 
general those obtained by Nishiyama’s group (87-99% ee) but a higher catalyst 
loading was required (10 mol%).
10 moi% [RhfSjey,
Ph2SiH2) AgBF4,
THF, 10 0C, 20 h
----------------------------------------------------- ►
98% ee 
Et
Scheme 4.4: Hydrosilylation of ketones with a derivative of PyBOX ligand.
To the best of our knowledge, there are no examples of the study of the 
catalytic activity of oxazoline-containing ligands where the ligand is 
cyclometallated. The cyclometallation of an oxazoline to [IrCp*Cl2]2 was 
firstly reported by Davies et al. (Scheme 4.5).36'37 More recently, they studied
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the formation of the corresponding cationic species of 6, which was followed 
by insertion reaction with internal and terminal alkynes.38 All complexes were 
fully characterised but never tested for catalytic activity. This chapter presents 
the effort made in the design and synthesis of chiral cyclometallated Ir- 
oxazoline complexes and the study of asymmetric hydrogenation of an N~ 
benzyl inline with these complexes.
Scheme 4.5: Cyclometallated Ir-oxazoline complex synthesised by Davies.
4.2 Results and Discussion
A series of chiral oxazolines were synthesised from aromatic aldehydes 
and chiral aminoalcohols, following a procedure developed by Glorius et al 
(Scheme 4.6).39 hi addition, chiral imidazolidine ligands were also synthesised 
by other members of the group from aromatic aldehydes and chiral diamines, 
following a known procedure.40 They were used to form cyclometallated 
iridium complexes and tested for asymmetric hydrogenation of iniines.
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O
H* R' R"
OH
R'
1) 4 A MS, PCM, rt, N2 atm, o/n
2) MBS, N2 atm, rt, 2 h *
7
7a: R: H, R': Ph, R": Ph
Scheme 4.6: Synthesis of chiral oxazoline and imidazolidine ligands.
The oxazoline ligands synthesised were cyclometallated with [IrCp*Cl2]2 
in the presence of NaOAc, following the same procedure presented in Chapter 
3. The cyclometallation took place exclusively at the aromatic ring derived 
from the aldehyde.41 It was observed that two different diastereoisomers were 
formed. The diastereomeric ratio varies from 1:1 to 4:1 depending on the 
substituents; it is 2:1 for 8a:8b (Figure 4.2). When cyclometallation was 
carried out, the solid obtained as a product was washed with hexane/ether and 
used for the hydrogenation reactions.
Figure 4.2: Diastereoisomers observed in chiral cyclometallated Ir-oxazoline complexes.
hi a preliminary study, we applied the mixture of diastereoisomers 8 to 
asymmetric hydrogenation of imine 9 (Scheme 4.7). A promising 45% ee was
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obtained at 5 bar H2 and 25 °C with 1 mol% catalyst loading. This encouraged 
us to modify the oxazoline ligand backbone in order to increase the 
enantioselectivity. One of the main features of the oxazoline ligands is their 
modular structure. Their structure can be easily modified with different 
substituents in the aldehyde and/or amino alcohol moiety. In addition, different 
metal precursors can be applied.
1 mol% 8, TFE,
5 bar H2, 25 °C, 17 h
45% ee
Scheme 4.7: Initial study on asymmetric hydrogenation of imine with an Ir-oxazoline
complex.
Firstly, the effect of the metal centre on the enantioselectivity was studied. 
Specifically cyclometallated Rh, Ir and Ru metal centres were compared. 
Cyclometallation of oxazoline ligand (lS,2R)-7a with [RhCp*Cl2]2 and [Ru(/> 
cymene)Cl2]2 was undertaken. These complexes were then tested for the 
asymmetric hydrogenation of imine 9, which was used as a model substrate for 
the optimisation of conditions (Scheme 4.8). As can be seen, the 
enantioselectivity obtained previously with Ir-oxazoline complex was not 
suipassed: Only 23% ee was obtained with the analogous Rh-oxazoline 
complex. In the case of the ruthenium, the cyclometallated complex was not 
even formed and only decomposition took place.
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Scheme 4.8: Metal effect on asymmetric hydrogenation of 9.
As previously mentioned, chiral imidazolidine ligands were also tested on 
the asymmetric hydrogenation of 9. These catalysts were previously tested for 
ATH of imines by a different member of the group.41 The results are presented 
in Scheme 4.9. Lower enantioselectivity was obtained when the unsubstituted 
imidazolidine 11 was used as the ligand, compared to the unsubstituted 
oxazoline 7a (15% vs 45% ee). A more promising result was obtained with 
disubstituted imidazolidine 12 (53% ee). It is worth noting that this ligand 
provides better enantioselectivity under hydrogenation conditions than transfer 
hydrogenation conditions, where only 33% ee was obtained.41 hi the hope to 
increase the enantioselectivity, a substituent was introduced on one of the 
nitrogen atoms of the imidazolidine ligand. Disappointingly, ligand 13 gave a 
practically racemic mixture for the hydrogenation of 9 (3% ee).
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1 mol% Ir-imidazolidine, TFE, 
5 bar H2, 25 °C, 17h
Ph Ph
lr-11:15% ee 
lr-12: 53% ee 
lr-13: 3% ee
Ph
O MeO'
Scheme 4.9: Imidazolidine ligands for the asymmetric hydrogenation of 9.
Although a promising result was obtained with 12, it was decided to focus 
the study on the oxazoline ligands, hi contrast to oxazolines {vide supra), in the 
cyclometallation of imidazolidines with [IrCp*Cl2]2, three different isomers 
were observed by !H NMR, although mass spectrometry only shows one value. 
This is due to cyclometallation at the phenyl ring from the aldehyde and at one 
of the phenyl rings from the diamine moiety (Figure 4.3). Therefore, it is more 
difficult to determine which one of the three complexes formed is the active 
and enantioselective species.
Figure 4.3: Isomers observed in cyclometallated chiral Ir-imidazolidine complexes.
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However, before turning our attention exclusively to oxazoline ligands, we 
tested the chiral imidazolidine 14 for the Ir-catalysed asymmetric 
hydrogenation of 9. This ligand would force the cyclometallation into one of 
the phenyl rings of the diamine moiety. This could help us to determine if this 
third isomer is the key to obtain high enantioselectivity. Unfortunately, the 
catalyst turned black when TFE was added, and only 3% ee was obtained 
(Scheme 4.10). X-ray diffraction finally showed that cyclometallation actually 
took place on one of the methyl groups, instead of the phenyl ring from the 
diamine side (Scheme 4.10). The low enantioselectivity could thus be due to 
dissociation of 14 from the iridium following protonolysis of the Ir-C bond.
1 mol% lr-14, TFE, 
5 bar H2, 25 °C, 17h
Ph 3% ee
14
Expected Obtained
Scheme 4.10: Asymmetric hydrogenation of 9 with lr-14.
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Most of the oxazoline ligands 7 contain two stereogenic centres, leading to 
two diastereoisomers. For this reason, we compared the enantioselectivity 
between and {S,R)-lsi ligands for the hydrogenation of 9 (Scheme
4.11). (S,R)-la. showed to be superior, leading to 45% ee compared to 9% ee 
obtained with Crystals of Ir-OS^-Va and Ir-(^i?)-7a for X-ray
diffraction experiments were obtained by other member of the group.41 It is 
worth noting that the X-ray diffraction shows that the diastereomeric ratio of 
Ir-(^,i^)-7a was 1:1, while the diastereomeric ratio of Ii-(5',^)-7a was 2:1. 
These observations suggests that a high diastereomeric ratio is required in 
order to obtain high enantioselectivity.
(S,f?)-7a: 45% ee 
(R,R)~7a: 9% ee
Ph
Scheme 4.11: Effect of ligand configuration on the hydrogenation of 9.
The effect of the amino alcohol moiety was also studied by comparing 
oxazoline ligands derived from different amino alcohols. The results are shown 
in Scheme 4.12. The bulkiness has a dramatic effect on the enantioselectivity. 
Only 3>% ee was obtained with oxazoline 7b, derived from Z-valinol. A better 
enantioselectivity of 35% ee was obtained with the bulkier oxazoline 7c,
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although it did not smpass the initial enantioselectivity of 45% ee with {S,R)-lvt 
(Scheme 4.12). It is also noteworthy that product of ^-configuration was 
obtained with ligands 7b and 7c, while ^-configuration was obtained with 
every oxazoline ligand derived from (IS, 2/^-2-amino-1,2-diphenyl ethanol.
7b 7c (S,f?)-7a
3% ee (S) 35% ee (S) 45% ee (R)
Scheme 4.12: Effect of aminoalcohol on asymmetric hydrogenation of 9.
The substitution at the or/Z/o-position of the aldehyde was subsequently 
studied (Table 4.1). The presence of a substituent on the 2-position had a 
positive effect on the enantioselectivity (entry 1 vs 2-6). Moving on to 
electron-donating substituents, bulkiness seemed to improve the 
enantioselectivity (entries 5 vs 6). These results prompted us to synthesise an 
oxazoline ligand with an /Pr substituent at the o/V/?o-positon. Unfortunately, 
almost a racemic mixture was obtained (entry 7). The diastereoselectivity on 
the cyclometallated complexes with ligands 7h and 7i increases from 2.6:1 to 
4:1, respectively. We rationalise that the complex providing the lowest 
enantioselectivity for the hydrogenation of 9 increased in proportion. An 
example of oxazoline derived from 3-substitued aldehyde was also studied
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(entry 8). This oxazolme has two inequivalent positions for cyclometallation, 
leading to four possible isomers. This situation makes it very difficult to 
determine the most selective catalyst.
Table 4.1: Effect of ortho- and me/a-substitution at the oxazoline ligand on the 
enantioselectivity of hydrogenation of 9.a
1 mol% lr-7, TFE, 
bar H2, 25 0C, 17h
7a,d-i
Entry Ligand R ee (%) Entry Ligand R ee (%)
1 7a H 45 5 7g OMe 19
2 7d Cl 57 6 7h Me 66
3 7e Br 63 7 7i /Pr 8
4
a/\
7f Ph 56 8b 7j Me 56
“0.25 mmol 9, 2.5 gmol catalyst, 4 mL TFE, 5 bar H2, 25 °C, 17 hours; Full
conversion for all the reactions. bOxazoline derived from m- 
methylbenzaldehyde.
In addition to the ortho- and wefa-substituents, oxazolines derived from 
^^-substituted benzaldehydes were also studied (Table 4.2). Electron- 
donating substituents showed better enantioselectivities (entry 1 v.y 2-6). Within 
electron-donating substituents, the increase in bulkiness had a positive effect 
on the enantioselectivity. With /Pr and /Bu substituents, the enantioselectivity 
reached a maximum of -71% ee (entries 4 and 5). There was a clear need for a 
much bulkier oxazoline to boost the enantioselectivity.
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Table 4.2: Effect of/;ara-substitution at the oxazoline ligand on the enantioselectivity of
hydrogenation of 9.a
1 mol% lr-7, TFE,
7k-p
Entry Ligand R ee (%) Entry Ligand R ee (%)
1 7k cf3 45 4 7n iPr 71
2 71 OMe 55 5 7o /Bu 70
3 7m Me 55 6
a ■, b t. .
7p Rb 78
Same reactions conditions as those in Table 4.1.b R:
A diaryl benzaldehyde could lead to a bulkier chiral oxazoline. We, 
therefore, decided to synthesise aldehyde 15, by Suzuki coupling (Scheme 
4.13).42 The corresponding oxazoline 7p was then synthesised, cyclometallated 
and tested for hydrogenation of 9. Delightfully, the enantioselectivity increased 
to 78% ee (Table 4.2, entry 6).
Scheme 4.13: Synthesis of aldehyde 15 by Suzuki coupling.
Given this finding and the positive effect noted in Table 4.1, we then 
studied the effect of disubstitution at the oxazoline ligand on the
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enantioselectivity. Ligand 16 had previously proved to be one of the most 
effective imidazolidine ligands for ATH with Ir-cyclometallated complex 
(Figure 4.4).41 Prompted by this, we decided to synthesise and test 7q first, an 
oxazoline analogue of 16 (Figure 4.4). Unfortunately, only 12% ee was 
obtained (Table 4.3, entry 1). It is worth noting that for ligand 7q, 
cyclometallation is observed in two different phenyl rings, resulting in 3 
different isomers (see Figure 4.3). This is probably due to steric effects on the 
phenyl ring from the aldehyde.
Ph
Ph
Figure 4.4: Imidazolidine ligand applied for ATH of imines with cyclometallated Ir-complex.
On the other hand, we presumed that a synergistic effect could take place 
with a 2,4-disubstitued benzaldehyde, where both substituents would boost the 
enantioselectivity. Indeed, the combination of o-Br and /?-Me substituents 
increased the enantioselectivity up to 69% ee, from 63 and 55% ee for the 
mono-substitution, respectively (Table 4.3, entries 2 and 3 vs- 4). This 
improvement on the enantioselectivity indicates that the combination of the 
two best substituents, oMe and /j-triisopropylphenyl would be very promising.
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Table 4.3: Effect of disubstitution on the oxazoline ligand on the enantioselectivity of
hydrogenation of 9.
7e,m,p,r
Entry” Ligand Ri r2 ee (%)
1 7q OMe 5-Br 12
2 7e Br 4-H 63
3 7m H 4-Me 55
4 7r Br 4-Me 69
"Same reactions conditions as those in Table 4.1.
Therefore, we synthesised aldehyde 17, following the procedure shown in 
Scheme 4.14. The corresponding oxazoline was then synthesised, 
cyclometallated and the catalyst tested for the hydrogenation of 9. 
Unfortunately, only few milligrams of the complex were obtained and some 
impurities were observed by !Ii NMR; the crystallization (i.e. purification) of 
the catalyst became very difficult. The enantioselectivity obtained was only 
42% ee. This could be due to the impurities present in the solid.
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Scheme 4.14: Synthesis of aldehyde 17 by Suzuki coupling.
4.3 Conclusion and future work
We have described the efforts to develop a chiral cyclometallated Ir- 
oxazoline catalyst for asymmetric hydrogenation of imines. It is the first time 
that this type of catalyst has been synthesised and applied for asymmetric 
hydrogenation. A promising 78% enantiomeric excess was obtained with 
ligand 7p. Future work should focus on the synthesis of bulkier chiral 
oxazoline ligands and expand the scope to other iV-alkyl imines.
4. 4 Experimental
General procedure for the synthesis of oxazoline ligands39
A Schlenk tube was charged with 4 A MS (1 g), an amino alcohol (1 
mmol) and an aldehyde (1 mmol), followed by degassing with N2 three times. 
Distilled DCM was then added. The mixture was stirred for 14 hours at room 
temperature. NBS was then added and the mixture was further stirred for 2 
hours. The mixture was filtered through celite and washed with saturated 
NaHCOataq) solution (4 x 10 niL) and H2O (1 x 10 mL). The organic layer was 
dried over MgSCU, filtered through celite and concentrated to afford the crude 
product. Flash chromatography purification with a column of silica gel eluted
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with petroleum ether/ethyl acetate (20/1 to 10/1) yielded the desired oxazoline 
product.
General procedure for the synthesis of cyclometallated complexes36'37,43
An oven-dried Schlenk tube containing a stir bar was charged with 
[IrCp*Cl2]2 (1 eq), an oxazoline ligand (2 eqs) and NaOAc (10 eqs.). 
Following degassing three times, freshly distilled DCM was injected. The 
resulting mixture was stirred at room temperature overnight. The reaction 
mixture was then filtered through cehte and concentrated in vacuo. The 
resulting solid was washed with diethyl ether/hexane and used for imine 
hydrogenation without further purification.
General procedure for the hydrogenation of imine 9
To a glass liner equipped with a stir bar was added 9 (0.25 mmol), catalyst 
(2.5 pmol) and TFE (4 mL). The glass liner was then placed into an autoclave, 
followed by degassing with H2 three times. The hydrogenation was carried out 
at 5 bar H2 with stirring at 25 °C for 15 hours. The hydrogen gas was then 
carefully released in a fume hood and the solution was filtered, transferred to a 
flask, and concentrated to afford the crude product. 1H NMR showed full 
conversion for all the reactions. Flash chromatography purification with a 
column of silica gel eluted with petroleum ether/ethyl acetate (20/1 to 5/1) 
yielded the desired amine product.
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Procedure for the synthesis of aldehydes 15 and 1742
An oven-dried Schlenk tube containing a stir bar was charged with boronic 
acid (1.2 eq), aryl halide (1 eq) and BU4NHSO4 (0.1 eq). Following degassing 
three times, Pd(PPh3)4 (0.03 eq) was then added. The Schlenk tribe was 
degassed again 3 times. Freshly distilled toluene was injected (10 mL), 
followed by Na2C03(aq) (2 M, 6 mL). The reaction was then carried out at 110 
°C for 24 hours under a N2 atmosphere. The mixture was extracted with ethyl 
acetate, and the organic layer was dried over MgS04, filtered through celite, 
and concentrated in vacuo. Flash chromatography purification with a column 
of silica gel eluted with petroleum ether/DCM (5/1 to 0/1) yielded the desired 
aldehyde product.
Procedure for the synthesis of alcohol 18
An oven-dried two-necked flask containing a stir bar was charged with 4- 
bromo-2-methylbenzoic acid (3.2 g, 15 mmol). It was then comiected to a 
reflux condenser and degassed three times. THF (20 mL) was added. NaBH4 
(680 mg, 18 mmol) was then added in small portions. H2 evolution occurred 
for approximately 10 min. After FL evolution stopped, the reaction temperature 
was set up at 65 °C for 17 hours under N2 atmosphere. The mixture was then 
cooled to room temperature and washed with saturated NaHCOa^q), and then 
extracted with ethyl acetate. The organic layer was dried over MgS04, filtered 
through celite, and concentrated in vacuo. The product was used in the 
following step without further purification.
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Procedure for the synthesis of aldehyde 19
An oven-dried Schlenk tube containing a stir bar was charged with 
pyridinium chlorochromate (PCC) (1.51 g, 7 mmol). It was then connected to a 
pressure-equalising dropping funnel and degassed three times. The funnel was 
then charged with a solution of 18 (1.2 g, 6 mmol) in THF (10 mL), which was 
added slowly into the Schlenk tube. The reaction mixture was left stirring 
overnight at room temperature under N2 atmosphere. The reaction mixture was 
then filtered through celite, and concentrated in vacuo. Flash chromatography 
purification with a column of silica gel eluted with petroleum ether/ethyl 
acetate (15/1 to 10/1) yielded 19.
4.5 Analytical data
Compounds 7d~s, 17 and 19 are new compounds.
(s,R)-7a
(4R,55f)-2,4,5-Triphenyl-4,5-dihydrooxazole.41 The product (254 mg, 85% 
yield) was obtained as a white solid according to the general procedure;
‘H NMR (400 MHz, CDC13) 8 5.68 (d, 10.1 Hz, 1H), 5.96 (d, J= 10.1 Hz,
1H), 6.85-6.90 (m, 4H), 6.93-7.02 (m, 6H), 7.41-7.45 (m, 2FI), 7.48-7.53 (m, 
1H), 8.11 (dd, J= 8.3, 1.2 Hz, 2H);
13C NMR (100 MHz, CDC13) 5 74.9, 85.7, 126.7, 127.4, 127.8, 128.0(1), 
128.0(7), 128.1(1), 128.3, 128.9(6), 129.0(1), 132.2, 137.0, 138.1, 165.4; 
HRMS forCaiHigNO [M+H]+: Calcd: 300.1388; Found: 300.1389;
Anal Calcd for C21H17NO: C, 84.25; H, 5.72; N, 4.58. Found: C, 84.27; H, 
5.82; N, 4.34.
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o
N \ //
{R,R)-7a
(^i?,5i?)-2,4,5“Triphenyl-4,5-dihydrooxazole.39,44 The product (245 mg, 82% 
yield) was obtained as a white solid according to the general procedure;
^ NMR (400 MHz, CDCI3) 5 5.22 (d, J= 7.6 Hz, 1H), 5.41 (d,J= 7.6 Hz, 
1H), 7.29-7.56 (m, 13H), 8.13-8.15 (m, 2H);
13C NMR (100 MHz, CDC13) 6 79.5, 89.4, 126.1, 127.2, 127.9, 128.2, 128.8, 
128.9, 129.1, 129.3, 129.4, 132.1, 140.9, 142.2, 164.5;
HRMS for C21H18NO [M+H]+: Calcd: 300.1388; Found: 300.1385;
Anal Calcd for C2iH]7NO: C, 84.25; H, 5.72; N, 4.58. Found: C, 84.60; H, 
5.77; N, 4.58.
o-"\
"N
7b
(5)-4-Isopropyl-2-phenyl-4,5-dihydrooxazole.39 The product (132 mg, 70% 
yield) was obtained as a colourless oil according to the general procedure;
’H NMR (400 MHz, CDCI3) 5 0.93 (d, 6.8 Hz, 3H), 1.03 (d, J= 6.8 Hz,
3H), 1.87 (septetd, J= 6.8, 1.6 Hz, 1H), 4.07-4.16 (m, 2H), 4.41 (td, 7.2, 
1.6 Hz, 1H), 7.38-7.42 (m, 2H), 7.44-7.49 (m, 1H), 7.94-7.97 (m, 2H);
13C NMR (100 MHz, CDC13) 8 18.5, 19.4, 33.2, 70.5, 73.0, 128.4, 128.6, 
128.7, 131.6, 163.7;
HRMS for Ci2Hi6NO [M+H]+: Calcd: 190.1226; Found: 190.1224;
Anal Calcd for C12H15NO: C, 76.16; H, 7.99; N, 7.40. Found: C, 75.73; H, 
8.16; N, 7.44.
(3aR,5^)5)-2-Phenyl-8,8a-dihydro-3aH-indeno[ 1,2-d]oxazole.39,45 The product 
(179 mg, 76% yield) was obtained as a white solid according to the general 
procedure;
Mp= 114-116 °C
^ NMR (400 MHz, CDC13) 8 3.36 (dd, 17.0, 1.4 Hz, 1H), 3.50 (dd, / = 
17.0, 6.7 Hz, 1H), 5.48 (ddd, J= 8.0, 6.7, 1.4 Hz, 1H), 5.74 (d, /= 8.0 Hz, 1H), 
7.25-7.30 (m, 3H), 7.34-7.38 (m, 2H), 7.41-7.45 (m, 1H), 7.56-7.58 (m, 1H), 
7.91-7.94 (m, 2H);
13C NMR (100 MHz, CDC13) 8 40.2, 77.4, 83.6, 125.7, 126.0, 127.9, 128.2, 
128.6, 128.7, 128.9, 131.7, 140.1, 142.4, 164.4;
HRMS for CI4H]6NO [M+H]+: Calcd: 214.1226; Found: 214.1227;
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Anal Calcd for Ci6H,3NO: C3 81.68; H, 5.57; N, 5.95. Found: C, 79.84; H, 
5.54; N, 5.55.
(4R, 55)-2~(2-Chlorophenyl)-4,5-diphenyl-4,5-dihydrooxazole. The product 
(176 mg, 53% yield) was obtained as a white solid according to the general 
procedure;
^ NMR (400 MHz, CDC13) 5 5.80 (d, J= 10.2 Hz, 1H), 6.06 (d, ./= 10.2 Hz, 
1H), 6.98-7.11 (m, 10H), 7.39 (td, J= 7.6, 1.3 Hz, 1H), 7.46 (td, J= 7.6, 1.8 
Hz, 1H), 7.55 (dd, J= 7.6, 1.3 Hz, 1H), 8.01 (dd, /= 7.6, 1.8 Hz, 1H);
13C NMR (100 MHz, CDC13) 5 75.1, 86.0, 126.9, 127.1, 127.4, 127.6, 127.9, 
128.0(8), 128.1(2), 128.3, 131.4, 132.1, 132.3, 134.2, 136.6, 137.8, 164.1; 
HRMS for C2iH17ClNO [M+Hf: Calcd: 334.0999; Found: 334.1007;
Anal Calcd for C2]H16ClNO: C, 75.56; H, 4.83; N, 4.20. Found: C, 75.57; H, 
4.95; N, 4.62.
{4R, 55)-2-(2-Bromophenyl)-4,5-diphenyl-4,5-dihydrooxazole. The product 
(189 mg, 50% yield) was obtained as a white solid according to the general 
procedure;
Mp = 95-97 °C
'H NMR (400 MHz, CDC13) 5 5.80 (d, J= 10.3 Hz, 1H), 6.07 (d, J= 10.3 Hz, 
1H), 7.00-7.10 (m, 10H), 7.37 (td, 7.7, 1.8 Hz, 1H), 7.44 (td, J= 7.7, 1.3 
Hz, 1H), 7.75 (dd, J= 7.7, 1.3 Hz, 1H), 7.96 (dd, J= 7.7, 1.8 Hz, 1H);
13C NMR (100 MHz, CDC13) 5 75.1, 86.1, 122.5, 127.0, 127.4, 127.7, 127.9, 
128.0(7), 128.1(2), 128.3, 129.8, 132.2, 132.4, 134.6, 136.6, 137.8, 164.7; 
HRMS for C2iHi779BrN02 [M+H]+: m/z Calcd: 378.0494; Found: 378.0490; 
Anal Calcd for C2iHi6BrNO: C, 66.68; H, 4.26; N, 3.70. Found: C, 66.00; H, 
4.31; N, 3.52.
161
Chapter 4: Chiral Cyclometallated Ir-Oxazoline Complexes for Asymmetric Imine Hydrogenation
(4i?,5JS)-2-(Biplienyl-2-yl)-4,5"diplienyl“4,5-diliydrooxazole. The product (105 
mg, 28% yield) was obtained as a white solid according to the general 
procedure;
% NMR (400 MHz, CDC13) 6 5.58 (d, J= 10.3 Hz, 1H), 5.65 (d, 10.3 Hz,
1H), 6.62-6.65 (m, 2H), 6.79-6.81 (m, 2H), 6.93-6.97 (m, 3H), 6.99-7.01 (m, 
3H), 7.37-7.46 (m, 4H), 7.48-7.53 (m, 3H), 7.57 (td, J= 1.6, 1.3 Hz, 1H), 8.02 
(d, .7=7.8 Hz, 1H);
13C NMR (100 MHz, CDC13) 6 74.2, 85.6, 125.8, 126.3, 126.8, 127.1, 127.3,
127.4, 127.5, 127.7, 127.9, 128.1, 128.3, 128.8, 130.3, 130.6, 136.7, 137.8,
141.5, 142.3, 166.5;
HRMS for C27H22NO [M+H]+: Calcd: 376.1701; Found: 376.1716;
Anal Calcd for C27H21NO: C, 86.37; H, 5.64; N, 3.73. Found: C, 86.41; H, 
5.62; N, 3.54.
(7i?,5(S)-2-(2-Methoxyphenyl)-4,5-diphenyl-4,5-dihydrooxazole. The product 
(168 mg, 51% yield) was obtained as a white solid according to the general 
procedure;
% NMR (400 MHz, CDC13) 5 3.95 (s, 3H), 5.76 (d, J= 10.2 Hz, 1H), 5.98 (d, 
J= 10.2 Hz, 1H), 6.96-7.06 (m, 12H), 7.48 (td, 7r= 7.9, 1.8 Hz, 1H), 7.96 (dd, J 
= 7.9, 1.8 Hz, 1H);
13C NMR (100 MHz, CDC13) 5 56.1, 74.8, 84.8, 111.9, 117.2, 120.4, 126.5, 
126.8, 127.3, 127.5, 127.6, 128.0, 131.5, 132.6, 136.8, 137.9, 158.9, 163.9; 
HRMS for C20H20NO2 [M+H]+: Calcd: 330.1494; Found: 330.1495;
Anal Calcd for C22H19NO2 + im20: C, 70.08; H, 5.96; N, 4.14. Found: C, 
78.08; H, 5.96; N, 3.96.
(4i?,J*S)-4,5-Diphenyl-2-(o-tolyl)-4,5-dihydrooxazole. The product (147 mg, 
47% yield) was obtained as a white solid according to the general procedure; 
NMR (400 MHz, CDC13) 5 2.69 (s, 3H), 5.72 (d, J= 10.2 Hz, 1H), 5.91 (d,
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J= 10.2 Hz, 1H), 6.88-6.92 (m, 4H), 6.94-7.00 (m, 6H), 7.22-7.27 (m, 2H), 
7.35 (td,J= 7.5, 1.2 Hz, 1H), 8.01 (dd,.7=7.8, 1.2Hz, 1H);
13C NMR (100 MHz, CDC13) 6 25.8, 77.8, 84.6, 125.2, 126.4, 126.8, 126.9,
127.3, 127.6, 127.7, 127.9, 130.3, 136.8, 137.9, 139.4(6), 139.5(2), 139.9, 
165.4;
HRMS for C22H20NO [M+H]+: Calcd: 314.1545; Found: 314.1552.
Anal Calcd for C22H19NO: C, 84.31; H, 6.11; N, 4.47. Found: C, 84.20; H, 
5.96; N, 4.06.
(4R,55)-2-(2-Isopropylphenyl)-4,5-diphenyl-4,5-dihydrooxazole. The product 
(133 mg, 39% yield) was obtained as a white solid according to the general 
procedure;
Mp = 80-83 °C
'H NMR (400 MHz, CDC13) 5 1.32 (d, J= 6.8 Hz, 6H), 4.15 (septet, /= 6.8 
Hz, 1H), 5.78 (d, /= 10.2 Hz, 1H), 6.00 (d, J= 10.2 Hz, 1H), 6.96-6.99 (m, 
4H), 7.00-7.08 (111, 6H), 7.27-7.32 (m, 1H), 7.49-7.50 (111, 2H), 7.98 (d, J= 7.6 
Hz, 1H);
13C NMR (100 MHz, CDC13) 6 29.0, 30.2, 75.1, 86.0, 126.2(7), 126.3(1),
126.4, 126.9, 127.4, 127.6(7), 127.7(1), 127.9, 130.3, 131.9, 136.7, 137.9, 
149.7,149.8, 165.7;
IR (neat) 2977 (s), 2360 (m), 1635 (111), 1385 (m), 1153 (m), 1041 (m), 964 
(m), 760 (m), 694 (s) cm'1;
HRMS for C24H24NO [M+H]+: Calcd: 342.1858; Fomid: 342.1862;
Anal Calcd for C24H23NO: C, 84.42; H, 6.79; N, 4.10. Found: C, 84.41; H, 
6.82; N, 3.91.
(4i?, J5)-4,5-Diphenyl-2-m-tolyl-4,5-dihydrooxazole. The product (191 mg, 
61% yield) was obtained as a white solid according to the general procedure; 
'H NMR (400 MHz, CDCI3) 5 2.44 (s, 3H), 5.74 (d, J = 10.1 Hz, 1H), 6.02 (d, 
10.1 Hz, 1H), 6.92-6.98 (m, 4H), 7.01-7.40 (m, 6H), 7.39 (d, J= 5.8 Hz, 
2H), 7.96-7.98 (m, 1H), 8.02 (s, 1H);
13C NMR (100 MHz, CDC13) 5 21.3, 74.4, 85.3, 127.7, 126.4, 127.0, 127.3,
127.4, 127.6(6), 127.7(0), 127.9, 128.5, 129.2, 132.6, 136.6, 137.7, 138.4, 
165.2;
HRMS for C22H22NO [M+H]+: Calcd: 314.1545; Found: 314.1545;
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Anal Calcd for C22H19NO + H20: C, 79.73; H, 6.39; N, 4.23. Found: C, 79.45; 
H, 6.08; N, 4.47.
(4i?JJ5)-4,5-Diphenyl-2-(4-(trifluoromethyl)phenyl)-4,5-dihydrooxazole. The 
product (191 mg, 52% yield) was obtained as a white solid according to the 
general procedure;
fH NMR (400 MHz, CDC13) 8 5.79 (d, J= 10.2 Hz, 1H), 6.07 (d, J= 10.2 Hz, 
1H), 6.91-6.96 (m, 4H), 7.03-7.09 (m, 6H), 7.77 (d, J= 8.2 Hz, 2H), 8.30 (d, J 
= 8.2 Hz, 2H);
13c NMR (100 MHz, CDClj) 5 74.5, 85.7, 122.4, 125.6, 126.3, 127.2, 127.6, 
127.8, 128.4 (q, 7Cf = 3.2 Hz), 129.0, 130.8, 133.4 (q, JCf = 33.3 Hz), 136.2, 
137.2, 163.8 (The carbon resonance CF3 was not observed, possibly due to 
overlap with other aromatic carbon resonances);
HRMS for C22H17F3NO [M+H]+: Calcd: 368.1262; Found: 368.1274.
(4R, JiS)-2-(4-Methoxyphenyl)-4,5-diphenyl-4,5-dihydrooxazole. The product 
(197 mg, 60% yield) was obtained as a white solid according to the general 
procedure;
Mp = 114-118 °C
'H NMR (400 MHz, CDCI3) 6 3.90 (s, 3H), 5.72 (d, J= 9.8 Hz, 1H), 6.00 (d, J 
= 9.8 Hz, 1H), 6.92-6.97 (ra, 4H), 6.98-7.08 (m, 8H), 8.10-8.14 (m, 2H);
13C NMR (100 MHz, CDC13) 5 55.9, 74.8, 85.6, 114.3, 120.3, 126.7, 127.3, 
127.7, 128.0,128.1, 128.3, 130.8, 137.1, 138.3,162.9, 165.1;
HRMS for C22H20NO2 [M+H]+: Calcd: 330.1494; Found: 330.1495;
Anal Calcd for C22Hi9N02: C, 80.22; H, 5.81; N, 4.25. Found: C, 79.53; H, 
5.81; N, 4.08.
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(^55')-4,5-Diphenyl-2-p-tolyl-4,5-dihydrooxazole. The product (222 mg, 
71% yield) was obtained as a white solid according to the general procedure; 
Mp = 162-165 °C
'H NMR (400 MHz, CDC13) 5 2.45 (s, 3H), 5.73 (d, J= 10.0 Hz, 1H), 6.01 (d, 
J= 10.0 Hz, 1H), 6.92-6.97 (m, 4H), 7.00-7.07 (m, 6H), 7.31 (d, 8.1 Hz,
2H), 8.07 (d, J= 8.1 Hz, 2H);
13C NMR (100 MHz, CDC13) 5 22.1, 74.9, 85.6, 125.1, 126.7, 127.3, 127.8, 
128.0, 128.1, 128.3, 129.0, 129.7, 137.1, 138.2, 142.7, 165.4;
HRMS for C22H20NO [M+H]^ Calcd: 314.1545; Found: 314.1547;
Anal Calcd for C22H19NO +.%H20: C, 81.96; H, 6.25; N, 4.34. Found: C, 
81.84; H, 6.00; N, 4.09.
(4i?J56)-2-(4-Isopropylphenyl)-4,5-diphenyl-4,5-dihych'ooxazole. The product 
(235 mg, 69% yield) was obtained as a white solid according to the general 
procedure;
Mp= 133-137 °C
^ NMR (400 MHz, CDCI3) 6 1.24 (d, J= 6.9 Hz, 6H), 2.93 (septet, /= 6.9 
Hz, 1H), 5.67 (d, 10.0 Hz, 1H), 5.94 (d, J= 10.0 Hz, 1H), 6.84-6.90 (m,
4H), 6.93-7.01 (m, 6H), 7.29 (d, J= 8.2 Hz, 2H), 8.03 (d, /= 8.2 Hz, 2H);
13C NMR (100 MHz, CDCI3) 5 24.2, 34.7, 74.8, 85.6, 125.4, 126.7, 127.1, 
127.3, 127.8, 128.0, 128.1, 128.3, 129.1, 137.1, 138.2, 153.5, 165.4;
HRMS for C24H24NO [M+H]+: Calcd: 342.1858; Found: 342.1865;
Anal Calcd for C24H23NO: C, 84.42; H, 6.79; N, 4.10. Found: C, 84.06; H, 
6.83; N, 3.91.
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(^5,Sr)-2-(4-ter/-Butylphenyl)-4,5-diphenyl-4,5-dihydrooxazole. The product 
(248 mg, 70% yield) was obtained as a white solid according to the general 
procedure;
^ NMR (400 MHz, CDC13) 5 1.31 (s, 9H), 5.67 (d, J= 10.0 Hz, 1H), 5.94 (d, 
J= 10.0 Hz, 1H), 6.84-6.92 (m, 4H), 6.91-1 m (m, 6H), 7.44-7.47 (m, 2H), 
8.03-8.06 (m, 2H);
13C NMR (100 MHz, CDC13) 8 13.6, 35.5, 74.9, 85.6, 125.0, 125.9, 126.7, 
127.3, 127.7, 128.0, 128.1, 128.3, 128.8, 137.1, 138.2, 155.7, 165.4;
HRMS for C25H26NO [M+H]+: Calcd: 356.2010; Found: 356.2014;
Anal Calcd for C25H15NO: C, 84.47; H, 7.09; N, 3.94. Found: C, 84.54; H, 
7.18; N, 3.85.
(4i?,5JS)-4,5-Diphenyl-2-(2',4',6'-triisopropylbiphenyl-4-yl)-4,5-dihydi'ooxazole. 
The product (73 mg, 15% yield) was obtained as a white solid according to the 
general procedure;
^ NMR (400 MHz, CDC13) 5 1.04 (d, J= 6.9 Hz, 12H), 1.25 (d, J= 6.9 Hz, 
6H), 2.56 (septet, J= 6.9 Hz, 2H), 2.89 (septet, J= 6.9 Hz, 1H), 5.71 (d, J = 
10.1 Hz, 1H), 5.98 (d, /= 10.1 Hz, 1H), 6.90-7.04 (m, 12H), 7.26 (d, J= 8.3 
Hz, 2H), 8.13 (d, J= 8.3 Hz, 2H);
13C NMR (100 MHz, CDC13) 5 24.1, 24.2, 30.3, 34.3, 74.5, 85.3, 120.6, 125.7, 
126.4, 127.0, 127.4, 127.6(6), 127.7(1), 127.9, 128.2, 130.1, 136.2, 136.6, 
137.8,145.0, 146.3, 148.3, 165.1;
HRMS for C36H40NO [M+H]+: Calcd: 502.3110; Found: 502.3120;
Anal Calcd for C36H39NO: C, 86.18; H, 7.84; N, 2.79. Found: C, 86.25; H, 
8.10; N, 2.50.
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(^i?,51S)-2-(2-Bronio-5-metlioxyphenyl)-4,5-diphenyl-4,5-diliydi-ooxazole. The 
product (194 mg, 48% yield) was obtained as a white solid according to the 
general procedure;
'H NMR (400 MHz, CDC13) 6 3.96 (s, 3H), 5.77 (d, J= 10.2 Hz, 1H), 5.99 (d, 
J= 10.2 Hz, 1H), 6.93-7.10 (m, 11H), 7.59 (dd, J= 8.9, 2.6 Hz, 1H); 8.08 (d, J 
= 2.6 Hz, 1H);
13C NMR (100 MHz, CDC13) 6 56.8, 75.2, 85.4, 112.9, 114.1, 119.3, 126.9, 
127.3, 127.8, 128.0, 128.1, 128.3, 134.4, 135.6, 136.9, 138.0, 158.4, 163.0; 
HRMS for C22Hi879BrN02 [M+H]+: Calcd: 408.0599; Found: 408.0618;
Anal Calcd for C22Hi7BrN02: C, 64.72; H, 4.44; N, 3.43. Found: C, 64.79; H, 
4.43; N, 3.33.
(4i?,5fS)-2-(2-bromo-4-methylphenyl)-4,5-diphenyl-4,5-dihydrooxazole. The 
product (39 mg, 10% yield) was obtained as a translucent oil according to the 
general procedure;
^ NMR (400 MHz, CDC13) 5 2.33 (s, 3H), 5.70 (d, J= 10.3 Hz, 1H), 5.96 (d, 
10.3 Hz, 1H), 6.92-7.01 (m, 10H), 7.15 (dd, /= 7.9, 0.8 Hz, 1H), 7.50 (d, J 
= 0.8 Hz, 1H), 7.79 (d, 7.9 Hz, 1H);
13C NMR (100 MHz, CDC13) 5 21.1, 74.7, 85.6, 121.9, 126.3, 126.6, 127.0, 
127.4, 127.6, 127.7, 127.9, 128.1, 131.6, 134.8, 136.3, 137.5, 142.8, 164.3; 
HRMS for C22Hi979BrNO [M+H]+: Calcd: 392.0650; Found: 392.0653;
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(4R, 5,Sr)-4,5-Diphenyl-2"(2',4'56,-tnisopropyl-3-methylbiphenyl-4“yl)“4,5- 
dihydrooxazole. The product (46 mg, 9% yield) was obtained as a white solid 
according to the general procedure;
'H NMR (400 MHz, CDC13) 5 1.09 (d, /= 6.9 Hz, 6H), 1.13 (d, J = 6.9 Hz, 
6H), 1.31 (d, /= 6.9 Hz, 6H), 2.65 (septet, J = 6.9 Hz, 2H), 2.78 (s, 3H), 2.95 
(septet, J= 6.9 Hz, 1H), 5.81 (d, J= 10.2 Hz, 1H), 6.01 (d, J= 10.2 Hz, 1H), 
7.00-7.06 (m, 12H), 7.07-7.16 (m, 2H), 8.09 (d, J= 7.8 Hz, 1H).
vV-Benzyl-1 -phenylethanamine.46 The product (43 mg, 82% yield, 78% ee) was 
obtained according to the general hydrogenation procedure;
!H NMR (400 MHz, CDCI3) 8 1.29 (d, /= 6.6 Hz, 3H), 3.51 (d, A of AB, JAB 
= 13.1 Hz, 1H), 3.58 (d, B of AB, /Ab = 13.1 Hz, 1H), 3.73 (q, J= 6.6 Hz, 1H), 
7.13-7.27 (m, 10H);
13C NMR (100 MHz, CDC13) 5 23.4, 50.6, 56.4, 125.7, 125.8, 125.9, 127.1, 
127.3, 127.4, 139.5, 144.4;
HRMS for Ci5Hi8N [M+H]+: Calcd: 212.1434; Found: 212.1429;
HPLC (Chiralcel OD-H, hexane:isopropanol = 99.9:0.1, flow rate 1 mL/min, X 
= 220 nm): tR = 20.8 min (major), tR = 27.0 min (minor).
O
2',4',6'-Triisopropyl-[l,r-biphenyl]-4-carbaldehyde.42 The product (356 mg, 
81% yield) was obtained as a white solid;
IR (neat): 1697 (s) cm'1;
^ NMR (400 MHz, CDC13) 5 1.01 (d, J= 6.9 Hz, 12H), 1.24 (d, 6.9 Hz,
6H), 2.43 (septet, J= 6.9 Hz, 2H), 2.88 (septet, J= 6.9 Hz, 1H), 7.00 (s, 2H), 
7.29-7.31 (m, 2H), 7.84-7.87 (m, 2H), 10.01 (s, 1H);
13C NMR (100 MHz, CDC13) 5 23.0, 23.1, 29.4, 33.3, 119.7, 128.4, 129.6, 
133.9, 134.7, 145.0, 147.1, 147.6, 191.0;
HRMS for C22H29O [M+H]+: Calcd: 309.2213; Found: 309.2210;
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Anal Calcd for C22H28O: C, 85.66; H, 9.15. Found: C, 85.74; H, 9.20.
2',4',6,-Triisopropyl“3-methyl-[l,r-biphenyl]-4-carbaldehyde. The product (78 
mg, 24% yield) was obtained as a white solid;
IR (neat): 1697 (s) cm'1;
JH NMR (400 MHz, CDC13) 8 1.08 (d, J= 6.6 Hz, 6H), 1.09 (d, 6.7 Hz,
6H), 1.30 (d, 6.8 Hz, 6H), 2.49-2.57 (m, 2H), 2.70 (s, 3H), 2.93 (septet, J=
6.8 Hz, 1H), 7.05 (s, 2H), 7.10 (s, 1H), 7.20 (d, /= 7.8 Hz, 1H), 7.84 (d, J =
7.8 Hz, 1H), 10.31 (s, 1H);
13C NMR (100 MHz, CDC13) 8 19.8, 24.0(8), 24.1(4), 24.3, 30.4, 34.2, 120.7, 
128.0, 131.9, 132.7, 133.2, 135.8, 140.3, 146.0, 147.3, 148.5, 192.6;
HRMS for C23H30O [M+Hf: Calcd: 322.2297; Found: 322.2295;
rp ^ OH
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(4-Bromo-2-methylphenyl)methanol.47 The product (1.5 g, 49% yield) was 
obtained as a white solid;
^ NMR (400 MHz, CDC13) 8 2.31 (s, 3H), 4.64 (s, 2H), 7.23 (d, 8.6 Hz,
1H), 7.32-7.33 (m 2H);
13C NMR (100 MHz, CDC13) 8 18.9, 63.3, 121.8, 129.4(2), 129.4(4), 133.4, 
138.0, 138.6;
HRMS for CsHuBrN [M+NH^Of: Calcd: 200.0069; Found: 200.0071.
4-Bromo-2-methylbenzaldehyde. The product (418 mg, 35% yield) was 
obtained as a white solid;
IR (neat): 1682 (s) cm'1;
^ NMR (400 MHz, CDC13) 8 2.65 (s, 3H), 7.45 (d, J= 1.9 Hz, 1H), 7.51 (dd, 
J= 8.2, 1.9 Hz, 1H), 7.66 (d,J= 8.2 Hz, 1H), 10.22 (s, 1H);
I3C NMR (100 MHz, CDCI3) 8 30.0, 127.2, 128.0, 133.2, 134.3, 143.5, 171.7, 
201.5;
HRMS for C8H8BrO [M+H]+: Calcd: 198.9753; Found: 198.9748;
Anal Calcd for C8H7BrO: C, 48.27; H, 3.54. Found: C, 48.36; H, 4.34.
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Chapter 5
Metal- and Organo-Catalysed Asymmetric 
Hydroaminomethylation
5.1 Introduction
Chapter 2 attempted the synthesis of p-chiral amines by DARA of a- 
branched aldehydes. As it was shown, only moderate enantioselectivities could 
be achieved with the cooperative chiral h-diamine/phosphate catalyst. This is 
not the only drawback on this reaction: a-branched aldehydes are not, in 
general, commercially available; therefore the synthesis of the starting 
aldehydes was required in order to develop a scope of substrates. This 
prompted us to design a more efficient pathway for the synthesis of P-chiral 
amines. We envisioned that a commercially available styrene could be 
selectively hydroformylated to the corresponding a-branched aldehyde, and 
following in situ condensation with an amine, asymmetric reduction of the 
enamine/imine would lead to the desired p-chiral amine (Scheme 5.1). The 
enantioselectivity would be obtained by dynamic kinetic resolution (DKR). hi 
the presence of an acid catalyst, imines would undergo racemisation by fast 
tautomerisation. One of the enantiomers of the iminium cation could be 
selectively reduced leading to p-chiral amines (Scheme 5.1).1
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H2/CO, [M] 
Hydroformylation 0
R-NH2, Chiral acid, [H] Ar-T-A
Reductive amination
r-nh2 Chiral acid
Ar
H
Ar
N.
H
Ar
HN„r
[H]
H
I
N.,R .......R "'R
Scheme 5.1: Tandem hydroformylation/asymmetric reductive amination.
This sequential reaction, involving hydroformylation of an alkene, 
followed by reductive amination of the aldehyde intermediate with an amine, is 
also known as “hydroaminomethylation”.2 It represents a one-pot, atom- 
efficient reaction for the synthesis of amines. A suitable catalyst for 
hydroaminomethylation must fulfil a number of requirements (Scheme 5.2). It 
must be highly regioselective to either the linear or branched aldehyde, 
depending on the desired final product. The catalyst must be active for the 
enamine/imine hydrogenation, as a slow hydrogenation leads to aldol-type side 
reactions.3 Finally, the catalyst must be selective for enamine/imine 
hydrogenation over hydrogenation of aldehydes. In addition, the 
enamine/imine isomerisation must be faster than the subsequent hydrogenation 
to ensure efficient DKR.
Cat.
CO/H,
l-l R,NH2, cat., H2 .R’
Reduction Aldol-type reactions
V_________ J
Y
Undesired reactions
Scheme 5.2: Chemo- and regio-selectivity issues for the hydroaminomethylation sequence.
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The first example of hydroaminomethylation was reported by Reppe at 
BASF in 1943.4 Simple alkenes, like ethene or propene, were converted to 
secondary and tertiary amines in low yields, with ammonia under harsh 
conditions of 390 °C and 950 bar H2 using [Fe(CO)5] in almost stoichiometric 
quantity. Iron catalysts resulted in low efficiency and were later substituted by 
the mixed-metal system mthenium/iron,5 rhodium catalysts6 and cobalt 
catalysts.7 For instance, Laine showed an enhancement in the activity with a 
mixed-metal catalyst.5 A series of metal-carbonyl complexes were tested (Co, 
Os, Ir, Fe, Rli, Ru). In general, the most active hydrofomiylation catalysts were 
also the most active hydrogenation catalysts. There is a clear enhancement in 
the activity by using mixtures of ruthenium and iron, rather than the individual 
metals, which are relatively inefficient hydroaminomethylation catalysts 
(Scheme 5.3). IR spectra suggested that mixed-metal clusters fonned in the 
reaction media.5
5 mol% [M], KOH, MeOH, 
53 bar syngas, 150 0CI 0.5 h
N.
Entry [M] TOF (IT1) 11/iso selectivity
1 Fe3(CO)i2 8 3:1
2 Ru3(CO)i2 20 49:1
3 Fe3(CO)12/Ru3(CO)12 70 16:1
Scheme 5.3: Enhanced catalysis with combination of metal catalysts.
The group of Eilbracht has focused on the research of domino reactions 
involving hydroformylation as the first step.815 Within this area, this group has
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developed a wide range of syntheses based on the hydroaminomethylation 
sequence.16’32 They have therefore reported the synthesis of a wide variety of 
compounds containing an amine functionality, including polyamines for 
azamacroheterocycles ' ’ and dendritic cores. ’ ’
Within the wide range of compounds with amine functionality synthesised 
via hydroaminomethylation by Eilbracht’s group,16'21,24,26'28,30 it is worth noting 
the synthesis of pharmacologically active y- and (5-aminofunctionalised 
phenothiazine, iminodibenzyl, carbazole and pyrazole derivatives. For 
instance, ethymemazine, an antihistaminicum, can be synthesised in one-pot 
from vV-allylic amine 1 with 97% yield and 71% regioselectivity (Scheme 
5.4).28
Scheme 5.4: Synthesis of antihitaminicum ethymemazine by hydroaminomethylation.
The hydroaminomethylation methodology was then extended to the 
synthesis of azamacroheterocyclic systems with up to 36 atoms, starting from 
easily available diolefins.23 hi a further publication, bismethylallyl systems 
were used to avoid mixtures of regioisomers (Scheme 5.5).31 For these olefins, 
hydroformylation is expected to occur- exclusively in the terminal position, 
leading to /7-aldehydes.31
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5 mol% [Rh(acac){CO)2] O
1,4-dioxane, |
80 bar syngas, 80 °C, 3 ^jr
O
Scheme S.S: Hydroaminomethylation of bismethylallyl systems.
Initial investigations to generate amino-polyglycerols by 
hydroaminomethylation pathway were firstly reported using a Rh-XANTPHOS 
catalyst.32 At the hydroformylation step, amines can coordinate to the catalyst 
and decrease the regioselectivity {vide infra). For this reason, the amine was 
added after quantitative conversion was observed for the hydroformylation 
step, leading to a one-pot but sequential procedure (Scheme 5.6). Further 
applications of this pathway to the synthesis of dendrimers were later described 
for the hydroaminomethylation of A-methylallylphthalimide19 and for the 
convergent synthesis of polynitrile dendrimers.16
1) [Rh(acac){CO)2] 
XANTPHOS, toluene,
30 bar syngas, 70 °C, 5 d 
CX *
, 1 h2)C o
n/iso 14:1
Scheme 5.6: Hydroaminomethylation of a polyallyl ether.
One of the most impressive examples of hydroaminomethylation was 
reported by Beller et al in 2002.33 Linear aliphatic amines were synthesised 
from internal olefins or olefin mixtures, where not only the
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hydroaminomethylation pathway occurs in one-pot, but also the initial 
isomerisation of the alkene to the corresponding terminal alkene takes place, 
prior to the hydroformylation step. The reaction takes place with 0.1 mol% 
cationic Rh complex, 0.4 mol% ligand IPHOS 2, in a toluene/tetrahydrofuran 
mixture (1:1) at 120 °C and 60 bar CO/H2 (1:5) (Scheme 5.7). The active 
catalyst is capable of catalysing a fast isomerisation between the internal and 
terminal olefins and hydroformylation of the terminal alkene with high 77- 
selectivity, and it is active and selective for the enamine hydrogenation.
Scheme 5.7: Isomerisation of internal alkene followed by hydroaminomethylation.
Later in the decade, Belief’s group reported the hydroaminomethylation of 
various aliphatic and aromatic olefins with a Rh-carbene catalyst.34 Although 
the results did not surpass those from the previous publication, this is the only 
example where a Rh-carbene complex is used for this tandem reaction. The 
reaction takes place at 95 °C and 60 bar CO/H2 (1:5) with 0.1 mol% catalyst 
loading in THF (Scheme 5.8). High linear selectivities are only obtained with 
a-substituted styrenes. However, the selectivity for aliphatic olefins is 
relatively low, in the range of 2-64% of the linear aldehyde, whilst
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kydroformylation of styrene gives preferentially the branched aldehyde. The n- 
iso selectivity is determined at the hydroformylation step.
3
Scheme 5.8: Hydroaminomethylation with Rh-carbene catalyst.
The n/iso selectivity is, therefore, one of the main drawbacks for this 
domino reaction. The same group then decided to focus their studies on the 
regioselectivity of different catalysts applied to hydroaminomethylation. 
Although the regioselectivity of hydroformylation catalysts has been widely 
studied, the presence of the amine influences the regioselectivity, as it may 
compete with the ligand for the metal centre. Indeed, the presence of 
triethylamine decreases the n/iso selectivity from 95:5 to 80:20, for the 
hydroformylation of 1-pentene with a Rh~PPh3 catalyst.3 As expected, 
chelating phosphines maintain high selectivity as they make ligand exchange 
less favourable, XANTPHOS being the most regioselective ligand with 97:3 
n/iso selectivity in the presence of triethylamine. The cationic Rh-XANTPHOS 
catalyst is effective for a large number of aliphatic and aromatic olefins bearing 
a wider variety of functional groups, as well as primary and secondary amines 
possessing functional groups.3 High regioselectivities (90:10 to 99:1 n/iso 
selectivity) are obtained in general. Even when styrene is used, the n/iso
179
Chapter 5: Metal- and Organo-Catalysed Asymmetric Hydroaminomethylation
selectivity is 82:18; this value is very high taking into account that 
hydroformylation of styrene gives preferentially the branched product in 
general.35 An example is shown in Scheme 5.9, where the reaction takes place 
in MeOH-toluene, under 40 bar CO/H2 (4.7:1) and 125 °C with 0.1 mol% 
catalyst loading.
0.1 mol% [Rh(COD)(XANTPHOS)]BF4l 
MeOH-Toluene,
7 bar CO, 33 bar H2,125 °C, 30 h
n:iso 98:2
XANTPHOS
Scheme 5.9: Hydroaminomethylation with cationic Rh-XANTPHOS catalyst.
5.2 Results and Discussion
As shown in Section 5.1., hydroaminomethylation has been widely 
reported in the literature as an effective pathway for the synthesis of achiral 
amines. In this regard, the linear aldehyde is usually the desired product in the 
hydroformylation step. This leads to the formation of a single amine (Scheme 
5.10, pathway A). On the other hand, the branched aldehyde leads to a racemic 
mixture of two enantiomeric amines (Scheme 5.10, pathway B). Due to the 
selectivity issue, until now, hydroaminomethylation has been most useful for 
the synthesis of amines derived from linear aldehydes.
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Pathway A
O ^-selectivity
R'
R'NHg, cat., H;'2
R
H R'NHs, cat., H2
R’
O
/so-selectivity
Pathway B
Scheme 5.10: n/iso Regioselectivities for the hydroaminomethylation sequence.
However, the main aim of this chapter is the synthesis of (3-chiral amines. 
Therefore, a catalyst that offers high selectivity for the branched aldehyde is 
required, where a stereogenic centre is formed. Li and co-workers reported the 
selective hydroformylation of styrene to the corresponding ot-branched 
aldehyde with a rhodium catalyst containing a triarylphosphine ligand 
possessing a long-chain alkoxy group.36 The reaction takes place in toluene, 
with 0.2 mol% [Rh(acac)(CO)2], 0.4 mol% phosphine ligand, at 15 bar syngas 
and 50 °C (Scheme 5.11). As a starting point, we decided to use these 
conditions for the hydroaminomethylation sequence.
0.2 mo[% [Rh(acac)(CO)2] O
17.1 : 1
4
Scheme 5.11: Hydroformylation of styrene with Rh-4.
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Preliminary studies with different phosphine ligands, e.g. PPI13, (R)- 
BINAP, 0S)-PHAPHOS, (i?,i?)-BDPP, among others, showed different n/iso 
selectivities for the hydroformylation of styi’ene, as well as enamine formation 
(Scheme 5.12). Hydrogenation of the enamine was never observed, showing 
that these Rh-phosphine hydroformylation catalysts are ineffective for the 
hydrogenation step. This is not surprising as one of the main problems for the 
current hydroaminomethylation protocols is the slow hydrogenation of the 
enamine/imine intermediate.3
0.2 mol% [Rh(acac)(CO)2], 
0.4 mol% ligand, Toluene, 
11 bar syngas, 50 0C, 24 h
major
minor
Scheme 5.12: Preliminary studies on the hydroaminomethylation of styrene.
We then turned our attention to the use of two different catalysts for the 
hydroformylation and hydrogenation steps. As mentioned in Chapter 2, List et 
al. developed the DARA of a—branched aldehydes via DKR using a chiral 
phosphoric acid as organocatalyst and HEH as the hydrogen source (Scheme 
5.13).37 This became our'catalyst of choice for the reductive animation step.
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Scheme 5.13: DARA of an a-branched aldehyde with chiral organocatalyst.
We combined the [Rli(acac)(CO)2] catalyst precursor with PPI13, Et-HEH 
and 5 in toluene at 11 bar syngas and 50 °C for the reaction of ^-methylstyrene 
and /7-anisidine. The reaction was left stirring for 2 days. Gratifyingly, after 
flash chromatography purification, a very promising 41% isolated yield was 
obtained for the desired product 6b with a good enantioselectivity of 81% ee 
(Scheme 5.14).
h2n
0.2 mol% [Rh(acac)(CO)2] 
0.4 mol% PPh3] 5 mol% 5, 
.OMe Et-HEH, 4 A MS, Toluene, 
11 bar syngas, 50 °C, 2 d
41% yield, 81% ee
Scheme 5.14: Preliminary study on the metal- and organo-catalysed asymmetric 
hydroaminomethylation.
Encouraged by this result, optimisation of conditions was then undertaken 
for an improvement in the yield. First, the effect of the HEH was studied. The 
results are listed in Table 5.1. The reaction takes place under syngas pressure;
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therefore H2 could act as the reductant for the hydrogenation step. However, 
the experiments show that the presence of HEH is essential in this reaction 
(entry 1). An excess of Et-HEH provides a positive effect on the yield (entry 2 
vs entry 3). A bulkier /Bu-HEH 7 provided an increase in the enantioselectivity 
for the DARA of a-branched aldehydes.37 We therefore studied the effect of 7 
on this procedure. Unfortunately, very low yield was obtained (entry 5). A 
decrease in the activity with bulkier HEH’s was also observed by List et al?1
Table 5.1: Effect of Hantzsch ester on the asymmetric hydroaminomethylation ofp- 
methylstyrene with /?-amsidine,a
IBuOoC, COgtBu
Entry Eqs. Et-HEH Yield (%)b Ee (%)c
1 - N.R.d N.D.e
2 1.2 40 81
3 2.2 67 80
4 4.0 64 80
5 1.2 eq 7 <10 N.D.e
JT --------------J J ——
mmol jy-anisidine, 1.25 jmimol [Rh(acac)(CO)2]5 2.5 
j-immol PPh3, Et-HEH (unless otherwise specified), 12.5 
pmmol 5, 100 mg 4 A MS, 4 mL toluene, 11 bar CO/H2 
1:1, 50 °C, 2 d. bIsolated yield. ^Determined by HPLC. 
dN.R., no reaction. CN.D., not detennined.
The effect of the temperature was also studied. The optimal temperature 
for the hydroformylation step is 50 °C,36 while better enantioselectivities are
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obtained a low temperature of 6 °C for the reductive amination step in the 
organocatalysis.37 There was indeed an increase in enantioselectivity when the 
temperature was dropped to 25 °C; however, the hydroformylation did not 
reach completion after 3 days (Table 5.2, entry 2). A higher temperature of 80 
°C led to higher yield but a slight decrease in enantioselectivity (entry 3). A 
temperature of 50 °C was finally chosen that offered good enantioselectivities 
whilst still maintaining a reasonable rate of reaction.
Table 5.2: Effect of temperature on the asymmetric hydroaminomethylation of p- 
methylstyrene with /?-anisidine.a
Entry Temp. (°C) Time (d) Yield (%)b Ee (%)c
1 50 2 40 81
2 25 3 24 83
3 80 2 55 79
“Reaction conditions were the same as those in Table 5.1 except with 
0.6 mmol Et-HEH, temperature and time. isolated yield. 
“Determined by HPLC.
Table 5.3 shows the effect of the phosphines ligand in this asymmetric 
hydroaminomethylation procedure. Monophosphine ligands are in general 
superior compared to diphosphine ligands (entries 1-3 vs 4-8). Within 
derivatives of PPI13, a more electron-donating substituent in the ligand leads to 
an increase in yield (entry 8), while an electron-deficient substituent has a 
negative effect on the yield (entry 7). We can rationalise that the increase in 
yield results from a higher selectivity for the branched aldehyde in the
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hydroformylation step. Moser and co-workers showed that />electron-donating 
groups in the phosphine increase the basicity of the phosphine and the 
selectivity for a-branched aldehydes.38
Table 5.3: Effect of the ligand on the asymmetric hydroaminomethylation of /;-methylstyrene
with ^-anisidine.0
Entry Ligand Yield (%)b
1 DPPP N.R.C
2 DPPB N.R.C
3 XANTPHOS 20
4 8 <5
5 9 43
6 PPI13 30
7 (4-CF3C6H4)3P 25
8 (4-MeOC6H4)3P 48
Reactions conditions were the same as those 
in Table 5.1 except with different phosphine 
ligand, 0.6 mmol Et-HEH and 17 hours 
reaction time. bIsolated yield. CN.R., no 
reaction, only linear product obtained.
The generality of the methodology is shown in Tables 5.4 and 5.5, using a 
range of styrenes and anilines under the optimised conditions. Table 5.4 shows 
the effect of substituents at the aniline on the hydroaminomethylation of p- 
methylstyrene. All the products 6b-f were obtained with good
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enantioselectivity (78-86% ee). Better enantioselectivities were obtained when 
more sterically-hindered anilines were used (entry 1 vs 2, entry 3 vs 4). This 
observation was previously shown in the DARA of ketones.39'40 Lower yield 
was obtained when using electron-deficient p-bromoaniline (entry 5). This was 
also obscived by List in the organocatalytic DARA of a-branched aldehydes 
by DKR37 and in transition metal-41 and organo-catalysed42'43 DARA of 
ketones, previously described in Chapter 2.
Table 5.4: Asymmetric hydroaminomethylation of /^-methylstyrene with different anilines.a
[Rh], HER, 
CO/Ho
Product Yield
p-OMe
Reactions conditions were the same as those in Table 5.1 except with 0.25 mmol
aniline derivative, 2.5 pmmol ^-CITjOCglLLP, 0.6 mmol Et-HEH and 3 d reaction 
time, isolated yield, determined by HPLC.
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We next investigated the asymmetric hydroaminomethylation of different 
derivatives of styrene with aniline and its analogues (Table 5.5). Good yields 
and enantioselectivities were obtained in general. A lower yield was obtained 
when using an o/^o-substituted styrene (entry 4). This is due to the 
branched/linear (b:l) selectivity in the hydrofonnylation step being lower as a 
result of steric effects, with the ortho substituent inhibiting the formation of the 
benzylic Rh-species that would favour producing the branched aldehyde.44'45 hi 
fact, when hydrofonnylation of ^-methyl and o-methylstyrene was compared, 
the n/iso selectivity decreased from 1:13.3 to 1:6.7.
Table 5.5: Asymmetric hydroaminomethylation of different derivatives of styrene.3
1 H p-OUQ
2 o-Me w-OMe
3 w-Me /?-OMe
4 m-Me m-OMe
5 ?«-Me H
80 83
49 91
61 80
78 84
56 80
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Reactions conditions were the same as those in Table 5.1 except with 0.4 mmol styrene 
derivative, 0.25 mmol aniline derivative, 2.5 pinmol ^-CI-^OQTLOaP, 0.6 mmol Et-HEH and 
3 d reaction time, isolated yield, determined by HPLC. dN.D,, not determined. e2- 
vinylnaphthalene (R: 3,4-C4H4) used as olefin.
Similar to what is shown in Table 5.4, electron-deficient groups in the 
aniline ring have a negative effect on the yield (Table 5.5, entries 3, 6, 9-10). 
This is likely to result from an inefficient condensation reaction of the aniline 
with the aldehyde.37,43 The same could be expected from electron-deficient 
groups in the styrene ring (entries 8-10).37 However, higher selectivities for the 
branched aldehyde in the hydroformylation step are expected with electron- 
withdrawing groups in the styrene.46 This could explain the good yield 
obtained for product 6n (entry 8).
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5.3 Conclusions and Future work
The synthesis of p-chiral amines has been achieved with good yields and 
enantioselectivities following a tandem hydroformylation/reductive amination 
procedure. To our knowledge, this is the first example of an asymmetric 
version of this sequential procedure. This first asymmetric 
hydroaminomethylation is made feasible by combining metal- and organo- 
catalysis in a tandem fashion. This provides an attractive pathway for the 
synthesis of P-chiral amines, as they can be obtained in one step from 
commercially available starting materials.
The main drawbacks of organocatalytic reduction with HEH as hydrogen 
source are the long reaction times required, as well as the production of 
stoichiometric amounts of pyridine by-product. A single chiral organometallic 
complex to catalyse the three steps will be more desirable. This would lead to a 
greener procedure where H2 would be the only hydrogen source.
5. 4 Experimental
General procedure for the synthesis of racemic mixtures of 6a-p
MeO
To a glass liner equipped with a stir bar was added alkene (5 mmol), 
[Rh(acac)(CO)2] (25 pmol), (^-MeOCeH^P (50 pmol) and toluene (2 mL).
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The glass liner was then placed into an autoclave, followed by degassing with 
syngas three times. The reaction was carried out at 11 bar syngas with stirring 
at 50 °C overnight. The stirring was then stopped, and the autoclave allowed to 
cool down to room temperature. The syngas was then carefully released in a 
fume hood and the solution was filtered through celite, transferred to a flask, 
and concentrated to afford the crude product. Flash chromatography 
purification with a column of silica gel eluted with petroleum ether/ethyl 
acetate (50/1) yielded the desired aldehyde product 10.
To an oven-dried Schlenk tube equipped with a stir bar was added 10 (0.5 
mmol), amine (0.5 mmol) and 11 (5 pmol).47 The tube was degassed with 
nitrogen three times. MeOH (4 mL) was then added with syringe, followed by 
HCOOH/EtsN (5:2, 1 mL). The resulting mixture was stirred at 80 °C for 3 
hours. The stirring was then stopped, and the reaction mixture allowed to cool 
down to room temperature. The reaction was then quenched with water and 
basifled with satmated KOH(aq) solution, extracted with ethyl acetate and dried 
over MgS04. Flash chromatography purification with a column of silica gel 
eluted with petroleum ether/ethyl acetate (15/1) yielded the racemic mixtures 
of 6a-p.
General procedure for asymmetric hydroaminomethylation
To a glass liner equipped with a stir bar was added 4 A MS (100 mg), 
alkene (0.4 mmol), amine (0.25 mmol), [Rli(acac)(CO)2] (1.25 pmol), (4-MeO- 
(2.5 pmol), Et-HEH (0.6 mmol), 5 (12.5 pmol) and toluene (2 mL). 
The glass liner was then placed into an autoclave, followed by degassing with
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syngas three times. The reaction was carried out at 11 bar syngas with stirring 
at 50 °C for 3 d. The stirring was then stopped, and the autoclave allowed to 
cool down to room temperature. The syngas was then carefully released in a 
fume hood and the solution was filtered through celite, transferred to a flask, 
and concentrated to afford the crude product. Flash chromatography 
purification with a column of silica gel eluted with petroleum ether/ethyl 
acetate (40/1 to 30/1) yielded the desired amine product.
5.5 Analytical data
Aldehydes lOa-f were synthesised as intermediates for the preparation of 
racemic mixtures of amines 6a-p. They are known compounds; therefore, only
1 13H and C NMR spectra have been acquired. Compounds 6c-n are new 
compounds.
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10a
2-/7-Tolylpropanal.37 The product (0.46 g, 62% yield) was obtained as a 
colourless oil according to the general procedure in 5 h;
NMR (400 MHz, CDC13) 8 1.33 (d, J= 7.0 Hz, 3H), 2.26 (s, 3H), 3.51 (qd, 
J= 7.0, 1.4 Hz, 1H), 7.01 (d, J= 8.0 Hz, 2H), 7.10 (d, J= 8.0 Hz, 2H), 9.57 (d, 
J= 1.4 Hz, 1H);
13C NMR (100 MHz, CDC13) 5 14.6, 21.1, 52.7, 128.2, 129.8, 134.6, 137.3, 
201.4.
10b
2-w-Tolylpropanal48 The product (0.50 g, 67% yield) was obtained as a 
colourless oil according to the general procedure in 5 h;
XH NMR (400 MHz, CDC13) 5 1.43 (d,J= 7.0 Hz, 3H), 2.36 (s, 3H), 3.59 (qd, 
J= 7.0, 1.3 Hz, 1H), 7.00-7.02 (m, 2H), 7.12 (dd, J= 7.8, 0.5 Hz, 1H), 121 (t, 
J= 7.8 Hz, 1H), 9.67 (d, J= 1.3 Hz, 1H);
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13C NMR (100 MHz, CDC13) § 15.0, 21.8, 53.4, 125.8, 128.7, 129.4, 129.5, 
138.0, 139.2, 201.6.
10c
2-0-Tolylpropanal.49 The product (0.33 g, 45% yield) was obtained as a 
colourless oil according to the general procedure in 5 h;
^ NMR (400 MHz, CDC13) 5 1.65 (d, 7.0 Hz, 3H), 2.37 (s, 3H), 3.85 (q, J
= 7.0 Hz, 1H), 7.05-7.09 (m, 1H), 7.18-7.26 (m, 3H), 9.66 (d, J= 1.1 Hz, 1H); 
13C NMR (100 MHz, CDC13) 5 14.3, 19.6, 49.3, 126.0, 127.4, 127.5, 130.9, 
136.3, 136.6, 201.0.
2-(4-Methoxyphenyl)propanal.50 The product (0.53 g, 64% yield) was obtained 
as a colourless oil according to the general procedure in 5 h;
^ NMR (400 MHz, CDC13) 5 1.41 (d, J= 7.1 Hz, 3H), 3.58 (qd, J= 7.1, 1.5 
Hz, 1H), 3.80 (s, 3H), 6.89-6.93 (m, 2H), 7.11-7.14 (m, 2H), 9.64 (d, 1.5
Hz, 1H);
I3C NMR (100 MHz, CDC13) 5 14.6, 52.1, 55.3, 114.5, 129.3, 129.5, 159.0, 
201.2;
10e
2-(4-(Trifluoromethyl)phenyl)propanal.50'51 The product (0.73 g, 72% yield) 
was obtained as a colourless oil according to the general procedure from in 5 h; 
*H NMR (400 MHz, CDC13) 5 1.49 (d, J=1A Hz, 3H), 3.73 (qd, 7.1, 1.2 
Hz, 1H), 7.34 (d, J= 8.1 Hz, 2H), 7.65 (d, J= 8.1 Hz, 2H), 9.70 (d, J= 1.2 Hz, 
1H);
13C NMR (100 MHz, CDC13) 5 15.0, 53.1, 126.4 (q, Jcf = 3.7 Hz), 127.1 (q, 
Jcf = 270.6 Hz), 129.1, 130.3 (q, Tcf = 31.7 Hz), 142.2,200.5;
H
10f
2-(Naphthalen-2-yl)propanal.37 The product (0.52 g, 56% yield) was obtained 
as a white solid according to the general procedure in 17 h;
!H NMR (400 MHz, CDC13) 5 1.54 (d, 7.0 Hz, 3H), 3.82 (qd, 7.0, 1.2
Hz, 1H), 7.32 (dd, J= 8.4, 1.8 Hz, 1H), 7.46-7.53 (m, 2H), 7.68 (d, J= 0.7 Hz, 
1H), 7.82-7.88 (m, 3H), 9.77 (d, /= 1.2 Hz, 1H);
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13C NMR (100 MHz, CDCI3) 5 15.1, 53.5, 117.7, 126.5, 126.6, 126.9, 127.6, 
128.1, 129.3, 133.1, 134.0, 135.5,201.5;
4-Methoxy-77-(2-phenylpropyl)aniline.37 The product (45 mg, 74% yield, 83% 
ee) was obtained as a colourless oil according to the general procedure in 3 d; 
'H NMR (400 MHz, CDC13) 5 1.32 (d, J= 7.0 Hz, 3H), 3.00-3.08 (m, 1H), 
3.19 (dd, A of ABX, Jm = 12.2 Hz, = 8.3 Hz, 1H), 3.30 (dd, B of ABX, 
■4b = 12.2 Hz, JBx = 6.1 Hz, 1H), 3.74 (s, 3H), 6.52-6.56 (m, 2H), 6.74-6.77 
(m, 2H), 7.21-7.25 (m, 3H), 7.30-7.35 (m, 2H);
13C NMR (100 MHz, CDCI3) 5 19.8, 39.2, 52.0, 55.8, 114.4, 114.9, 126.6, 
127.3, 128.7, 142.4, 144.6, 152.1;
HRMS for Ci6H2oNO [M+H]+: Calcd: 242.1539; Found: 242.1537;
HPLC (Chiralcel OJ, hexane:isopropanol = 90:10, flow rate 0.5 mL/min, X = 
254 mu): tR = 19.6 min (minor), tR = 23.1 min (major).
4-Methoxy“jV“(2-/?-tolylpropyl)aniline.37 The product (50 mg, 79% yield, 80% 
ee) was obtained as a colourless oil according to the general procedure in 3 d; 
^ NMR (400 MHz, CDC13) 5 1.30 (d, 7= 7.0 Hz, 3H), 2.33 (s, 3H), 2.98-3.05 
(m, 1H), 3.16 (dd, A of ABX, Tab = 12.1 Hz, Tax = 8.4 Hz, 1H), 3.28 (dd, B of 
ABX, Tab = 12.1 Hz, TBx = 6.2 Hz, 1H), 3.74 (s, 3H), 6.53-6.57 (m, 2H), 6.74- 
6.78 (m, 2H), 7.10-7.15 (m, 4H);
13C NMR (100 MHz, CDC13) 5 20.0, 21.1, 38.8, 52.1, 55.8, 114.4, 114.9, 
127.2, 129.4, 136.1, 141.6, 142.4, 152.1;
HRMS for C17H22NO [M+H]+: Calcd: 256.1701; Found: 256.1706;
HPLC (Chiralcel OJ, hexane:isopropanol = 90:10, flow rate 0.5 mL/min, X = 
254 nm): tR = 16.5 min (minor), tR = 18.7 min (major).
3-Methoxy-A-(2-;j>-tolylpropyl)aniline. The product (53 mg, 83% yield, 84% 
ee) was obtained as a colourless oil according to the general procedure in 3 d; 
^ NMR (400 MHz, CDC13) 5 1.31 (d, 7= 6.9 Hz, 3H), 2.33 (s, 3H), 2.97-3.06 
(m, 1H), 3.19 (dd, A of ABX, Tab = 12.2 Hz, Tax = 8.3 Hz, 1H), 3.30 (dd, B of 
ABX, JAB = 12.2 Hz, TBx = 6.2 Hz, 1H), 3.75 (s, 3H), 6.13 (t, 7= 2.1 Hz, 1H), 
6.18 (dd, T = 8.1, 2.1 Hz, 1H), 6.25 (dd,7= 8.1, 2.1 Hz, 1H), 7.05 (t, 7= 8.1 
Hz, 1H), 7.10-7.15(m, 4H);
13C NMR (100 MHz, CDC13) 5 18.5, 21.0, 38.8, 50.9, 55.1, 98.8, 102.4, 106.1, 
127.1, 129.3, 129.9, 136.1, 141.4, 149.5, 160.8;
HRMS for C17H22NO [M+H]+: 111/z Calcd: 256.1696; Found: 256.1698;
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HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X = 
254 mn): tR = 30.1 min (minor), 1r = 37.2 min (major).
3-Methyl-N-(2-Jtf-tolylpropyl)aniline. The product (52 mg, 87% yield, 78% ee) 
was obtained as a clear yellow oil according to the general procedure in 3 d;
^ NMR (400 MHz, CDC13) 5 1.31 (d, 7.0 Hz, 3H), 2.26 (s, 3H), 2.34 (s,
3H), 2.97-3.05 (m, 1H), 3.19 (dd, A of ABX, /AB = 12.2 Hz, Ax = 8.3 Hz, 
1H), 3.31 (dd, B of ABX, Jm = 12.2 Hz, JBx = 6.2 Hz, 1H), 3.52 (brs, 1H), 
6.38-6.39 (m, 2H), 6.51 (d, /= 7.4 Hz, 1H), 7.02-7.06 (m, 1H), 7.11-7.15 (m, 
4H);
13C NMR (100 MHz, CDC13) 5 20.0, 21.2, 21.8, 39.0, 51.1, 110.2, 113.9, 
118.4, 127.3, 129.2, 129.5, 136.2, 139.0, 141.7, 148.4;
HRMS C17H22N [M+Hf: Calcd: 240.1747; Found: 240.1744;
HPLC (Chiralcel OD-H, hexane:isopropanol — 99.8:0.2, flow rate 1 mL/min, A, 
= 254 mn): tR = 20.2 min (minor), tR = 20.9 min (major).
2-Methyl-iV-(2-/?-tolylpropyl)aniline. The product (36 mg, 61% yield, 86% ee) 
was obtained as a colourless oil according to the general procedure in 3 d;
^ NMR (400 MHz, CDC13) 5 1.34 (d, J= 6.9 Hz, 3H), 1.93 (s, 3H), 2.33 (s, 
3H), 3.04-3.09 (m, 1H), 3.19 (dd, A of ABX, JAB = 11.9 Hz, Ax = 8.4 Hz, 
1H), 3.37 (dd, B of ABX, Ab = 12.0 Hz, Ax = 5.8 Hz, 1H), 3.43 (brs, 1H), 
6.64 (d, J= 7.7 Hz, 2H), 7.00, (d, J= 7A Hz, 1H), 7.10-7.12 (m, 5H);
13C NMR (100 MHz, CDC13) 5 17.2, 19.6, 21.0, 38.7, 51.0, 109.9, 116.8, 
122.1, 127.1, 129.4, 129.5, 130.0,136.2, 141.4, 146.1;
HRMS for Ci7H22N [M+H]+: Calcd: 240.1747; Found: 240.1746;
HPLC (Chiralcel OD-H, hexane :isopropanol = 99:1, flow rate 1 mL/min, A = 
254 mn): tR = 7.2 min (major), tR = 7.9 min (minor).
4-Bromo-A-(2-p-tolylpropyl)aniline. The product (34 mg, 45% yield, 79% ee) 
was obtained as a clear oil according to the general procedure in 3 d;
‘H NMR (400 MHz, CDC13) 5 1.30 (d, J= 7.0 Hz, 3H), 2.33 (s, 3H), 2.95-3.03 
(m, 1H), 3.15 (dd, A of ABX, Ab = 12.3 Hz, Ax = 8.5 Hz, 1H), 3.28 (dd, B of 
ABX, Ab = 12.3 Hz, Ax = 6.0 Hz, 1H), 3.57 (brs, 1H), 6.41-6.44 (m, 2H), 
7.08-7.14 (m, 4H), 7.19-7.23 (m, 2H);
13C NMR (100 MHz, CDC13) 5 19.8, 21.0, 38.7, 50.9, 108.8, 114.5, 127.5, 
129.4, 131.9, 136.3, 141.1, 147.1;
HRMS forCi6H]979BrN [M+H]+: Calcd: 304.0701; Found: 304.0704;
195
Chapter 5: Metal- and Organo-Catalysed Asymmetric Hydroaminomethylation
HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X = 
254 nm): Ir = 14.7 min (minor), 1r = 15.3 min (major).
3-Metlioxy-AL(2-(o-tolyl)propyl)aniline. The product (31 mg, 49% yield, 91% 
ee) was obtained a pale yellow oil according to the general procedure in 3 d;
^ NMR (400 MHz, CDC13) S 1.21 (d, /= 6.4 Hz, 3H), 2.24 (s, 3H), 3.18-3.32 
(m, 3H), 3.54 (brs, 1H), 3.68 (s, 3H), 6.06 (t, J= 2.2 Hz, 1H), 6.11 (dd, 8.0, 
1.5 Hz, 1H), 6.18 (dd, 8.0, 2.2 Hz, 1H), 6.98 (t, ./= 8.0 Hz, 1H), 7.04-7.11 
(m, 2H), 7.13-7.15 (m, 2H);
13C NMR (100 MHz, CDC13) 6 19.6 (2C), 34.2, 50.2, 55.1, 98.8, 102.5, 106.0, 
125.3, 126.2, 126.5,129.9, 130.5, 136.2, 142.6, 149.6,160.9;
HRMS for C17H22NO [M+H]+: Calcd: 256.1701; Found: 256.1703;
HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X = 
254 nm): tR = 41.3 min (minor), tR = 52.7 min (major).
4-Methoxy-AL(2-w-tolylpropyl)aniline. The product (39 mg, 61% yield, 80% 
ee) was obtained as a pale yellow oil according to the general procedure in 3 d; 
^ NMR (400 MHz, CDC13) 5 1.31 (d, 7.0 Hz, 3H), 2.35 (s, 3H), 2.97-3.03
(m, 1H), 3.18 (dd, A of ABX, Jab = 12.1 Hz, JAx = 8.3 Hz, 1H), 3.28 (dd, B of 
ABX, Jab = 12.1 Hz, JBx = 6.1 Hz, 1H), 3.74 (s, 3H), 6.53-6.57 (m, 2H), 6.74- 
6.78 (m, 2H), 7.01-7.06 (m, 3H), 7.21 (d, J= 8.2 Hz, 1H);
13C NMR (100 MHz, CDC13) 5 20.0, 21.6, 39.3, 52.1, 55.9, 114.5, 115.0, 
124.4, 127.5, 128.1, 128.7,138.4,142.5,144.7, 152.2;
HRMS for Cn^NO [M+H]+: Calcd: 256.1701; Found: 256.1700;
HPLC (Chiralcel OD-H, hexane:isopropanol = 99:1, flow rate 0.5 mL/min, X = 
254 nm): tB = 42.7 min (major), tR = 49.9 min (minor).
3~Methoxy-jV-(2-(/?7-tolyl)propyl)aniline. The product (50 mg, 78% yield, 84% 
ee) was obtained as a pale yellow oil according to the general procedure in 3 d; 
‘H NMR (400 MHz, CDC13) 5 1.24 (d, J= 7.0 Hz, 3H), 2.27 (s, 3H), 2.89-2.98 
(m, 1H), 3.14 (dd, A of ABX, Jab = 12.3 Hz, Jax = 8.3 Hz, 1H), 3.23 (dd, B of 
ABX, Jab = 12.3 Hz, JBx = 6.2 Hz, 1H), 3.53 (brs, 1H), 3.68 (s, 3H), 6.06 (t, J 
= 2.3 Hz, 1H), 6.11 (dd, J = 8.1, 2. Hz, 1H), 6.18 (dd, J= 8.1, 2.3 Hz, 1H), 
6.94-7.00 (m, 4H), 7.15 (t, J= 7.7 Hz, 1H);
13C NMR (100 MHz, CDC13) 5 19.8, 21.5, 39.2, 50.9, 55.1, 98.9, 102.5, 106.2, 
124.3, 127.4, 128.0, 128.6, 129.9, 138.3, 144.4, 149.5, 160.8;
HRMS for C17H22NO [M+H]+: Calcd: 256.1701; Found: 256.1703;
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HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X = 
254 rnn): tR = 37.8 min (minor), tR = 47.9 min (major).
7V-(2-w-Tolylpropyl)aniline. The product (32 mg, 56% yield, 80% ee) was 
obtained as a colourless oil according to the general procedure in 3 d;
'H NMR (400 MHz, CDC13) 5 1.24 (d, J= 7.0 Hz, 3H), 2.27 (s, 3H), 2.89-2.98 
(m, 1H), 3.14 (dd, A of ABX, Jab = 12.1 Hz, Jax = 8.3 Hz, 1H), 3.24 (dd, B of 
ABX, JAb = 12.2 Hz, JBx = 6.2 Hz, 1H), 3.49 (brs, 1H), 6.49 (dd, J= 8.4, 0.9 
Hz, 2H), 6.61 (t, J= 7.3 Hz, 1H), 6.96 (t, J= 8.4 Hz, 3H), 7.08-7.12 (m, 2H), 
7.14-7.16 (m, 1H);
13C NMR (100 MHz, CDC13) 5 19.9, 21.5, 39.2, 50.9, 113.0, 117.3, 124.3, 
127.4, 128.0, 128.6, 129.3, 138.3, 144.5, 148.2;
MS (Cl) for C16H20N [M+H]+: m/z 226 (100%);
Anal Calcd for Ci6H]9N: C, 85.28; H, 8.50; N, 6.22. Fomid: C, 84.71; H, 8.83; 
N, 6.42.
HPLC (Chiralcel OD-H, hexane:isopropanol = 99.5:0.5, flow rate 4 mL/min, X 
= 254 nm): tR = 11.3 min (minor), tR — 12.3 min (major).
MeCr"^ 6k
iV-(2-(4-Methoxyphenyl)propyl)-4-methylaniline. The product (39 mg, 61% 
yield, 82% ee) was obtained as a colourless oil according to the general 
procedure in 3 d;
% NMR (400 MHz, CDC13) 5 1.29 (d, J= 6.9 Hz, 3H), 2.23 (s, 3H), 2.96-3.04 
(m, 1H), 3.15 (dd, A of ABX, JAb = 12.2 Hz, Jax = 8.4 Hz, 1H), 3.29 (dd, B of 
ABX, Jab = 12.2 Hz, JBx = 6.0 Hz, 1H), 3.80 (s, 3H), 6.48-6.51 (m, 2H), 6.85- 
6.88 (m, 2H), 6.97 (d, J= 8.4 Hz, 2H), 7.12-7.16 (m, 2H);
13C NMR (100 MHz, CDC13) 5 20.0, 20.4, 38.4, 51.5, 55.3, 113.2, 114.1, 
126.5, 128.2, 129.7, 136.6, 145.9, 158.3;
HRMS for C17H22NO [M+H]+: Calcd: 256.1701; Found: 256.1700;
HPLC (Chiralcel OD-H, hexane:isopropanol = 98.5:1.5, flow rate 0.5 mL/min, 
X = 254 nm): tR = 19.9 min (minor), tR = 22.2 min (major).
MeO 61 Br
4-Bromo-A-(2-(4-methoxyphenyl)propyl)aniline. The product (41 mg, 51% 
yield, 84% ee) was obtained as a pale yellow oil according to the general 
procedure in 3 d;
^ NMR (400 MHz, CDC13) 5 1.30 (d, J= 6.9 Hz, 3H), 2.94-3.03 (m, 1H), 
3.13 (dd, A of ABX, Jab = 12.2 Hz, JAx = 8.6 Hz, 1H), 3.28 (dd, B of ABX,
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Jab = 12.2 Hz, JBx = 6.0 Hz, 1H), 3.80 (s, 3H), 6.41-6.45 (m, 2H), 6.86-6.88 
(m, 2H), 7.11-7.14 (m, 2H), 7.20-7.24 (m, 2H);
13C NMR (100 MHz, CDC13) 5 20.3, 38.7, 51.4, 55.7, 109.2, 114.5, 114.9, 
128.5, 132.3, 136.6, 147.5, 158.8;
HRMS for C16Hi9BrNO [M+H]+: Calcd: 320.0650; Found: 320.0659;
HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X = 
254 mn): tR = 23.0 min (minor), tR = 27.3 min (major).
4-Methoxy-iV-(2-(4-(trifluoromethyl)phenyl)propyl)aniline. The product (54 
mg, 70% yield, 81 % ee) was obtained as a colourless oil according to the 
general procedure in 3 d;
rH NMR (400 MHz, CDC13) 5 1.34 (d, J= 6.9 Hz, 3H), 3.08-3.17 (m, 1H), 
3.22 (dd, A of ABX, JAB = 12.4 Hz, Jax = 8.2 Hz, 1H), 3.33 (dd, B of ABX, 
Jab = 12.4 Hz, JBx = 6.0 Hz, 1H), 3.75 (s, 3H), 6.52-6.56 (m, 2H), 6.75-6.79 
(m, 2H), 7.33 (d, J= 8.1 Hz, 2H), 7.58 (d, J= 8.1 Hz, 2H);
13C NMR (100 MHz, CDC13) 6 19.5, 39.2, 51.8, 55.8, 114.5, 115.0, 124.3 (q, 
Jcf = 268.9 Hz), 125.6 (q, JCf = 3.6 Hz), 127.8,128.9 (q, JCf = 21.1 Hz), 141.9, 
148.9, 152.3;
HRMS for CifiHisBrNO [M+H]+: Calcd: 310.1419; Found: 310.1419;
HPLC (Chiralcel OD-H, hexane:isopropanol = 98:2, flow rate 0.5 mL/min, X = 
254 mn): tR = 27.1 min (major), tR = 29.9 min (minor).
vV-(2-(4-(Trifluoromcthyl)phenyl)propyl)aniline. The product (39 mg, 56% 
yield, 79% ee) was obtained as a colourless oil according to the general 
procedure in 3 d;
^ NMR (400 MHz, CDC13) 5 1.35 (d, J= 6.9 Hz, 3H), 3.09-3.18 (m, 1H), 
3.26 (dd, A of ABX, JAB - 12.6 Hz, Jax = 8.3 Hz, 1H), 3.37 (dd, B of ABX, 
Jab = 12.6 Hz, JBX = 6.2 Hz, 1H), 3.52 (brs, 1H), 6.56-6.59 (m, 2H), 6.64-6.72 
(m, 1H), 7.14-7.19 (m, 2H), 7.33 (d, J= 8.1 Hz, 2H), 7.58 (d, J= 8.1 Hz, 2H); 
13C NMR (100 MHz, CDC13) 6 19.6, 38.6, 50.7, 112.9, 117.6, 125.6 (q, JCf = 
3.8 Hz), 127.2 (q, JCf = 289.9 Hz), 127.6, 129.0 (q, Jcf = 32.1 Hz), 129.3, 
147.7, 148.7;
HRMS for Ci6H17F3N [M+H]+: Calcd: 280.1313; Found: 280.1707;
HPLC (Chiralcel OD-H, hexaneusopropanol = 98:2, flow rate 0.5 mL/min, X = 
254 mn): tR = 29.3 min (minor), tR = 33.7 min (major).
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4-Methoxy-7V-(2-(naplithalen-2-yl)propyl)aniline.37 The product (59 mg, 81% 
yield, 83% ee) was obtained as a pale yellow oil according to the general 
procedure in 3 d;
% NMR (400 MHz, CDC13) 5 1.41 (d, 6.8 Hz, 3H), 3.18-3.26 (m, 1H),
3.29 (dd, A of ABX, JAb = 12.0 Hz, /ax = 8.4 Hz, 1H), 3.39 (dd, B of ABX, 
Jab = 12.0 Hz, JBx = 5.7 Hz, 1H), 3.74 (s, 3H), 6.52-6.56 (m, 2H), 6.74-6.78 
(m, 2H), 7.37 (dd, J= 8.5, 1.7 Hz, 1H), 7.43-7.50 (m, 2H), 7.66 (s, 1H), 7.79- 
7.83 (m, 3H);
13C NMR (100 MHz, CDC13) 5 19.9, 39.4, 51.8, 55.8, 114.4, 114.9, 125.5, 
125.9, 126.1, 127.6(2), 127.6(4), 128.4, 130.2, 132.5, 133.6, 142.0, 142.3, 
152.1;
HRMS for C20H22NO [M+H]+: Calcd: 292.1701; Found: 292.1711;
HPLC (Chiralcel OD-H, hexanedsopropanol = 98:2, flow rate 0.5 mL/min, X = 
254 nm): tR = 36.4 min (major), tR = 39.3 min (minor).
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Chapter 6
Conclusions and Perspectives
This thesis describes different methodologies for the synthesis of amines, 
in particular a- and P-chiral amines. Overall, several strategies have been 
developed, leading to the synthesis of chiral amines, i.e. a-chiral amines from 
aliphatic ketones, a chiral iV-benzyl amine and p-chiral amines. These 
substrates have been historically considered as “challenging”, and the literature 
describing their synthesis is limited. Scheme 1 summarises all the strategies 
and catalysts developed during this PhD research.
Scheme 1: Different strategies for the synthesis of amines developed during this research.
The synthesis of a-chiral amines from aliphatic ketones has been achieved 
via DARA with an Ir-diamine/phosphate complex. The catalytic system is 
based on the cooperative catalysis of the hydrogen-activating metal cation and 
a Bronsted acid. The DARA takes place under mild conditions of temperature 
and pressure, showing excellent yields and enantioselectivities. However, this
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methodology had two main challenges: the ineffectiveness of DARA with 
aliphatic amines, in particular benzylamine; and the poor enantiocontrol for the 
synthesis of p-chiral amines by DARA of a-branched aldehydes. This 
prompted us to explore new catalytic systems and pathways to overcome these 
drawbacks.
The problem in the synthesis of chiral JV-benzyl amines was then 
addressed. Initially, achiral cyclometallated iridium complexes were found to 
be excellent catalysts for imine hydrogenation, presenting high activity and a 
wide scope of substrates. Chiral analogues of cyclometallated iridium catalysts 
were subsequently developed, providing enantioselectivity up to 78% ee in the 
hydrogenation of an JV-benzyl imine.
Finally, a tandem strategy that involves hydroformylation and subsequent 
reductive amination was proposed for the synthesis of p-chiral amines. Styrene 
is selectively hydroformylated to the corresponding a-branched aldehyde with 
a Rh-phosphine catalyst; DARA of this a-branched aldehyde with aromatic 
amines takes place in situ, catalysed by a chiral Bronsted acid. Good yields and 
enantioselectivities have been obtained. To our knowledge, this is the first 
example of an asymmetric version of the hydroaminomethylation reaction.
It is hoped that this research work has gone some way towards overcoming 
the challenges associated with the reduction of imino bonds, but new questions 
have also emerged. There still exists a need for a ‘universal’ catalyst that would 
reduce imino bonds derived from aromatic/aliphatic ketones and 
aromatic/aliphatic amines. A greener approach for the asymmetric 
hydroaminomethylation procedure could be achieved by the design of a single
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chiral metal catalyst that uses H2 in the imine/enamine reduction step, hi 
addition, Chapter 1 shows that late transition metals have been dominating the 
area of metal-catalysed asymmetric hydrogenation of imines. An endeavour 
must be made to search for cheap and non-toxic metal catalysts, which would 
give rise to more affordable and sustainable methodology.
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